<SEC-DOCUMENT>0001104659-25-104389.txt : 20251030
<SEC-HEADER>0001104659-25-104389.hdr.sgml : 20251030
<ACCEPTANCE-DATETIME>20251030161608
ACCESSION NUMBER:		0001104659-25-104389
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20251024
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251030
DATE AS OF CHANGE:		20251030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MultiSensor AI Holdings, Inc.
		CENTRAL INDEX KEY:			0001863990
		STANDARD INDUSTRIAL CLASSIFICATION:	OPTICAL INSTRUMENTS & LENSES [3827]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				863962954
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40916
		FILM NUMBER:		251435789

	BUSINESS ADDRESS:	
		STREET 1:		2105 WEST CARDINAL DRIVE
		CITY:			BEAUMONT
		STATE:			TX
		ZIP:			77705
		BUSINESS PHONE:		(866) 861-0788

	MAIL ADDRESS:	
		STREET 1:		2105 WEST CARDINAL DRIVE
		CITY:			BEAUMONT
		STATE:			TX
		ZIP:			77705

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Infrared Cameras Holdings, Inc.
		DATE OF NAME CHANGE:	20231219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sportsmap Tech Acquisition Corp.
		DATE OF NAME CHANGE:	20210524
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2529555d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:MSAI="http://infraredcameras.com/20251024">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_MSAI_infraredcameras.com_20251024 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20251024_20251024 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001863990 -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000005" name="dei:EntityCentralIndexKey">0001863990</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="msai-20251024.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-10-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001863990</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-24</xbrli:startDate>
        <xbrli:endDate>2025-10-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001863990</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">MSAI:CommonStock0.0001ParValuePerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-24</xbrli:startDate>
        <xbrli:endDate>2025-10-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001863990</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">MSAI:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-24</xbrli:startDate>
        <xbrli:endDate>2025-10-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_903_edei--DocumentType_c20251024__20251024_zpWL1gPMj74k"><span id="xdx_90A_edei--DocumentType_c20251024__20251024_zPSsIsSCGgmc"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000011" name="dei:DocumentType"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000012" name="dei:DocumentType">8-K</ix:nonNumeric></ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT<br/>
Pursuant to Section 13 or 15(d) of the<br/>
Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)
<b><span id="xdx_90E_edei--DocumentPeriodEndDate_c20251024__20251024_z94CVeUlv4f3"><span id="xdx_904_edei--DocumentPeriodEndDate_c20251024__20251024_zFPitlhpKe22"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:datemonthdayyearen" id="Fact000013" name="dei:DocumentPeriodEndDate"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:datemonthdayyearen" id="Fact000014" name="dei:DocumentPeriodEndDate">October 24, 2025</ix:nonNumeric></ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20251024__20251024_zcJ083ydwav2"><span id="xdx_90D_edei--EntityRegistrantName_c20251024__20251024_zg7y0cxYG6F4"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000015" name="dei:EntityRegistrantName"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000016" name="dei:EntityRegistrantName">MultiSensor AI Holdings, Inc.</ix:nonNumeric></ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 0.5pt; width: 33%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20251024__20251024_zVAwpnWWEqM7"><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20251024__20251024_ziz2ib2QYYta"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityIncorporationStateCountryCode"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></ix:nonNumeric></span></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction
    of<br/>incorporation)</p></td>
    <td style="padding: 0.5pt; text-align: center; width: 34%; vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_903_edei--EntityFileNumber_c20251024__20251024_zfytzMnnxnW8"><span id="xdx_909_edei--EntityFileNumber_c20251024__20251024_zVx9rfvj6Y67"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000019" name="dei:EntityFileNumber"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000020" name="dei:EntityFileNumber">001-40916</ix:nonNumeric></ix:nonNumeric></span></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Commission File Number)</p></td>
    <td style="padding: 0.5pt; width: 33%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20251024__20251024_zMl2xdoxx8Kf"><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20251024__20251024_zHEDTmihsY25"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000021" name="dei:EntityTaxIdentificationNumber"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000022" name="dei:EntityTaxIdentificationNumber">86-3938682</ix:nonNumeric></ix:nonNumeric></span></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer<br/>
    Identification No.)</p></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20251024__20251024_zhZeY7T6e7T1"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20251024__20251024_z4IUdgGX8qSg"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000023" name="dei:EntityAddressAddressLine1"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000024" name="dei:EntityAddressAddressLine1">2105 West Cardinal Drive</ix:nonNumeric></ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20251024__20251024_zVHGULlMrmDb"><span id="xdx_905_edei--EntityAddressCityOrTown_c20251024__20251024_z7zbEa4KuLL4"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000025" name="dei:EntityAddressCityOrTown"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000026" name="dei:EntityAddressCityOrTown">Beaumont</ix:nonNumeric></ix:nonNumeric></span></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20251024__20251024_zbcNsUtiYWn5"><span id="xdx_904_edei--EntityAddressStateOrProvince_c20251024__20251024_znb4SSjRCVp"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt-sec:stateprovnameen" id="Fact000027" name="dei:EntityAddressStateOrProvince"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt-sec:stateprovnameen" id="Fact000028" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></ix:nonNumeric></span></span>
<span id="xdx_903_edei--EntityAddressPostalZipCode_c20251024__20251024_zibIel9bhAW6"><span id="xdx_909_edei--EntityAddressPostalZipCode_c20251024__20251024_zspDVDsDbepg"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000029" name="dei:EntityAddressPostalZipCode"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000030" name="dei:EntityAddressPostalZipCode">77705</ix:nonNumeric></ix:nonNumeric></span></span>
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)
(Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_906_edei--CityAreaCode_c20251024__20251024_zqm0KddncSq2"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000031" name="dei:CityAreaCode">866</ix:nonNumeric></span>) <span id="xdx_90E_edei--LocalPhoneNumber_c20251024__20251024_zlPnHduyPK6j"><ix:nonNumeric contextRef="AsOf2025-10-24" id="Fact000032" name="dei:LocalPhoneNumber">861-0788</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_902_edei--WrittenCommunications_c20251024__20251024_zVHWrtXg47Ja"><span id="xdx_90C_edei--WrittenCommunications_c20251024__20251024_zVFD8YrhWtFa"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleanfalse" id="Fact000033" name="dei:WrittenCommunications"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleanfalse" id="Fact000034" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td style="width: 98%; font-size: 10pt; text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90E_edei--SolicitingMaterial_c20251024__20251024_zbwtVgeIxNG"><span id="xdx_907_edei--SolicitingMaterial_c20251024__20251024_zTEYUIZRl391"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleantrue" id="Fact000035" name="dei:SolicitingMaterial"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleantrue" id="Fact000036" name="dei:SolicitingMaterial">x</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td style="width: 98%; font-size: 10pt; text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top; text-align: justify">
<td style="width: 2%; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20251024__20251024_zoHxDE7fhVAe"><span id="xdx_908_edei--PreCommencementTenderOffer_c20251024__20251024_z3m3O3OA43Nb"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleanfalse" id="Fact000037" name="dei:PreCommencementTenderOffer"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleanfalse" id="Fact000038" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></ix:nonNumeric></span></span></span></td><td style="text-align: justify; width: 98%">Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 2%; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20251024__20251024_zWs03p0xVtc8"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20251024__20251024_zGnWXjXMT4Ug"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleanfalse" id="Fact000039" name="dei:PreCommencementIssuerTenderOffer"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleanfalse" id="Fact000040" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></ix:nonNumeric></span></span></span></td>
    <td style="width: 98%; font-size: 10pt; text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 0.5pt; width: 34%">
    <p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Title of each
    class</b></p></td>
    <td style="padding: 0.5pt; width: 1%">&#160;</td>
    <td style="padding: 0.5pt; width: 32%">
    <p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Trading Symbol(s)</b></p></td>
    <td style="padding: 0.5pt; width: 1%">&#160;</td>
    <td style="padding: 0.5pt; width: 32%">
    <p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Name of each
    exchange<br/>
    on which registered</b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.5pt; text-align: center"><span id="xdx_901_edei--Security12bTitle_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.0001ParValuePerShareMember_zEJUMEz75l7e"><span id="xdx_908_edei--Security12bTitle_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.0001ParValuePerShareMember_zYpaHWjFmyHe"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember" id="Fact000041" name="dei:Security12bTitle"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember" id="Fact000042" name="dei:Security12bTitle">Common stock, $0.0001 par value per share</ix:nonNumeric></ix:nonNumeric></span></span></td>
    <td style="padding: 0.5pt">&#160;</td>
    <td style="padding: 0.5pt; text-align: center"><span id="xdx_90D_edei--TradingSymbol_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.0001ParValuePerShareMember_zJ5GB1wKLkyc"><span id="xdx_900_edei--TradingSymbol_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.0001ParValuePerShareMember_zZKGybLCYLKd"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember" id="Fact000043" name="dei:TradingSymbol"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember" id="Fact000044" name="dei:TradingSymbol">MSAI</ix:nonNumeric></ix:nonNumeric></span></span></td>
    <td style="padding: 0.5pt">&#160;</td>
    <td style="padding: 0.5pt; text-align: center">The <span id="xdx_903_edei--SecurityExchangeName_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.0001ParValuePerShareMember_zgJlOQjlzrb6"><span id="xdx_904_edei--SecurityExchangeName_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.0001ParValuePerShareMember_zxWmoC2Ubk1l"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember" format="ixt-sec:exchnameen" id="Fact000045" name="dei:SecurityExchangeName"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember" format="ixt-sec:exchnameen" id="Fact000046" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></ix:nonNumeric> </span></span>Stock Market, LLC</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.5pt; text-align: center"><span id="xdx_90E_edei--Security12bTitle_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zyUcsnC4gfVc"><span id="xdx_907_edei--Security12bTitle_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zBCBjVxkXmml"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember" id="Fact000047" name="dei:Security12bTitle"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember" id="Fact000048" name="dei:Security12bTitle">Warrants to purchase common stock</ix:nonNumeric></ix:nonNumeric></span></span></td>
    <td style="padding: 0.5pt">&#160;</td>
    <td style="padding: 0.5pt; text-align: center"><span id="xdx_907_edei--TradingSymbol_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zmyWSxpPjhh6"><span id="xdx_900_edei--TradingSymbol_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zpVQ6NYiUD2i"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember" id="Fact000049" name="dei:TradingSymbol"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember" id="Fact000050" name="dei:TradingSymbol">MSAIW</ix:nonNumeric></ix:nonNumeric></span></span></td>
    <td style="padding: 0.5pt">&#160;</td>
    <td style="padding: 0.5pt; text-align: center">The <span id="xdx_909_edei--SecurityExchangeName_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zJgZxIxaHD5h"><span id="xdx_902_edei--SecurityExchangeName_c20251024__20251024__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_z7Z6PcIlAhKj"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember" format="ixt-sec:exchnameen" id="Fact000051" name="dei:SecurityExchangeName"><ix:nonNumeric contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember" format="ixt-sec:exchnameen" id="Fact000052" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></ix:nonNumeric> </span></span>Stock Market, LLC</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20251024__20251024_zbphEPngQXJj"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20251024__20251024_z5XGkgkKLy6g"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleantrue" id="Fact000053" name="dei:EntityEmergingGrowthCompany"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleantrue" id="Fact000054" name="dei:EntityEmergingGrowthCompany">x</ix:nonNumeric></ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings"><span id="xdx_907_edei--EntityExTransitionPeriod_c20251024__20251024_zN0CLzZ3f0qe"><span id="xdx_90A_edei--EntityExTransitionPeriod_c20251024__20251024_zAvXORknl7B8"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleanfalse" id="Fact000055" name="dei:EntityExTransitionPeriod"><ix:nonNumeric contextRef="AsOf2025-10-24" format="ixt:booleanfalse" id="Fact000056" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></ix:nonNumeric></span></span></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Item 1.01 Entry into a Material Definitive
Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><i>Placement Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">On October&#160;24,
2025, MultiSensor AI Holdings,&#160;Inc. (the &#8220;Company&#8221;) entered into a placement agency agreement (the &#8220;Placement
Agreement&#8221;) with Roth Capital Partners, LLC (&#8220;Roth&#8221;), pursuant to which the Company engaged Roth to act as the exclusive
placement agent in connection with a private placement of (i)&#160;an aggregate of 34,229,826 shares (the &#8220;Shares&#8221;) of the
Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), and (ii)&#160;warrants (the &#8220;Warrants&#8221;)
to purchase up to 68,459,652 shares of Common Stock (collectively, the &#8220;Private Placement&#8221;). Pursuant to the Placement Agreement,
the Company agreed to pay Roth a cash fee equal to 5.0% of the gross proceeds received by the Company from the Private Placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The Placement Agreement
contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations
of the Company, including for liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and termination provisions. The foregoing description of the Placement Agreement does not purport to be complete and
is qualified in its entirety by reference to the full text of the Placement Agreement, a copy of which is attached as Exhibit&#160;1.1
hereto and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><i>Securities Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">On
October&#160;24, 2025 (the &#8220;Subscription Date&#8221;), the Company entered into a securities purchase agreement (the
&#8220;Purchase Agreement&#8221;) with 325 Capital, LLC (collectively with its affiliates, &#8220;325 Capital&#8221;) and certain
other accredited investors (collectively with 325 Capital, the &#8220;Investors&#8221;), pursuant to which it agreed to sell to the
Investors (i)&#160;the Shares at a purchase price of $0.409 per share and (ii)&#160;the Warrants, with an exercise price of $0.409
per share, for an aggregate purchase price of $14.0 million before deducting placement agent fees and offering expenses. Pursuant to
the Purchase Agreement, the Company agreed to issue to the Investors, and the Investors agreed to purchase, a number of Shares equal
to 19.99% of the number of shares of Common Stock issued and outstanding immediately prior to the Subscription Date and Warrants to
purchase up to a number of shares of Common Stock equal to 200% of the Shares issued at the initial closing of the Private Placement
(the &#8220;Initial Closing&#8221;). The remaining Shares and Warrants will be issued upon the Company&#8217;s receipt of
stockholder approval of the Private Placement (&#8220;Stockholder Approval&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The Warrants are
not exercisable unless and until the Company obtains Stockholder Approval. The Warrants are not subject to any redemption provision,
and once exercisable, can be exercised for cash or on a cashless basis at the discretion of the holder. The Warrants do not have any
voting rights, but do have the right to participate in any dividends or distributions made by the Company. The number of shares of the
Common Stock underlying, and the exercise price of, the Warrants is subject to full ratchet antidilution protection and standard adjustments
in the event of certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate
changes; provided, however, that in no event will the exercise price of the Warrants equal less than $0.14944 per share of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The Purchase
Agreement and the Warrants provide that each Investor&#8217;s beneficial ownership of Common Stock, including after taking into
account the full exercise of such Investor&#8217;s Warrant, shall in no event exceed 49.5% of the issued and outstanding Common
Stock (the &#8220;Maximum Ownership Limitation&#8221;). Pursuant to the Warrants, in the event that an Investor&#8217;s Warrant is
not exercisable for shares of Common Stock due to the beneficial ownership of such Investor exceeding the Maximum Ownership
Limitation, the applicable Warrant will be exercisable for shares of the Company&#8217;s Series&#160;A Convertible Preferred Stock,
par value $0.0001 per share (the &#8220;Preferred Stock&#8221;), that are convertible into an equivalent number of shares of Common
Stock for which the Warrant is exercisable. The Warrants will expire seven years from the date of issuance.
The foregoing description of the Warrants does not purport to be complete and is qualified in its entirety by reference to the full
text of the Warrant, a form of which is attached as Exhibit&#160;4.1 hereto and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">On
October&#160;30, 2025, the Initial Closing occurred, and the Company issued 6,970,890 shares of Common Stock and Warrants to
purchase up to 13,941,780 shares of Common Stock to the Investors, for gross proceeds of $2.85 million before deducting placement
agent fees and offering expenses. The gross proceeds from the sale of the remaining Shares and Warrants was funded by the Investors
into a third-party escrow account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The Private Placement
is exempt from the registration requirements of the Securities Act pursuant to the exemption for transactions by an issuer not involving
any public offering under Section&#160;4(a)(2)&#160;of the Securities Act and Rule&#160;506 of Regulation D of the Securities Act and
in reliance on similar exemptions under applicable state laws. Each of the Investors has represented to the Company that it is an accredited
investor within the meaning of Rule&#160;501(a)&#160;of Regulation D and that it is acquiring the applicable securities for investment
only and not with a view towards, or for resale in connection with, the public sale or distribution thereof. The Shares and Warrants
were offered and sold without any general solicitation by the Company or its representatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The Purchase
Agreement contains a &#8220;most favored nation&#8221; provision that allows each Investor to claim any preferable terms from any
future securities offering by the Company and also provides the Investors with certain participation rights in future financings. In
addition, pursuant to the Purchase Agreement, the Company agreed not to increase the size of the Company&#8217;s board of directors
to more than seven directors without the prior written consent of 325 Capital until the two-year anniversary of the final closing
date of the Private Placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The Purchase Agreement
contains customary representations, warranties and covenants, customary conditions to closing, indemnification obligations of the Company, and termination provisions. Among other covenants, the Purchase Agreement requires the Company to file
a proxy statement on Schedule 14A with the Securities and Exchange Commission (the &#8220;SEC&#8221;) within fifteen (15) days of the
Initial Closing and hold a special meeting of stockholders at the earliest practical date thereafter for purposes of obtaining Stockholder
Approval. In the event  the Company fails to obtain Stockholder Approval by February&#160;28, 2026, the Investors will be refunded
all amounts paid into the escrow account for the remaining Shares and Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The Company
intends to use the net proceeds from the Private Placement for working capital and other general corporate purposes.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The foregoing description
of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase
Agreement, a form of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><i>Registration Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">In connection with
the Initial Closing, the Company entered into a registration rights agreement, dated as of October&#160;30, 2025, with the Investors
(the &#8220;Registration Rights Agreement&#8221;) pursuant to which the Company is required to file a registration statement with the
SEC to register the resale of the Shares and the shares of Common Stock and Preferred Stock issuable upon exercise of the Warrants. All
fees relating to the filing of such resale registration statement will be borne by the Company. The foregoing description of the Registration
Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Registration Rights
Agreement, a form of which is attached as Exhibit&#160;10.2 hereto and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><i>Voting Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">In connection
with the Initial Closing, the Company entered into voting agreements, dated as of October&#160;30, 2025 (the &#8220;Voting
Agreements&#8221;), with certain stockholders of the Company representing greater than 36.5% of the number of shares of Common Stock
issued and outstanding immediately prior to the Subscription Date, as well as with certain of the Investors, to support the
transactions contemplated by the Purchase Agreement, including obtaining Stockholder Approval. The foregoing description of the
Voting Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the Voting
Agreements, a form of which is attached as Exhibit&#160;9.1 hereto and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">325 Capital and
its affiliates beneficially own more than 5.0% of the outstanding Common Stock. In addition, Daniel M. Friedberg, who is a Managing Member
of 325 Capital, serves on the Company&#8217;s board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Item 3.02 Unregistered Sales of Equity
Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The information
set forth in Item 1.01 relating to the Private Placement and in Item 5.03 relating to the Preferred Stock is incorporated by
reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Item 3.03 Material Modification to
Rights of Security Holders.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The information
set forth in Item 5.03 relating to the Preferred Stock is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Item 5.03 Amendments to Articles
of Incorporation or Bylaws; Change in Fiscal Year.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">On
October&#160;27, 2025, the Company filed a Certificate of Designations for the Preferred Stock with the Secretary of State of the
State of Delaware (the &#8220;Certificate of Designation&#8221;), which became effective upon filing. The Preferred Stock is pari
passu with the  Common Stock, having the same dividend and liquidation rights (on an as-converted basis) as the
Common Stock. The shares of the Preferred Stock are convertible on a one-for-1,000 basis (adjustable for certain recapitalizations
and similar events) into shares of Common Stock (i) at the holder&#8217;s request as long as the conversion does not cause such
holder&#8217;s beneficial ownership of Common Stock to exceed the Maximum Ownership Limitation, and (ii)&#160;automatically upon
transfer as long as such transfer does not cause the transferee&#8217;s beneficial ownership of Common Stock to exceed the Maximum
Ownership Limitation. Except as otherwise required by law, the Preferred Stock has no voting rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The foregoing
description of the Certificate of Designation does not purport to be complete and is qualified in its entirety by reference to the
full text of the Certificate of Designation, a copy of which is attached hereto as Exhibit&#160;3.1 and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Item 8.01 Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">On October&#160;24,
2025, the Company issued a press release announcing the pricing of the Private Placement. A copy of the press release is attached hereto
as Exhibit&#160;99.1 and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b><i>Additional Information and Where
to Find It</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">In connection with
the Private Placement, the Company intends to file preliminary and definitive proxy statements and other materials with the SEC. In addition,
the Company may also file other relevant documents with the SEC regarding the Private Placement. INVESTORS AND SECURITY HOLDERS ARE URGED
TO READ THE PROXY STATEMENT WHEN IT BECOMES AVAILABLE AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC BECAUSE THEY WILL CONTAIN IMPORTANT
INFORMATION ABOUT THE PROPOSED TRANSACTION. The definitive proxy statement and other relevant documents will be sent or given to the
Company&#8217;s stockholders as of the record date established for voting. Investors and stockholders may also obtain a free copy of
the proxy statement (when available) and other documents filed by the Company at its website, www.multisensorai.com, or at the SEC&#8217;s
website, www.sec.gov. The proxy statement and other relevant documents may also be obtained for free from the Company by directing such
request to the Company, to the attention of the Company&#8217;s Secretary, at 2105 West Cardinal Drive, Beaumont, Texas, 77705.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b><i>Participants in the Solicitation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The Company and
its respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the Company&#8217;s
stockholders in connection with the Private Placement. Investors and stockholders may obtain more detailed information regarding the
names, affiliations and interests of the Company&#8217;s directors and executive officers by reading the Company&#8217;s Annual Report
on Form&#160;10-K for the fiscal year ended December&#160;31, 2024, which was filed with the SEC on March&#160;28, 2025. To the extent
holdings of Common Stock by the Company&#8217;s directors and executive officers have changed from the amounts of Common Stock held by
such persons as reflected in the Company&#8217;s Annual Report on Form&#160;10-K, such changes have been or will be reflected on Statements
of Change in Ownership on Form&#160;4 filed with the SEC. Additional information regarding potential participants in such proxy solicitation
and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the proxy statement
and other relevant materials filed with the SEC in connection with the Private Placement when they become available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b><i>No Offer or Solicitation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">This Current Report
on Form&#160;8-K is not a proxy statement or solicitation of a proxy, consent, or authorization with respect to the Private Placement
and shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities
in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under
the securities laws of such state or jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>Item 9.01 Financial Statements and
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font-size: 10pt; text-align: justify; width: 85%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="font-size: 10pt; text-align: center; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>

<tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td></tr>
<tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></a></td>
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement
    Agency Agreement, dated October&#160;24, 2025, by and between the Company and Roth Capital Partners, LLC</span></a></td></tr>
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex3-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></a></td>
    <td style="font-size: 10pt; text-align: left"><a href="tm2529555d1_ex3-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Designations of the Powers, Preferences and Relative, Participating, Optional and Other Special Rights of Preferred Stock and
    Qualifications, Limitations and Restrictions Thereof of Series&#160;A Convertible Preferred Stock</span></a></td></tr>
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of
    Warrant</span></a></td></tr>
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex9-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</span></a></td>
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex9-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of
    Voting Agreement</span></a></td></tr>
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1&#8224;</span></a></td>
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of
    Securities Purchase Agreement</span></a></td></tr>
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2&#8224;</span></a></td>
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of
    Registration Rights Agreement</span></a></td></tr>
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="font-size: 10pt; text-align: justify"><a href="tm2529555d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
    Release dated October&#160;24, 2025</span></a></td></tr>
  <tr style="font-size: 10pt; vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The annexes, schedules, and certain exhibits to this
    Exhibit&#160;have been omitted pursuant to Item 601(a)(5)&#160;of Regulation S-K. The Company hereby agrees to furnish supplementally
    a copy of any omitted annex, schedule or exhibit to the SEC upon request.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MULTISENSOR
    AI HOLDINGS,&#160;INC.</b></span></td></tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; width: 50%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; width: 47%"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: October&#160;30,
    2025</span></td>
    <td style="font-size: 10pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font-size: 10pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Robert Nadolny</span></td></tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Nadolny </span></td></tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZi42hLtqlRUWsUoqI22BHCbaZMolaj+QtjS3iMDAM/7//hZiINa1MgwynRVXAAduu0R6hwgsy2jMGR77ZZhBuhVfjPGvrh/cH5hQYDMx8qpQOwmB9GId1BjKJ5TxWCcg0S1IodyL66jnZi6nReqMb0LaGkqljg17za0w46J4sta+h6ojsDNkMZlM5ym9QcqZgTw/9JL45KIpcRJNhIrFmunfBtew92i8JywbbUOdG+r/RBwyaSpc= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2529555d1_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENCY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">October&nbsp;24, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Roth Capital Partners, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">888 San Clemente Drive, Suite&nbsp;400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Newport Beach, CA 92660</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the terms and conditions
herein (this &ldquo;<U>Agreement</U>&rdquo;), MultiSensor AI Holdings,&nbsp;Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
hereby agrees to sell up to an aggregate of $13,999,998.83 of securities of the Company, comprising 34,229,826 shares (the &ldquo;<U>Shares</U>&rdquo;)
of the Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), and warrants (the &ldquo;<U>Warrants</U>&rdquo;)
to purchase&nbsp;68,459,652 shares of Common Stock (the &ldquo;<U>Warrant Shares</U>&rdquo; and, collectively with the Shares and the
Warrants, the &ldquo;<U>Securities</U>&rdquo;), directly to certain purchasers (each, a &ldquo;<U>Purchaser</U>&rdquo; and, collectively,
the &ldquo;<U>Purchasers</U>&rdquo;) through Roth Capital Partners, LLC, as exclusive placement agent (the &ldquo;<U>Placement Agent</U>&rdquo;).
The documents executed and delivered by the Company and the Purchasers in connection with the Offering (as defined below), including,
without limitation, a securities purchase agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;) and the form of Warrant, shall be collectively
referred to herein as the &ldquo;<U>Transaction Documents</U>.&rdquo; The purchase price to the Purchasers for each Share and accompanying
Warrants is $0.409. The exercise price to the Purchasers for each share of Common Stock issuable upon exercise of the Warrants is $0.409
per share. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection
with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby confirms
its agreement with the Placement Agent as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Agreement
to Act as Exclusive Placement Agent</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Appointment
of Placement Agent</U>. On the basis of the representations, warranties and agreements of the Company herein contained, and subject to
all the terms and conditions of this Agreement, the Placement Agent shall be the exclusive placement agent in connection with the offering
and sale by the Company of the Securities, with the terms of such offering (the &ldquo;<U>Offering</U>&rdquo;) to be subject to market
conditions and negotiations between the Company, the Placement Agent, and the prospective Purchasers. The Placement Agent will act on
a reasonable best efforts basis and the Company agrees and acknowledges that there is no guarantee of the successful placement of the
Securities, or any portion thereof, in the prospective Offering. Under no circumstances will the Placement Agent or any of its Affiliates
(as defined below) be obligated to underwrite or purchase any of the Shares for its own account or otherwise provide any financing. The
Placement Agent shall act solely as the Company&rsquo;s agent and not as principal. The Placement Agent shall have no authority to bind
the Company with respect to any prospective offer to purchase Shares and the Company shall have the sole right to accept offers to purchase
Shares and may reject any such offer, in whole or in part. Subject to the terms and conditions hereof, payment of the purchase price for,
and delivery of, the Securities shall be made at each of the Initial Closing and the Final Closing (in each case, as defined in the Purchase
Agreement). As compensation for services rendered, the Company shall pay to the Placement Agent the fees and expenses set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
cash fee equal to 5.0% of the aggregate gross proceeds received by the Company from the sale of the Securities at each of the Initial
Closing and the Final Closing, due and payable on the Initial Closing Date and the Final Closing Date, respectively; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;at
the Initial Closing, reimbursement of a non-accountable sum of $60,000 for the Placement Agent&rsquo;s legal fees and expenses. The foregoing
expense reimbursement shall be in addition to any reimbursement of legal or other expenses payable to the Purchasers pursuant to the Purchase
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exclusive
Term</U>. The term of the Placement Agent&rsquo;s exclusive engagement under this Agreement shall continue until April&nbsp;7, 2026 (the
 &ldquo;<U>Exclusive Term</U>&rdquo;) unless earlier terminated as provided herein. During the Exclusive Term, the Company shall not, directly
or indirectly, solicit, engage, or enter into any agreement with any other placement agent, underwriter, financial advisor, or similar
intermediary in connection with any private placement of its equity or equity-linked securities without the prior written consent of the
Placement Agent. Subject to the foregoing, either party may terminate this Agreement at any time upon 30 days&rsquo; prior written notice
to the other party. Notwithstanding anything to the contrary contained herein, (i)&nbsp;the provisions concerning confidentiality, indemnification
and contribution contained herein, (ii)&nbsp;the Company&rsquo;s obligations contained in the indemnification provisions, and (iii)&nbsp;the
Company&rsquo;s obligation to pay fees actually earned and payable and to reimburse expenses actually incurred and reimbursable pursuant
to Section&nbsp;1 hereof, will survive any expiration or termination of this Agreement. Nothing in this Agreement shall be construed to
limit the ability of the Placement Agent or its Affiliates to pursue, investigate, analyze, invest in, or engage in investment banking,
financial advisory or any other business relationship with Persons (as defined below) other than the Company. As used herein (i)&nbsp;&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind, and (ii)&nbsp;&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule&nbsp;405 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Tail
Fee</U>. If, within 12 months after the expiration or termination of this Agreement, the Company consummates any private placement or
other financing of its equity or equity-linked securities with any Person (a &ldquo;<U>Covered Investor</U>&rdquo;) that was introduced
to the Company by the Placement Agent during the Exclusive Term or that became aware of the Offering through the Placement Agent&rsquo;s
efforts, the Company shall pay to the Placement Agent the same cash fees as if such transaction had been completed during the term of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Representations,
Warranties and Covenants of the Company</B>. The Company acknowledges and agrees that the Placement Agent shall be entitled to rely on
the representations, warranties and covenants contained in Section&nbsp;3.1 of the Purchase Agreement to the same extent as if they were
made pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Representations
and Warranties of the Placement Agent</B>. The Placement Agent hereby represents and warrants that it is not subject to any of the &ldquo;bad
actor&rdquo; disqualifications within the meaning of Rule&nbsp;506(d)&nbsp;of Regulation D under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Covenants
and Agreements of the Company</B>. The Company further covenants and agrees with the Placement Agent as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a)&nbsp;by 9:30 a.m.&nbsp;(New York City time) on the Trading Day immediately following
the date hereof, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b)&nbsp;file a Current
Report on Form&nbsp;8-K, including the Transaction Documents as exhibits thereto, with the United States Securities and Exchange Commission
(the &ldquo;<U>Commission</U>&rdquo;) within the time required by the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange
Act</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Form&nbsp;D;
Blue Sky Filings</U>. The Company agrees to timely file a Form&nbsp;D with respect to the Securities as required under Regulation D and
to provide a copy thereof upon request of the Placement Agent. The Company shall take such action as the Company shall reasonably determine
is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers under applicable securities
or &ldquo;Blue Sky&rdquo; laws of the states of the United States and shall provide evidence of such actions upon request of the Placement
Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section&nbsp;2
of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration
under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes
of the rules&nbsp;and regulations of any Trading Market (as defined in the Purchase Agreement) such that it would require shareholder
approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent
transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
Agent</U>. The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities pursuant to the Transaction Documents for working
capital purposes and shall not use such proceeds: (a)&nbsp;for the satisfaction of any portion of the Company&rsquo;s debt (other than
payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b)&nbsp;for the redemption of
any Common Stock or Common Stock Equivalents (as defined in the Purchase Agreement), (c)&nbsp;for the settlement of any outstanding litigation,
or (d)&nbsp;in violation of the FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Periodic
Reporting Obligations</U>. Until such date that no Purchasers hold any Securities, the Company shall duly file, on a timely basis, with
the Commission and the Trading Market all reports and documents required to be filed under the Exchange Act within the time periods and
in the manner required by the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Additional
Documents</U><I>.</I> The Company will enter into any subscription, purchase or other customary agreements as the Placement Agent or the
Purchasers deem necessary or appropriate to consummate the Offering, all of which will be in form and substance reasonably acceptable
to the Placement Agent and the Purchasers. The Company agrees that the Placement Agent may rely upon, and each is a third party beneficiary
of, the representations and warranties, and applicable covenants, set forth in any such purchase, subscription or other agreement with
Purchasers in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Manipulation of Price</U><I>.&nbsp; </I>The Company will not take, directly or indirectly, any action designed to cause or result in,
or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acknowledgment</U>.
The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit and use of the Board of
Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement Agent's prior written
consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Announcement
of Offering</U>. The Company acknowledges and agrees that the Placement Agent may, subsequent to the Initial Closing, make public its
involvement with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reliance
on Others</U>. The Company confirms that it will rely on its own counsel and accountants for legal and accounting advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Research
Matters</U><FONT STYLE="font-variant: small-caps">.</FONT> By entering into this Agreement, the Placement Agent does not provide any promise,
either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees
that the Placement Agent&rsquo;s selection as a placement agent for the Offering was in no way conditioned, explicitly or implicitly,
on the Placement Agent providing favorable or any research coverage of the Company. In accordance with FINRA Rule&nbsp;2711(e), the parties
acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific rating or a specific
price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business or
compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Subsequent
Equity Sales</U>. From the date hereof until 90 days after the later of the receipt of Stockholder Approval or the Effective Date (in
each case, as defined in the Purchase Agreement), neither the Company nor any Subsidiary (as defined in the Purchase Agreement) shall
(i)&nbsp;issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common
Stock Equivalents or (ii)&nbsp;file any registration statement or any amendment or supplement thereto, in each case other than as contemplated
pursuant to the Registration Rights Agreement (as defined in the Purchase Agreement); provided that nothing herein shall prohibit the
Company from supplementing or amending any existing registration statement in order to keep such registration statement current.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Conditions
of the Obligations of the Placement Agent</B>. The obligations of the Placement Agent in connection with each of the Initial Closing and
the Final Closing shall be subject to the accuracy in all material respects (or, to the extent representations or warranties are qualified
by materiality or Material Adverse Effect (as defined in the Purchase Agreement), in all respects) when made and as of the Initial Closing
Date of the representations and warranties of the Company contained in Section&nbsp;3.1 of the Purchase Agreement (unless as of a specific
date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified
by materiality or Material Adverse Effect, in all respects) as of such date) and, as of the Final Closing Date, of the representations
and warranties of the Company in Section&nbsp;3.1(b), (d)&nbsp;and (f)&nbsp;of the Purchase Agreement (unless as of a specific date therein
in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality
or Material Adverse Effect, in all respects) as of such date), to the timely performance by each of the Company of its covenants and other
obligations hereunder on and as of such dates, and to each of the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Corporate
Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement, the Transaction Documents, and the
sale and delivery of the Securities, shall have been completed or resolved in a manner reasonably satisfactory to the Placement Agent&rsquo;s
counsel, and such counsel shall have been furnished with such papers and information as it may reasonably have requested to enable such
counsel to pass upon the matters referred to in this Section&nbsp;5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Material Adverse Change</U>. Subsequent to the execution and delivery of this Agreement and prior to each of the Initial Closing Date
and the Final Closing Date, in the Placement Agent&rsquo;s sole judgment after consultation with the Company, there shall not have occurred
any Material Adverse Effect or any material adverse change or development involving a prospective material adverse change in the condition
or the business activities, financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the
Transaction Documents (&ldquo;<U>Material Adverse Change</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Opinion
of Counsel for the Company</U>. The Placement Agent shall have received on the Initial Closing Date the favorable opinion of U.S. legal
counsel to the Company, dated as of such Initial Closing Date, and in form and substance satisfactory to the Placement Agent (the &ldquo;<U>Initial
Opinion</U>&rdquo;). In addition, the Placement Agent shall have received on the Final Closing Date a bringdown letter from such counsel,
dated as of the Final Closing Date, confirming that the Initial Opinion may be relied upon as of the Final Closing Date (subject to any
changes set forth therein and acceptable to the Placement Agent in its reasonable discretion).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Officers&rsquo;
Certificate</U>. The Placement Agent shall have received on each of the Initial Closing Date and Final Closing Date a certificate of the
Company, dated as of the date thereof, signed by the Chief Executive Officer and Chief Financial Officer of the Company, to the effect
that, and the Placement Agent shall be satisfied that, the signers of such certificate have reviewed this Agreement and the Transaction
Documents and to the further effect that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(A)&nbsp;with
respect to the First Closing, the representations and warranties of the Company in the Purchase Agreement and herein are true and correct,
as if made on and as of such closing date in all material respects (or, to the extent representations or warranties are qualified by materiality
or Material Adverse Effect, in all respects), and the Company has complied with all the agreements and satisfied all the conditions on
its part to be performed or satisfied at or prior to such closing date, and (B)&nbsp;with respect to the Final Closing, the representations
and warranties of the Company in Section&nbsp;3.1(b), (d)&nbsp;and (f)&nbsp;of the Purchase Agreement are true and correct, as if made
on and as of such closing date (unless as of a specific date therein in which case they shall be accurate in all material respects (or,
to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;subsequent
to the respective dates as of which information is given in the SEC Reports and the Transaction Documents, there has not been: (A)&nbsp;any
Material Adverse Change; (B)&nbsp;any transaction that is material to the Company and the Subsidiaries taken as a whole, except transactions
entered into in the ordinary course of business; (C)&nbsp;any obligation, direct or contingent, that is material to the Company and the
Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred in the ordinary course of business;
(D)&nbsp;any material change in the capital stock (except changes thereto resulting from the issuance of the Securities pursuant to the
Purchase Agreement, the designation of the Preferred Stock (as defined in the Purchase Agreement) and the exercise of outstanding stock
options or warrants) or outstanding indebtedness of the Company or any Subsidiary; (E)&nbsp;any dividend or distribution of any kind declared,
paid or made on the capital stock of the Company; or (F)&nbsp;any loss or damage (whether or not insured) to the property of the Company
or any Subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Stock
Exchange Listing</U>. The Common Stock shall be registered under the Exchange Act and shall be listed on the Trading Market, and the Company
shall not have taken any action designed to terminate, or likely to have the effect of terminating,&nbsp;the registration of the Common
Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market, nor shall the Company have
received any information suggesting that the Commission or the Trading Market is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Additional
Documents</U>. On or before each of the Initial Closing Date and the Final Closing Date, the Placement Agent and counsel for the Placement
Agent shall have received such information and documents as they may reasonably require for the purposes of enabling them to pass upon
the issuance and sale of the Securities as contemplated herein, or in order to evidence the accuracy of any of the representations and
warranties, or the satisfaction of any of the conditions or agreements, herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any condition specified
in this Section&nbsp;5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Placement Agent
by notice to the Company at any time on or prior to the Initial Closing Date or the Final Closing Date, as applicable, which termination
shall be without liability on the part of any party to any other party, except that Section&nbsp;6 (Payment of Expenses), Section&nbsp;7
(Indemnification and Contribution), Section&nbsp;8 (Representations and Indemnities to Survive Delivery), and Section&nbsp;9 (Right of
First Refusal) shall at all times be effective and shall survive such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Payment
of Expenses</B>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance of
its obligations hereunder and in connection with the transactions contemplated hereby and: (i)&nbsp;all expenses incident to the issuance,
delivery and qualification of the Securities (including all printing and engraving costs); (ii)&nbsp;all fees and expenses of the registrar
and transfer agent of the Common Stock; (iii)&nbsp;all necessary issue, transfer and other stamp taxes in connection with the issuance
and sale of the Securities; (iv)&nbsp;all fees and expenses of the Company&rsquo;s counsel, independent public or certified public accountants
and other advisors; (v)&nbsp;the fees and expenses associated with including the Shares and Warrant Shares on the Trading Market; (vi)&nbsp;and
all costs and expenses incident to the travel and accommodation of the Company&rsquo;s and the Placement Agent's employees on the &ldquo;roadshow.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Indemnification
and Contribution</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; The Company
agrees to indemnify and hold harmless the Placement Agent, its affiliates and each person controlling the Placement Agent (within the
meaning of Section&nbsp;15 of the Securities Act), and the directors, officers, agents and employees of the Placement Agent, its affiliates
and each such controlling person (the Placement Agent, and each such entity or person, an &ldquo;<U>Indemnified Person</U>&rdquo;) from
and against any losses, claims, damages, judgments, assessments, costs and other liabilities (collectively, the &ldquo;<U>Liabilities</U>&rdquo;),
and shall reimburse each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of one counsel for all
Indemnified Persons, except as otherwise expressly provided herein) (collectively, the &ldquo;<U>Expenses</U>&rdquo;) as they are incurred
by an Indemnified Person in investigating, preparing, pursuing, defending, or enforcing any Actions (as defined in the Purchase Agreement),
including in connection with the enforcement of this Section&nbsp;7, whether or not any Indemnified Person is a party thereto, (i)&nbsp;caused
by, or arising out of or in connection with, any untrue statement or alleged untrue statement of a material fact contained in any SEC
Report or Transaction Document or by any omission or alleged omission to state therein a material fact necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, or (ii)&nbsp;otherwise arising out of or in connection
with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement, the transactions contemplated
thereby or any Indemnified Person's actions or inactions in connection with any such advice, services or transactions; <U>provided, however</U>,
that, in the case of clause (ii)&nbsp;only, the Company shall not be responsible for any Liabilities or Expenses of any Indemnified Person
that are finally judicially determined to have resulted solely from such Indemnified Person&rsquo;s (x)&nbsp;gross negligence or willful
misconduct in connection with any of the advice, actions, inactions or services referred to above or (y)&nbsp;use of any offering materials
or information concerning the Company in connection with the offer or sale of the Securities in the Offering which were not authorized
for such use by the Company and which use constitutes gross negligence or willful misconduct. The Company also agrees to reimburse each
Indemnified Person for all Expenses as they are incurred in connection with enforcing such Indemnified Person's rights under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
receipt by an Indemnified Person of actual notice of an Action against such Indemnified Person with respect to which indemnity may be
sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure by any Indemnified
Person so to notify the Company shall not relieve the Company from any liability which the Company may have on account of this indemnity
or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by such failure. The Company shall,
if requested by the Placement Agent, assume the defense of any such Action including the employment of counsel reasonably satisfactory
to the Placement Agent, which counsel may also be counsel to the Company. Any Indemnified Person shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
such Indemnified Person unless: (i)&nbsp;the Company has failed promptly to assume the defense and employ counsel or (ii)&nbsp;the named
parties to any such Action (including any impeded parties) include such Indemnified Person and the Company, and such Indemnified Person
shall have been advised in the reasonable opinion of counsel that there is an actual conflict of interest that prevents the counsel selected
by the Company from representing both the Company (or another client of such counsel) and any Indemnified Person; provided that the Company
shall not in such event be responsible hereunder for the fees and expenses of more than one firm of separate counsel for all Indemnified
Persons in connection with any Action or related Actions, in addition to any local counsel. The Company shall not be liable for any settlement
of any Action effected without its written consent (which shall not be unreasonably withheld). In addition, the Company shall not, without
the prior written consent of the Placement Agent (which shall not be unreasonably withheld), settle, compromise or consent to the entry
of any judgment in or otherwise seek to terminate any pending or threatened Action in respect of which indemnification or contribution
may be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise, consent or termination
includes an unconditional release of each Indemnified Person from all Liabilities arising out of such Action for which indemnification
or contribution may be sought hereunder, and does not contain any statement as to or admission of fault, culpability, or failure to act
by or on behalf of any Indemnified Person. The indemnification required hereby shall be made by periodic payments of the amount thereof
during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company
shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i)&nbsp;the relative benefits to the Company, on the one hand, and to the Placement Agent and any other Indemnified Person, on the other
hand, of the matters contemplated by this Agreement or (ii)&nbsp;if the allocation provided by the immediately preceding clause is not
permitted by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and the Placement
Agent and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate,
as well as any other relevant equitable considerations; provided that in no event shall the Company contribute less than the amount necessary
to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of fees
actually received by the Placement Agent pursuant to this Agreement. For purposes of this paragraph, the relative benefits to the Company,
on the one hand, and to the Placement Agent on the other hand, of the matters contemplated by this Agreement shall be deemed to be in
the same proportion as (a)&nbsp;the total value paid or contemplated to be paid to or received or contemplated to be received by the Company
in the transaction or transactions that are within the scope of this Agreement, whether or not any such transaction is consummated, bears
to (b)&nbsp;the fees paid to the Placement Agent under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person's actions or inactions in connection with any such advice, services or
transactions except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted solely
from such Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with any such advice, actions, inactions or
services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person's services under
or in connection with, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Representations
and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties and other statements of the
Company or any person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant to this Agreement
will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent, the Company, or any
of its or their partners, officers or directors or any controlling person, as the case may be, and will survive delivery of and payment
for the Securities sold hereunder and any termination of this Agreement. A successor to a Placement Agent, or to the Company, its directors
or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and reimbursement
agreements contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Right
of First Refusal</B>. In the event the Company or any of its Subsidiaries proposes to engage the services of a placement agent, underwriter,
or similar financial intermediary to assist the Company in any private placement or public offering of its equity, equity-linked, or debt
securities (including convertible or derivative instruments) during the period commencing on the date of this Agreement and ending on
April&nbsp;7, 2027 (the &ldquo;<U>ROFR Period</U>&rdquo;), the Company shall first offer the Placement Agent the right to act as the Company&rsquo;s
exclusive placement agent, or lead underwriter and sole bookrunner, as applicable, for such transaction (the &ldquo;<U>Right of First
Refusal</U>&rdquo;) by providing written notice to the Placement Agent describing the proposed transaction in reasonable detail (the &ldquo;<U>ROFR
Notice</U>&rdquo;). The Placement Agent shall have 10 business days following receipt of the ROFR Notice to notify the Company in writing
of its election to accept such engagement. If the Placement Agent elects to accept such engagement, the agreement governing such engagement
will contain, among other things, terms that are customary for the Placement Agent and mutually agreed upon by the Company and the Placement
Agent. For clarity, if the Placement Agent elects to accept such engagement, such financing shall not be subject to Section&nbsp;1(c)&nbsp;of
this Agreement. If the Placement Agent declines to exercise its Right of First Refusal within such period, or fails to respond to the
Company in writing, the Company may proceed to engage another financial intermediary on terms no more favorable in the aggregate to such
intermediary than those offered to the Placement Agent. Furthermore, if the Company proposes to engage a placement agent, underwriter,
or other intermediary for any other type of transaction not specifically described above (including, without limitation, any merger, acquisition,
divestiture, strategic transaction, strategic partnership, recapitalization, or other similar transaction or capital markets advisory
assignment) during the ROFR Period, the Company shall offer the Placement Agent the opportunity to act in such capacity exclusively. If
the Placement Agent accepts such engagement, the Company and the Placement Agent shall negotiate in good faith to determine fair and customary
compensation for such services, which shall be at market-based rates at the time of such engagement. Notwithstanding the foregoing, this
Section&nbsp;9 shall not apply to any sale under an equity line of credit or &ldquo;at the market offering&rdquo; that has previously
been announced by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notices</B>.
All communications hereunder shall be in writing and shall be mailed, hand delivered, telecopied or e-mailed and confirmed to the parties
hereto as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to the Placement Agent
to the address set forth above, attention: Equity Capital Markets, e-mail: rothECM@roth.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>With a copy to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Stradling Yocca Carlson&nbsp;&amp; Rauth
LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">660 Newport Center Drive, Suite&nbsp;1600</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Newport Beach, CA 92660</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Attention: Amanda McFall</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">MultiSensor AI Holdings,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">2105 West Cardinal Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Beaumont, Texas 77705</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: robert.nadolny@multisnorai.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>With a copy to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Haynes and Boone, LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">2801 N. Harwood Street, Suite&nbsp;2300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Dallas, Texas 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: Matthew L. Fry</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any party hereto may change
the address for receipt of communications by giving written notice to the others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Successors</B>.
This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and
directors and controlling persons referred to in Section&nbsp;7 hereof, and to their respective successors, and personal representative,
and no other person will have any right or obligation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Partial
Unenforceability</B>. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the
validity or enforceability of any other section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement
is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor
changes) as are necessary to make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Governing
Law Provisions</B>. This Agreement shall be deemed to have been made and delivered in New York City and both this engagement letter and
the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in all other respects
by the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Each of the Placement Agent
and the Company: (i)&nbsp;agrees that any legal suit, action or proceeding arising out of or relating to this engagement letter and/or
the transactions contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the United States
District Court for the Southern District of New York, (ii)&nbsp;waives any objection which it may have or hereafter to the venue of any
such suit, action or proceeding, and (iii)&nbsp;irrevocably consents to the jurisdiction of the New York Supreme Court, County of New
York, and the United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Placement
Agent and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action
or proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New
York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address shall be deemed in every
respect effective service of process upon the Company, in any such suit, action or proceeding, and service of process upon the Placement
Agent mailed by certified mail to the Placement Agent&rsquo;s address shall be deemed in every respect effective service process upon
the Placement Agent, in any such suit, action or proceeding. Notwithstanding any provision of this engagement letter to the contrary,
the Company agrees that neither the Placement Agent nor its affiliates, and the respective officers, directors, employees, agents and
representatives of the Placement Agent, its affiliates and each other person, if any, controlling the Placement Agent or any of its affiliates,
shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with the engagement
and transaction described herein except for any such liability for losses, claims, damages or liabilities incurred by us that are finally
judicially determined to have resulted from the bad faith or gross negligence of such individuals or entities. If either party shall commence
an action or proceeding to enforce any provision of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed
by the other party for its reasonable attorney&rsquo;s fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section&nbsp;14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;General
Provisions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof, including, without limitation, that certain
letter agreement, dated October&nbsp;7, 2025, by and between the Company and the Placement Agent. This Agreement may be executed in two
or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the
same instrument. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein
(express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. Section&nbsp;headings
herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company acknowledges that in connection with the offering of the Securities: (i)&nbsp;the Placement Agent has acted at arm&rsquo;s length,
are not agents of, and owe no fiduciary duties to the Company or any other person, (ii)&nbsp;the Placement Agent owes the Company only
those duties and obligations set forth in this Agreement and (iii)&nbsp;the Placement Agent may have interests that differ from those
of the Company. The Company waives to the full extent permitted by applicable law any claims it may have against the Placement Agent arising
from an alleged breach of fiduciary duty in connection with the offering of the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>The remainder of this page&nbsp;has been intentionally
left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing is in accordance
with your understanding of our agreement, please sign below whereupon this instrument, along with all counterparts hereof, shall become
a binding agreement in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Multisensor ai holdings, inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Robert
    Nadolny</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Robert Nadolny</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The foregoing Placement Agency Agreement is hereby confirmed
and accepted as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ROTH CAPITAL PARTNERS, LLC</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Aaron M. Gurewitz</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Aaron M. Gurewitz</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Co-Chief Executive Officer&nbsp;&amp; Head of Investment
Banking</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>tm2529555d1_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE OF DESIGNATIONS OF THE POWERS,
PREFERENCES AND RELATIVE, PARTICIPATING, OPTIONAL AND OTHER SPECIAL&nbsp;RIGHTS OF PREFERRED STOCK AND QUALIFICATIONS, LIMITATIONS AND
RESTRICTIONS THEREOF<BR>
of<BR>
SERIES A CONVERTIBLE PREFERRED STOCK<BR>
for<BR>
MULTISENSOR AI HOLDINGS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>MULTISENSOR AI HOLDINGS,&nbsp;INC.</B>,
a Delaware corporation (the &ldquo;<B><I>Corporation</I></B>&rdquo;), pursuant to the provisions of Section&nbsp;151 of the General Corporation
Law of the State of Delaware, does hereby make this Certificate of Designations and does hereby state and certify that pursuant to the
authority expressly vested in the Board of Directors of the Corporation (the &ldquo;<B><I>Board of Directors</I></B>&rdquo;) by the Second
Amended and Restated Certificate of Incorporation of the Corporation, as amended (the &ldquo;<B><I>Amended and Restated Certificate of
Incorporation</I></B>&rdquo;), the Board of Directors duly adopted the following resolutions, which resolutions remain in full force and
effect as of the date hereof:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>RESOLVED</B>, that, pursuant
to paragraph B of Article&nbsp;IV of the Amended and Restated Certificate of Incorporation, the Board of Directors hereby authorizes the
issuance of, and fixes the designation and preferences and relative, participating, optional and other special rights, and qualifications,
limitations and restrictions, of a series of Preferred Stock consisting of 20,000 shares (the &ldquo;<B><I>Series&nbsp;A Preferred Shares</I></B>&rdquo;),
par value $0.0001 per share, to be designated<B>&nbsp;</B>&ldquo;Series&nbsp;A Convertible Preferred Stock&rdquo;.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>RESOLVED</B>, that each
of the Series&nbsp;A Preferred Shares shall rank equally in all respects and shall be subject to the following terms and provisions:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Defined Terms</U></B>.&#8239;&#8239;For purposes of this Certificate of Designations, the following terms shall have the following meanings:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Business
Day</I></B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in the City of New York are authorized
or required by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Common
Shares</I></B>&rdquo; means fully paid, validly issued and non-assessable shares of Common Stock.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Common
Stock</I></B>&rdquo; means the common stock, par value $0.0001 per share, of the Corporation.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Common
Stock Equivalent</I></B>&rdquo; means any rights, warrants or options to purchase or other securities convertible into or exchangeable
or exercisable for, directly or indirectly, any (1)&nbsp;shares of Common Stock or (2)&nbsp;securities convertible into or exchangeable
or exercisable for, directly or indirectly, shares of Common Stock.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Equity
Security</I></B>&rdquo; means (i)&nbsp;any shares of capital stock of the Corporation, (ii)&nbsp;any rights, options, warrants or similar
securities to subscribe for, purchase or otherwise acquire any shares of capital stock of the Corporation, and (iii)&nbsp;debt or other
evidences of indebtedness, capital stock or other securities directly or indirectly convertible into or exercisable or exchangeable for
any shares of capital stock of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Exchange
Act</I></B>&rdquo; means the<B><I>&nbsp;</I></B>Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Holder</I></B>&rdquo;
means each holder of the Series&nbsp;A Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Initial
Issuance Date</I></B>&rdquo; means October&nbsp;27, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Liquidation
Event</I></B>&rdquo; means any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Pari
Passu Securities</I></B>&rdquo; means the Common Stock and each other class or series of Equity Security of the Corporation, the terms
of which do not expressly provide that it ranks senior in preference or priority to or on parity, without preference or priority, with
respect to the Common Stock or Series&nbsp;A Preferred Shares as to dividend rights or rights upon a Liquidation Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>SEC</I></B>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Securities
Act</I></B>&rdquo; means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Trading
Day</I></B>&rdquo; means 9:30AM to 3:59PM on any day on which the shares of Common Stock are traded on a Trading Market, or, if the shares
of Common Stock are not so traded, a Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Trading
Market</I></B>&rdquo; means the NYSE Amex Equities, the New York Stock Exchange or the NASDAQ Global Select Market, the NASDAQ Global
Market or the NASDAQ Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Transfer</I></B>&rdquo;
means any direct or indirect sale, exchange, redemption, assignment, distribution, encumbrance, hypothecation, gift, pledge, retirement,
transfer, conveyance or other disposition or alienation in any way (whether or not for value and whether voluntarily, involuntarily or
by operation of law);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Transfer
Agent</I></B>&rdquo; means Continental Stock Transfer&nbsp;&amp; Trust Company, a New York corporation, or such other person designated
by the Corporation as the transfer agent for the shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Designation</U>.</B>&#8239;&#8239;There
is hereby created out of the authorized and unissued shares of preferred stock of the Corporation a series of preferred stock designated
as the &ldquo;Series&nbsp;A Convertible Preferred Stock&rdquo; (the &ldquo;<B><I>Preferred Stock</I></B>&rdquo;).&#8239;&#8239;The number
of shares constituting such series shall be 20,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Dividends</U>.&#8239;&#8239;</B>Except
for stock dividends or distributions for which adjustments are to be made pursuant to Section&nbsp;5, Holders shall be entitled to receive,
and the Corporation shall pay, dividends on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock basis, without regard
to conversion limitations herein) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such
dividends are paid on shares of the Common Stock. Other than as set forth in the previous sentence, no other dividends shall be paid on
shares of Preferred Stock, and the Corporation shall pay no dividends (other than dividends in the form of Common Stock) on shares of
the Common Stock unless it simultaneously complies with the previous sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Liquidation
Preference</U>.</B>&#8239;&#8239;In the event of any Liquidation Event, the Holders of the Series&nbsp;A Preferred Shares shall be entitled
to receive <I>pari passu</I> with the Pari Passu Securities, on a pro rata basis, out of the assets of the Corporation available for distribution
to stockholders, the same amount that the Holders would have been entitled to receive had the Series&nbsp;A Preferred Shares converted
to Common Stock immediately prior to the Liquidation Event (without giving effect to the limitations on conversion set forth in <U>Section&nbsp;5(j))</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Optional
Conversion by the Holders</U>.</B>&#8239;&#8239;Each Holder shall have the right at any time and from time to time, at the option of such
Holder and without the payment of additional consideration by the Holder, to convert all or any portion of the Series&nbsp;A Preferred
Shares held by such Holder into fully paid and non-assessable shares of Common Shares at the rate of one thousand (1,000) Common Shares
for each Series&nbsp;A Preferred Share (the &ldquo;<B><I>Conversion Ratio</I></B>&rdquo;) (subject to the limitations set forth in <U>Section&nbsp;5(j)</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Delivery
of Conversion Notice.&#8239;&#8239;</I>To convert Series&nbsp;A Preferred Shares into Common Shares on any date (a &ldquo;<B><I>Conversion
Date</I></B>&rdquo;), the Holder shall give written notice (a &ldquo;<B><I>Conversion Notice</I></B>&rdquo;) to the Corporation in the
form of <U>Exhibit&nbsp;A</U> hereto (which Conversion Notice will be given by facsimile transmission, e-mail or other electronic means
no later than 11:59 p.m.&nbsp;New York City Time on such date, or sent via overnight delivery no later than one (1)&nbsp;Trading Day after
such date) stating that such Holder elects to convert the same and shall state therein the number of Series&nbsp;A Preferred Shares to
be converted and the name or names in which such Holder wishes the certificate or certificates (or book-entry if the Series&nbsp;A Preferred
Shares are uncertificated) for Common Shares to be issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Mechanics
of Conversion.</I>&#8239;&#8239;The Corporation shall, promptly upon receipt of a Conversion Notice (but in any event not less than one
(1)&nbsp;Trading Day after receipt of such Conversion Notice), (i)&nbsp;send, via facsimile, e-mail or other electronic means a confirmation
of receipt of such Conversion Notice to such Holder and the Transfer Agent, which confirmation shall constitute an instruction to the
Transfer Agent to process such Conversion Notice in accordance with the terms herein and (ii)&nbsp;on or before the first (1<SUP>st</SUP>)
Trading Day following the date of receipt by the Corporation of such Conversion Notice (the &ldquo;<B><I>Share Delivery Date</I></B>&rdquo;),
credit such aggregate number of Common Shares to which the Holder shall be entitled to such Holder&rsquo;s or its designee&rsquo;s account
in book entry with the Transfer Agent.&#8239;&#8239;If the number of Series&nbsp;A Preferred Shares represented by the Preferred Stock certificate(s)&nbsp;delivered
to the Corporation in connection with a Conversion Notice, to the extent requested by the Holder, is greater than the number of Series&nbsp;A
Preferred Shares being converted, then the Corporation shall, as soon as practicable and in no event later than three (3)&nbsp;Business
Days after receipt of such Preferred Stock certificate(s)&nbsp;and at its own expense, issue and deliver to the Holder a new Preferred
Stock certificate representing the number of Series&nbsp;A Preferred Shares not converted.&#8239;&#8239;The person or persons entitled to
receive the Common Shares issuable upon a conversion of Series&nbsp;A Preferred Shares shall be treated for all purposes as the record
holder or holders of such Common Shares on the Conversion Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>The Corporation&rsquo;s
obligation to issue Common Shares upon conversion of Series&nbsp;A Preferred Shares shall, except as set forth below, be absolute, is
independent of any covenant of any Holder, and shall not be subject to:&#8239;&#8239;(i)&nbsp;any offset or defense; or (ii)&nbsp;any claims
against the Holders of Series&nbsp;A Preferred Shares whether pursuant to this Certificate of Designations or otherwise, including, without
limitation, any claims arising out of any selling or short-selling activity by Holders.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[Reserved.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Adjustments
to the Conversion Ratio</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Adjustments
for Stock Splits and Combinations</I>.&#8239;&#8239;If the Corporation shall at any time or from time to time after the Initial Issuance
Date effect a stock split of the outstanding Common Stock, the applicable Conversion Ratio in effect immediately prior to the stock split
shall be proportionately decreased.&#8239;&#8239;If the Corporation shall at any time or from time to time after the Initial Issuance Date,
combine the outstanding shares of Common Stock, the applicable Conversion Ratio in effect immediately prior to the combination shall be
proportionately increased.&#8239;&#8239;Any adjustments under this <U>Section&nbsp;5(d)(i)</U>&nbsp;shall be effective at the close of business
on the date the stock split or combination occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Adjustments
for Certain Dividends and Distributions</I>.&#8239;&#8239;If the Corporation shall at any time or from time to time on or after the Initial
Issuance Date make or issue or set a record date for the determination of holders of Common Stock entitled to receive a dividend or other
distribution payable in Common Shares then, and in each event, the applicable Conversion Ratio in effect immediately prior to such event
shall be decreased as of the time of such issuance or, in the event such record date shall have been fixed, as of the close of business
on such record date, by multiplying the applicable Conversion Ratio then in effect by a fraction:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
numerator of which shall be the total number of Common Shares issued and outstanding immediately prior to the time of such issuance or
the close of business on such record date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
denominator of which shall be the total number of Common Shares issued and outstanding immediately prior to the time of such issuance
or the close of business on such record date plus the number of Common Shares issuable in payment of such dividend or distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Adjustment
for Other Dividends and Distributions</I>.&#8239;&#8239;If the Corporation shall at any time or from time to time on or after the Initial
Issuance Date make or issue or set a record date for the determination of holders of Common Stock entitled to receive a non-cash dividend
or other distribution payable in securities or property other than Common Shares, then, and in each event, an appropriate revision to
the applicable Conversion Ratio shall be made and provision shall be made (by adjustments of the Conversion Ratio or otherwise) so that
the Holders of Series&nbsp;A Preferred Shares shall receive upon conversions thereof, in addition to the number of Common Shares receivable
thereon, the number of securities of the Corporation or other issuer (as applicable) or other property that they would have received had
the Series&nbsp;A Preferred Shares been converted into Common Shares on the date of such event (<I>provided, however</I>, that, to the
extent the right of a Holder of Series&nbsp;A Preferred Shares to participate in any such distribution would result in such Holder of
Series&nbsp;A Preferred Shares exceeding the Beneficial Ownership Limitation, then such Holder of Series&nbsp;A Preferred Shares shall
not be entitled to participate in such distribution to such extent (or in the beneficial ownership of any Common Shares as a result of
such distribution to such extent) and the portion of such distribution shall be held in abeyance for the benefit of such Holder of Series&nbsp;A
Preferred Shares until such time, if ever, as its right thereto would not result in such Holder of Series&nbsp;A Preferred Shares exceeding
the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Notice
of Record Date.&#8239;&#8239;</I>In the event of any taking by the Corporation of a record date of the holders of any class of securities
for the purpose of determining the holders thereof who are entitled to receive any dividend or other distribution, any security or right
convertible into or entitling the holder thereof to receive additional Common Shares, or any right to subscribe for, purchase or otherwise
acquire any shares of stock of any class or any other securities or property, or to receive any other right, the Corporation shall deliver
to each Holder at least twenty (20) days prior to the date specified therein, a notice specifying the date on which any such record is
to be taken for the purpose of such dividend, distribution, security or right and the amount and character of such dividend, distribution,
security or right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Reservation
of Stock Issuable Upon Conversion.&#8239;&#8239;</I>The Corporation shall at all times reserve and keep available out of its authorized
but unissued Common Stock, solely for the purposes of effecting the conversion of the Series&nbsp;A Preferred Shares, an amount of shares
of Common Stock equal to 100% of the number of shares issuable upon conversion of the Series&nbsp;A Preferred Shares at the Conversion
Ratio (the &ldquo;<B><I>Required Reserve Amount</I></B>&rdquo;).&#8239;&#8239;If at any time while any of the Series&nbsp;A Preferred Shares
remain outstanding the Corporation does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its
obligation to reserve for issuance upon conversion of the Series&nbsp;A Preferred Shares at least a number of shares of Common Stock equal
to the Required Reserve Amount, then the Corporation shall promptly take all action necessary to increase the Corporation&rsquo;s authorized
shares of Common Stock to an amount sufficient to allow the Corporation to reserve the Required Reserve Amount for the Series&nbsp;A Preferred
Shares then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Fractional
Shares.&#8239;&#8239;</I>No fractional shares of Common Stock shall be issued upon the conversion of any Series&nbsp;A Preferred Shares.&#8239;&#8239;All
Common Shares (including fractions thereof) issuable upon conversion of more than one Series&nbsp;A Preferred Share by a Holder thereof
and all Series&nbsp;A Preferred Shares issuable upon the purchase thereof shall be aggregated for purposes of determining whether the
conversion and/or purchase would result in the issuance of any fractional share.&#8239;&#8239;If, after the aforementioned aggregation,
the conversion and/or purchase would result in the issuance of a fraction of a share of Common Stock, the Corporation shall, in lieu of
issuing any fractional share, either round up the number of shares to the next highest whole number or, at the Corporation&rsquo;s option,
pay the Holder otherwise entitled to such fraction a sum in cash equal to the fair market value of such fraction on the Conversion Date
(as determined in good faith by the Board of Directors of the Corporation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Reorganization,
Merger or Going Private.&#8239;&#8239;</I>In case of any reorganization or any reclassification of the capital stock of the Corporation
or any consolidation or merger of the Corporation with or into any other corporation or corporations or a sale or transfer of all or substantially
all of the assets of the Corporation to any other person or a &ldquo;going private&rdquo; transaction under Rule&nbsp;13e-3 promulgated
pursuant to the Exchange Act, then, as part of such reorganization, consolidation, merger, or transfer if the holders of shares of Common
Stock receive any publicly traded securities as part or all of the consideration for such reorganization, reclassification, consolidation,
merger or sale, then it shall be a condition precedent of any such event or transaction that provision shall be made such that each Series&nbsp;A
Preferred Share shall thereafter be convertible into such new securities at a conversion price and pricing formula which places the Holders
of Series&nbsp;A Preferred Shares in an economically equivalent position as they would have been if not for such event.&#8239;&#8239;The
Corporation shall give each Holder written notice at least ten (10)&nbsp;Trading Days prior to the consummation of any such reorganization,
reclassification, consolidation, merger or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Certificate
for Conversion Ratio Adjustment.</I>&#8239;&#8239;The Corporation shall promptly furnish or cause to be furnished to each Holder a certificate
prepared by the Corporation setting forth any adjustments or readjustments of the Conversion Ratio pursuant to this <U>Section&nbsp;5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Conversion
Limitations.</I> The Corporation shall not effect any conversion of Series&nbsp;A Preferred Shares, and a Holder of Series&nbsp;A Preferred
Shares shall not have the right to convert any portion of its Series&nbsp;A Preferred Shares, pursuant to this <U>Section&nbsp;5</U> or
otherwise, to the extent that after giving effect to such conversion as set forth in this <U>Section&nbsp;5</U>, the Holder of Series&nbsp;A
Preferred Shares (together with the Holder&rsquo;s Affiliates, and any other persons acting as a group together with the Holder or any
of the Holder&rsquo;s Affiliates (such persons, &ldquo;<B><I>Attribution Parties</I></B>&rdquo;)), would beneficially own in excess of
the Beneficial Ownership Limitation (as defined below). Except as set forth in the preceding sentence, for purposes of this <U>Section&nbsp;5(j)</U>,
beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and regulations
promulgated thereunder, it being acknowledged by the Holder of Series&nbsp;A Preferred Shares that the Corporation is not representing
to the Holder of Series&nbsp;A Preferred Shares that such calculation is in compliance with Section&nbsp;13(d)&nbsp;of the Exchange Act
and the Holder of Series&nbsp;A Preferred Shares is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this <U>Section&nbsp;5(j)</U>&nbsp;applies, the determination of whether the Series&nbsp;A
Preferred Shares are convertible (in relation to other securities owned by the Holder of such Series&nbsp;A Preferred Shares together
with any Affiliates and Attribution Parties) and of which portion of the Series&nbsp;A Preferred Shares is convertible shall be in the
sole discretion of the Holder of such Series&nbsp;A Preferred Shares, and the submission of any Conversion Notice shall be deemed to be
the Holder&rsquo;s determination of whether the Series&nbsp;A Preferred Shares are convertible (in relation to other securities owned
by the Holder together with any Affiliates and Attribution Parties) and of which portion of such Series&nbsp;A Preferred Shares is convertible,
in each case subject to the Beneficial Ownership Limitation, and the Corporation shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and regulations promulgated thereunder. For purposes of this <U>Section&nbsp;5(j)</U>,
in determining the number of outstanding shares of Common Stock, a Holder of Series&nbsp;A Preferred Shares may rely on the number of
outstanding shares of Common Stock as reflected in (A)&nbsp;the Corporation&rsquo;s most recent periodic or annual report filed with the
SEC, as the case may be, (B)&nbsp;a more recent public announcement by the Corporation, or (C)&nbsp;a more recent written notice by the
Corporation or Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder
of Series&nbsp;A Preferred Shares, the Corporation shall within one (1)&nbsp;Trading Day confirm orally and in writing to the Holder of
Series&nbsp;A Preferred Shares the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of
Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the Series&nbsp;A
Preferred Shares, held by such Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares
of Common Stock was reported. The &ldquo;<B><I>Beneficial Ownership Limitation</I></B>&rdquo; shall be 49.5% of the number of shares of
Common Stock outstanding immediately after giving effect to the conversion of Series&nbsp;A Preferred Shares for Common Shares. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section&nbsp;5(j)</U>&nbsp;to
correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Automatic
Conversion of Series&nbsp;A Preferred Shares.</I> Notwithstanding anything herein to the contrary, with respect to each Holder of Series&nbsp;A
Preferred Shares, upon the occurrence of a Transfer of Series&nbsp;A Preferred Shares held by such Holder, each share subject to such
Transfer shall automatically, without further action by the Corporation or the Holder thereof, convert into one (1)&nbsp;fully paid and
non-assessable share of Common Stock, provided that the Transfer does not cause the transferee&rsquo;s beneficial ownership of shares
of Common Stock to exceed the Beneficial Ownership Limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.</B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>Voting</U>.</B>&nbsp;
Except as required by law, the Series&nbsp;A Preferred Shares shall be non-voting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Reissuance</U>.</B>&#8239;&#8239;No Series&nbsp;A Preferred Shares acquired by the Corporation by reason of redemption, purchase, conversion
or otherwise shall be reissued.&#8239;&#8239;Series&nbsp;A Preferred Shares issued and reacquired by the Corporation, whether upon redemption,
conversion or otherwise, shall have the status of authorized and unissued undesignated shares of &ldquo;blank check&rdquo; preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitations</U>.</B>&#8239;&#8239;Except
as may otherwise be required by law, the Series&nbsp;A Preferred Shares shall not have any powers, preference or relative participating,
optional or other special rights other than those specifically set forth in this Certificate of Designations (as may be amended from time
to time) or otherwise in the Amended and Restated Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">****</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Corporation has
caused this Certificate of Designations to be executed by a duly authorized officer of the Corporation as of October&nbsp;27, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MULTISENSOR
    AI HOLDINGS,&nbsp;INC.</B></FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#8239;&#8239;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/
    Robert Nadolny</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Robert Nadolny
    &nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&#8239;&#8239;&#8239;Chief Financial Officer
    and Secretary</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Certificate of Designations Signature Page</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(To be Executed by Holder in order to Convert
Series&nbsp;A Preferred Shares)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONVERSION NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SERIES A CONVERTIBLE PREFERRED STOCK</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned, as a holder (&ldquo;<B><I>Holder</I></B>&rdquo;)
of shares of Series&nbsp;A Convertible Preferred Stock (&ldquo;<B><I>Series&nbsp;A Preferred Shares</I></B>&rdquo;) of MultiSensor AI
Holdings,&nbsp;Inc. (the &ldquo;<B><I>Corporation</I></B>&rdquo;), hereby irrevocably elects to convert _____________ Series&nbsp;A Preferred
Shares for shares of common stock, par value $0.0001 per share, of the Corporation (&ldquo;<B><I>Common Shares</I></B>&rdquo;) according
to the terms and conditions of the Certificate of Designations for the Series&nbsp;A Preferred Shares as of the date written below.&#8239;&#8239;The
undersigned hereby requests the Common Shares to be issued pursuant to this Conversion Notice in the name of, and delivered to the undersigned
or its designee as indicated below.&#8239;&#8239;No fee will be charged to the Holder of Series&nbsp;A Preferred Shares for any conversion.&#8239;&#8239;Capitalized
terms used herein and not otherwise defined shall have the meanings ascribed thereto in the Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Conversion Date:&#8239;&#8239;__________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Conversion Information:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
NAME OF HOLDER:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Address of Holder:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>If Common Shares are to be issued to a person
other than Holder, Holder&rsquo;s signature must be guaranteed below</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SIGNATURE GUARANTEED BY:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE COMPUTATION OF NUMBER OF COMMON SHARES TO
BE RECEIVED IS SET FORTH ON PAGE 2 OF THE CONVERSION NOTICE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><B><I>Page&nbsp; <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> to Conversion Notice</I></B></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page&nbsp;2 to Conversion Notice dated</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; ___________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;for:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Conversion Date)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Name of Holder)</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>COMPUTATION OF NUMBER OF COMMON SHARES TO BE
RECEIVED</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="padding-top: 3pt; border-top: black 1pt solid; border-bottom: black 1.5pt solid; border-left: black 1pt solid; text-align: center; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Series&nbsp;A Preferred Shares converted:</FONT></TD>
    <TD STYLE="padding-top: 3pt; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1.5pt solid; border-left: black 1pt solid; text-align: center; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: black 1.5pt solid; border-left: black 1pt solid; text-align: center; padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Series&nbsp;A Preferred Shares converted multiplied by 1,000:</FONT></TD>
    <TD STYLE="padding-top: 3pt; border-right: black 1pt solid; border-bottom: black 1.5pt solid; border-left: black 1pt solid; padding-bottom: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">_______________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Number of Common Shares to be issued)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please issue and deliver _____ certificate(s)&nbsp;for Common Shares
in the following amount(s):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><B><I>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> to Conversion Notice</I></B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>tm2529555d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY&nbsp;NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY&nbsp;BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>mULTISENSOR
AI HOLDINGS,&nbsp;INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 50%">Warrant Shares: [&bull;]</TD>
<TD STYLE="text-align: right; width: 50%"> Issue Date: [&bull;], 2025</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS COMMON STOCK PURCHASE
WARRANT (this &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [_______] or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m.&nbsp;(New York City time) on [____], 2032
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from MultiSensor AI Holdings,&nbsp;Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to [_____] shares of Common Stock (as subject to adjustment hereunder, the
 &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section&nbsp;2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated October&nbsp;24, 2025, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"> a) <U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i)&nbsp;two (2)&nbsp;Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period (as defined in Section&nbsp;2(d)(i)&nbsp;herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in Section&nbsp;2(c)&nbsp;below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3)&nbsp;Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)&nbsp;Trading Day of receipt of such notice. Notwithstanding the foregoing, with respect to any Notice(s)&nbsp;of Exercise delivered on or prior to 4:00 p.m.&nbsp;(New York City time) on the Trading Day prior to the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s)&nbsp;by 4:00 p.m.&nbsp;(New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise Price</U>.
The exercise price per share of Common Stock under this Warrant shall be $0.40978, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless Exercise</U>.
If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not
available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such
time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares equal to
the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">(A)&nbsp;=
as applicable: (i)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such
Notice of Exercise is (1)&nbsp;both executed and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof on a day that is not a Trading
Day or (2)&nbsp;both executed and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof on a Trading Day prior to the opening of
 &ldquo;regular trading hours&rdquo; (as defined in Rule&nbsp;600(b)&nbsp;of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii)&nbsp;at the option of the Holder, either (y)&nbsp;the VWAP on the Trading Day immediately preceding
the date of the applicable Notice of Exercise or (z)&nbsp;the Bid Price of the Common Stock on the principal Trading Market as
reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice
of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after the close of &ldquo;regular trading hours&rdquo; on a
Trading Day) pursuant to Section&nbsp;2(a)&nbsp;hereof or (iii)&nbsp;the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to
Section&nbsp;2(a)&nbsp;hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">(B)&nbsp;=&#8239;the
Exercise Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">(X)&nbsp;=&#8239;the
number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise
were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section&nbsp;3(a)(9)&nbsp;of the Securities
Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any
position contrary to this Section&nbsp;2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.&nbsp;(New York
City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.&nbsp;(New
York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 24px; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics of Exercise</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A)&nbsp;there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B)&nbsp;this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earliest of (i)&nbsp;two (2)&nbsp;Trading Days after the delivery to the Company of the Notice of Exercise, (ii)&nbsp;one (1)&nbsp;Trading
Day after delivery of the aggregate Exercise Price to the Company and (iii)&nbsp;the number of Trading Days comprising the Standard Settlement
Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of
(i)&nbsp;two (2)&nbsp;Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period following delivery
of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees
to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As
used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section&nbsp;2(d)(i)&nbsp;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise in addition to all other rights and remedies
at law, under this Warrant, or otherwise, and such failure shall also be deemed a material breach under this Warrant, and a material breach
under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section&nbsp;2(d)(i)&nbsp;above
pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or
inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an
open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A)&nbsp;pay in cash to the Holder, within one (1)&nbsp;business day of the Holder&rsquo;s request, the amount,
if any, by which (x)&nbsp;the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock
so purchased exceeds (y)&nbsp;the amount obtained by multiplying (1)&nbsp;the number of Warrant Shares that the Company was required to
deliver to the Holder in connection with the exercise at issue times (2)&nbsp;the price at which the sell order giving rise to such purchase
obligation was executed, and (B)&nbsp;at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of
Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder,
within one (1)&nbsp;business day of the Holder&rsquo;s request, the number of shares of Common Stock that would have been issued had the
Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A)&nbsp;of the immediately preceding sentence the Company
shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the
Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">v. <U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form&nbsp;attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another
established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares. The Company
shall pay all attorney fees required for the issuance of attorney legal opinions for removal of restrictive legends on Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section&nbsp;2 or otherwise, unless and until the terms of this Warrant shall have been approved
by the Company&rsquo;s stockholders, and thereafter to the extent that after giving effect to such issuance after exercise as set forth
on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group
together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially
own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common
Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares
of Common Stock which would be issuable upon (i)&nbsp;exercise of the remaining, nonexercised portion of this Warrant beneficially owned
by the Holder or any of its Affiliates or Attribution Parties and (ii)&nbsp;exercise or conversion of the unexercised or nonconverted
portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation
on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section&nbsp;2(e), beneficial ownership shall be calculated
in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and regulations promulgated thereunder, it being acknowledged
by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section&nbsp;13(d)&nbsp;of
the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that
the limitation contained in this Section&nbsp;2(e)&nbsp;applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and
regulations promulgated thereunder. For purposes of this Section&nbsp;2(e), in determining the number of outstanding shares of Common
Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A)&nbsp;the Company&rsquo;s most recent
periodic or annual report filed with the Commission, as the case may be, (B)&nbsp;a more recent public announcement by the Company or
(C)&nbsp;a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the
number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after
giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution
Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership
Limitation</U>&rdquo; shall be [4.99%] [9.99%] [19.99%] of the number of shares of Common Stock outstanding immediately prior to giving
effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase
or decrease the Beneficial Ownership Limitation provisions of this Section&nbsp;2(e), provided that prior to stockholder approval of the
transactions contemplated by the Purchase Agreement, the Beneficial Ownership Limitation in no event exceeds [9.99%] [19.99%] of the number
of shares of the Common Stock outstanding immediately prior to giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section&nbsp;2(e)&nbsp;shall continue to apply. Any increase in the Beneficial
Ownership Limitation shall not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;2(e)&nbsp;to
correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant. [Upon obtaining stockholder approval of the transactions
contemplated by the Purchase Agreement, the Beneficial Ownership Limitation shall no longer apply to 325 Capital.] Notwithstanding anything
herein to the contrary, each Holder&rsquo;s beneficial ownership of securities of the Company, including without limitation after taking
into account the full exercise of this Warrant, shall in no event exceed 49.5% of the issued and outstanding Common Stock, calculated
in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and regulations promulgated thereunder as set forth
above (the &ldquo;<U>Maximum Ownership Limitation</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;3</U>. <U>Preferred
Stock</U>. In the event that this Warrant is not exercisable for shares of Common Stock due to the beneficial ownership of a Holder exceeding
the Maximum Ownership Threshold (based upon the exercise of this Warrant or otherwise), this Warrant shall be exercisable for shares of
the Company&rsquo;s non-voting Series&nbsp;A Preferred Stock, par value $0.0001 per share (the &ldquo;<U>Preferred Stock</U>&rdquo;) that
are convertible into an equivalent number of shares of Common Stock for which this Warrant is exercisable. In such event, references to
Common Stock in this Warrant shall be deemed to refer to the Preferred Stock for so long as such Holder exceeds or would exceed the Maximum
Ownership Limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;4</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock Dividends
and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii)&nbsp;subdivides
outstanding shares of Common Stock into a larger number of shares, (iii)&nbsp;combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv)&nbsp;issues by reclassification of shares of the Common Stock any shares
of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be
the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise
of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this Section&nbsp;4(a)&nbsp;shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification. Notwithstanding anything to the contrary herein, in no event shall the Exercise Price equal less than
$0.14944 per Warrant Share (subject to adjustment for stock splits, combinations and similar events).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section&nbsp;4(a)&nbsp;above, if at any time the Company grants, issues
or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders
of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the
terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the
number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof,
including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent
that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares
of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation). If such distributed property is not delivered to Holder pursuant to the preceding sentence, then upon expiration of or any
exercise of the Warrant that occurs after such record date, such Holder shall remain entitled to receive, in addition to the Warrant Shares
otherwise issuable upon such exercise (if applicable), such property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change
the Company&rsquo;s name), (ii)&nbsp;the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any
sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series
of related transactions, (iii)&nbsp;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or
another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the
voting power of the common equity of the Company, (iv)&nbsp;the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v)&nbsp;the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons other
than 325 Capital or its Affiliates or its or their transferees whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock or more than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section&nbsp;2(e)&nbsp;on the exercise of this Warrant), the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for
which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;2(e)&nbsp;on
the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted
to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock
in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
the foregoing paragraph or anything contained herein to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 60 days after, the
consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of consideration equal to the Black Scholes Value (as defined
below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided,
however, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s
Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration
(and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to
the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of
cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative
forms of consideration in connection with the Fundamental Transaction; provided, further, that if the consideration is in the form of
stock or Alternate Consideration, the number of shares or the amount of Alternate Consideration to be received will be equal to the Black
Scholes Value of the unexercised portion of this Warrant divided by the same price per share used in determining the Black Scholes Value
referenced below in Clause C of this Section&nbsp;4(d). &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based
on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation
of the applicable Fundamental Transaction for pricing purposes and reflecting (A)&nbsp;a risk-free interest rate corresponding to the
U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B)&nbsp;an expected volatility equal to the 100 day volatility, as obtained from the HVT function
on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement
of the applicable contemplated Fundamental Transaction, (C)&nbsp;the underlying price per share used in such calculation shall be the
greater of (i)&nbsp;the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any,
being offered in such Fundamental Transaction and (ii)&nbsp;the greater of (x)&nbsp;the last VWAP immediately preceding the public announcement
of the applicable contemplated Fundamental Transaction and (y)&nbsp;the last VWAP immediately preceding consummation of the applicable
Fundamental Transaction, (D)&nbsp;a remaining option time equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date and (E)&nbsp;a zero cost of borrow. The payment of the Black Scholes Value
will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i)&nbsp;five Business
Days of the Holder&rsquo;s election and (ii)&nbsp;the date of consummation of the Fundamental Transaction. The Company shall cause any
successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to
assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the
provisions of this Section&nbsp;4(d)&nbsp;pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity
or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other
Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had
been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Calculations</U>.
All calculations under this Section&nbsp;4 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section&nbsp;4, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be
the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Notice to
Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section&nbsp;4, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in">ii. <U>Notice to
Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B)&nbsp;the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&nbsp;the Company
shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital
stock of any class or of any rights, (D)&nbsp;the approval of any stockholders of the Company shall be required in connection with any
reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale
or transfer of all or substantially all of its assets, any compulsory share exchange whereby the Common Stock is converted into other
securities, cash or property or Fundamental Transaction, or (E)&nbsp;the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email
to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar
days prior to the applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission,
in which case a notice shall not be required) stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form&nbsp;8-K. The Holder shall remain entitled to exercise this Warrant during the period
commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set
forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">g) <U>Share Combination Event
Adjustment</U>. In addition to the adjustments set forth in this Section&nbsp;4, if at any time on or after the Issue Date there occurs
any share split, reverse share split, share dividend, share combination recapitalization or other similar transaction involving the Common
Stock (each, a &ldquo;<U>Share Combination Event</U>&rdquo;, and such date on which the Share Combination Event is effected, the &ldquo;<U>Share
Combination Event Date</U>&rdquo;) and the lowest VWAP of the Common Stock during the period commencing on the Trading Day immediately
following the applicable Share Combination Event Date and ending on the fifth (5<SUP>th</SUP>) Trading Day immediately following the applicable
Share Combination Event Date (such period the &ldquo;<U>Share Combination Adjustment Period</U>&rdquo; and such price the &ldquo;<U>Event
Market Price</U>&rdquo;) (provided if the Share Combination Event is effective prior to the opening of trading on the Trading Market),
is less than the Exercise Price then in effect (after giving effect to the adjustment in Section&nbsp;4(a)&nbsp;above, then, at the close
of trading on the Trading Market on the last day of the Share Combination Adjustment Period, the Exercise Price then in effect on such
fifth (5<SUP>th</SUP>) Trading Day shall be reduced (but in no event increased) to the Event Market Price and the number of Warrant Shares
issuable upon exercise of this Warrant hereunder (such resulting number, the &ldquo;<U>Share Combination Issuable Shares</U>&rdquo;) shall
be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price, shall
be equal to the aggregate Exercise Price on the Issue Date for the Warrant Shares then outstanding. For the avoidance of doubt, if the
adjustment in this Section&nbsp;4(g)&nbsp;would otherwise result in an increase in the Exercise Price hereunder, no adjustment shall be
made, and if this Warrant is exercised, on any date on which the Holder delivers an Exercise Notice to the Company during the Share Combination
Adjustment Period, solely with respect to such portion of this Warrant exercised on such applicable Exercise Date, such applicable Share
Combination Adjustment Period shall be deemed to have ended on, and include, the Trading Day immediately prior to such Exercise Date and
the Event Market Price on such applicable Exercise Date will be the lowest VWAP of the Common Stock immediately prior to the Share Combination
Event Date and ending on, and including the Trading Day immediately prior to such Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;5</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The Holder shall surrender this Warrant to
the Company within three (3)&nbsp;Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section&nbsp;5(a), as to any transfer which may be involved in such division or combination, the
Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this
Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section&nbsp;6</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No Rights
as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section&nbsp;2(d)(i), except as expressly set
forth in Section&nbsp;4. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section&nbsp;2(c)&nbsp;or to receive cash payments pursuant to Section&nbsp;2(d)(i)&nbsp;and Section&nbsp;2(d)(iv)&nbsp;herein, in
no event, including if the Company is for any reason unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required
pursuant to the terms hereof, shall the Company be required to net cash settle an exercise of this Warrant or cash settle in any other
form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss, Theft,
Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays,&nbsp;etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii)&nbsp;take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page&nbsp;Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MULTISENSOR AI HOLDINGS,&nbsp;INC.</B></FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 47%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Robert Nadolny</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;&nbsp;&nbsp;Chief Financial Officer</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: MULTISENSOR AI HOLDINGS,&nbsp;INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1)&nbsp;The undersigned hereby
elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)&nbsp;Payment shall take
the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">[&#8239;&#8239; ] in lawful money of the United States;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">[&#8239;&#8239; ] if permitted the cancellation of
such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with
respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)&nbsp;Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ____________________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: ______________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ________________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _________________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ____________________________________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature: </FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address: </FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-9.1
<SEQUENCE>5
<FILENAME>tm2529555d1_ex9-1.htm
<DESCRIPTION>EXHIBIT 9.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 9.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Voting Agreement (this
 &ldquo;<U>Agreement</U>&rdquo;), dated as of October&nbsp;30, 2025, is by and among MultiSensor AI Holdings,&nbsp;Inc., a Delaware corporation
with offices located at 2105 West Cardinal Drive, Beaumont, Texas 77705 (the &ldquo;<U>Company</U>&rdquo;), and the Person listed on <U>Schedule&nbsp;A</U>
hereto (&ldquo;<U>Key Holder</U>&rdquo; and, collectively with the Company, the &ldquo;<U>Parties</U>&rdquo;). Except as otherwise defined
herein, capitalized terms have the meanings given to them in the Purchase Agreement (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Key
Holder, as of the date hereof, is the Beneficial Owner (as defined below) of the number of shares of the Company&rsquo;s common stock,
par value $0.0001 per share (&ldquo;<U>Common Stock</U>&rdquo;), set forth opposite Key Holder&rsquo;s name on <U>Schedule A</U> hereto
(such shares, the &ldquo;<U>Existing Shares</U>&rdquo; and, together with any additional shares of Common Stock acquired pursuant to <U>Section&nbsp;1(c)</U>,
the &ldquo;<U>Shares</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company proposes to enter into that certain securities purchase agreement, dated as of or about the date hereof (the &ldquo;<U>Purchase
Agreement</U>&rdquo;), with each purchaser identified on the signature pages&nbsp;thereto (each, including its successors and assigns,
a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;), pursuant to which, among other things, the Purchasers
shall purchase, and the Company shall issue and sell, for an aggregate purchase price of $13,999,998.83, (a)&nbsp;34,229,826 shares of Common
Stock, and (b)&nbsp;Warrants, which shall be exercisable for shares of Common Stock (the &ldquo;<U>Warrant Shares</U>&rdquo;), in substantially
the form attached as Exhibit&nbsp;B to the Purchase Agreement, upon the terms and conditions set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Pursuant
to the terms of the Purchase Agreement, and to induce the Company to execute and deliver the Purchase Agreement, the Company and Key Holder
desires to enter into this Agreement to set forth their agreements and understandings with respect to how shares of Common Stock held
by Key Holder shall be voted in connection with certain matters contemplated thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchasers are not intended third-party beneficiaries of this Agreement and shall not have any right to enforce the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the foregoing and the respective representations, warranties, covenants and agreements set forth in this Agreement and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD STYLE="text-align: justify"><B>SHARES SUBJECT TO THIS AGREEMENT; TRANSFER RESTRICTIONS.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Key
Holder irrevocably and unconditionally agrees to hold their Shares during the term of this Agreement subject to, and to vote their Shares
in accordance with, the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Until
the earlier to occur of (A)&nbsp;the date upon which the stockholders of the Company, in any annual, special or adjourned meeting of the
stockholders of the Company, or by written consent in lieu of any such meeting, approve the matters contemplated by <U>Section&nbsp;2(a)(i)-(ii)</U>,
and (B)&nbsp;the termination of the Purchase Agreement in accordance with its terms, Key Holder covenants and agrees that Key Holder shall
not directly or indirectly, (i)&nbsp;transfer, sell, offer, exchange, assign, gift, pledge, convey any legal or Beneficial Ownership interest
in, or otherwise dispose of (by merger (including by conversion into securities or other consideration), by tendering into any tender
or exchange offer, by operation of law, or otherwise), or encumber (each, a &ldquo;<U>Transfer</U>&rdquo;), any of the Shares, (ii)&nbsp;deposit
any of the Shares into a voting trust or enter into a voting agreement or arrangement with respect to any of the Shares or grant any proxy
or power of attorney with respect thereto which is inconsistent with this Agreement, or (iii)&nbsp;enter into any contract, option or
other arrangement or undertaking with respect to, or consent to, a Transfer of any of the Shares or Key Holder&rsquo;s voting or economic
interest therein. Any attempted Transfer of any Shares or any interest therein in violation of this <U>Section&nbsp;1(b)</U>&nbsp;shall
be null and void. Notwithstanding the foregoing, and subject to <U>Section&nbsp;5(i)</U>&nbsp;below, this <U>Section&nbsp;1(b)</U>&nbsp;shall
not prohibit a Transfer of the Shares by Key Holder if, as a precondition to such Transfer, the transferee agrees in a writing to be bound
by all of the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Key
Holder agrees that all shares of Common Stock that Key Holder purchases, acquires the right to vote, or otherwise acquires Beneficial
Ownership of, after the execution of this Agreement and prior to the termination of this Agreement, shall be subject to the terms and
conditions of this Agreement and shall constitute Shares for all purposes of this Agreement. In the event of any stock split, stock dividend,
merger, reorganization, recapitalization, reclassification, combination, exchange of shares, or the like of the capital stock of the Company
affecting the Shares, the terms of this Agreement shall apply to the resulting securities and such resulting securities shall be deemed
to be &ldquo;Shares&rdquo; for all purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
purposes of this Agreement, &ldquo;<U>Beneficially Own</U>&rdquo; or &ldquo;<U>Beneficial Ownership</U>&rdquo; shall have the meaning
assigned to such term in Rule&nbsp;13d-3 under the Securities Exchange Act of 1934, as amended, and a person&rsquo;s beneficial ownership
of securities shall be calculated in accordance with the provisions of such rule&nbsp;(in each case, irrespective of whether or not such
rule&nbsp;is actually applicable in such circumstance). For the avoidance of doubt, the terms &ldquo;Beneficially Own&rdquo; and &ldquo;Beneficial
Ownership&rdquo; shall also include record ownership of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>AGREEMENT TO VOTE SHARES.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
any annual, special, or adjourned meeting of the stockholders of the Company, and in every written consent in lieu of any such meeting,
at which the transactions contemplated by the Purchase Agreement are presented to the Company&rsquo;s stockholders for approval, Key Holder
agrees that it shall vote, by proxy or otherwise, the Shares (i)&nbsp;in favor of the transactions contemplated by the Purchase Agreement
and any matter that would reasonably be expected to facilitate such transactions (including, without limitation, any proposal for the
Company to obtain Stockholder Approval (as defined in the Purchase Agreement) waiving the Exchange Cap (as defined in the Purchase Agreement)
or seeking an increase in the authorized number of shares of Common Stock to permit the Company to issue shares of Common Stock to the
Purchasers as contemplated by the Purchase Agreement), (ii)&nbsp;against approval of any proposal made in opposition to the transactions
contemplated by the Purchase Agreement and (iii)&nbsp;in favor of any proposal to implement the most favored nation provision in favor
of the Purchasers contemplated by Section&nbsp;4.23 of the Purchase Agreement in each instance such most favored nation provision is implicated.
Key Holder shall retain at all times the right to vote its Shares in its sole discretion and without any other limitation on those matters
other than those set forth in this <U>Section&nbsp;2(a)</U>&nbsp;that are at any time or from time to time presented for consideration
to the Company&rsquo;s stockholders generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that a meeting of the stockholders of the Company is held, Key Holder shall, or shall cause the holder of record on any applicable
record date to, appear at such meeting or otherwise cause Key Holder&rsquo;s Shares to be counted as present thereat for purposes of establishing
a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
the foregoing, nothing in this Agreement shall limit or restrict Key Holder from acting in its capacity as a director or officer of the
Company, to the extent applicable, it being understood that this Agreement shall apply to Key Holder in its capacity as a stockholder
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Irrevocable
Proxy and Power of Attorney</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Key
Holder hereby irrevocably grants to and appoints, and hereby authorizes and empowers, the Company, and any individual designated in writing
by it, and each of them individually, as the Key Holder&rsquo;s sole and exclusive proxy and attorney-in-fact (with full power of substitution
and resubstitution), for and in the Key Holder&rsquo;s name, place and stead, to vote and exercise all voting and related rights (to the
fullest extent the Key Holder is entitled to do so) with respect to its Shares at any meeting of the stockholders of the Company called,
and in every written consent in lieu of such meeting, with respect to any of the matters specified in, and in accordance and consistent
with, <U>Section&nbsp;2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">ii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Key
Holder understands and acknowledges that the Company is entering into the Purchase Agreement in reliance upon Key Holder&rsquo;s execution
and delivery of this Agreement. Key Holder hereby affirms that the irrevocable proxy set forth in this <U>Section&nbsp;2(d)</U>&nbsp;constitutes
an inducement for the Company to enter into the Purchase Agreement. Except as otherwise provided for herein, the Key Holder hereby (a)&nbsp;affirms
that the irrevocable proxy is coupled with an interest and may under no circumstances be revoked, (b)&nbsp;ratifies and confirms all that
the proxies appointed hereunder may lawfully do or cause to be done by virtue hereof; and (c)&nbsp;affirms that such irrevocable proxy
is executed and intended to be irrevocable in accordance with the provisions of Section&nbsp;212(e)&nbsp;of the Delaware General Corporation
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">iii.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
the execution of this Agreement by the Key Holder, the Key Holder hereby revokes any and all prior proxies or powers of attorney given
by the Key Holder with respect to the Shares. The Key Holder acknowledges and agrees that no subsequent proxies with respect to such Shares
shall be given, and if given, shall not be effective or ineffective <I>ab initio. </I>All authority conferred herein shall be binding
upon and enforceable against any successors or assigns of the Key Holder and any permitted transferees of the Shares. Notwithstanding
any other provisions of this Agreement, the irrevocable proxy granted hereunder shall automatically terminate upon the termination of
this Agreement in accordance with <U>Section&nbsp;5(o)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>REPRESENTATIONS, WARRANTIES, AND OTHER COVENANTS OF KEY HOLDER.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Key Holder hereby represents,
warrants, and covenants to the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Key
Holder is the legal or beneficial owner of, and has the power to vote, the Existing Shares set forth on the signature page&nbsp;hereto.
The Existing Shares set forth next to Key Holder&rsquo;s name on the signature page&nbsp;hereof are owned free of any encumbrance that
would preclude Key Holder from exercising his, her or its voting power as provided in <U>Section&nbsp;2</U> or otherwise complying with
the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Key
Holder has all requisite power, legal capacity and authority to enter into this Agreement. This Agreement has been duly executed and delivered
by Key Holder and, assuming the due authorization, execution and delivery of this Agreement by the Company, constitutes a valid and binding
obligation of Key Holder, enforceable against Key Holder in accordance with its terms, except as limited by (i)&nbsp;applicable bankruptcy,
insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of creditors' rights generally, and
(ii)&nbsp;laws relating to the availability of specific performance, injunctive relief or other equitable remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
execution, delivery and performance by Key Holder of this Agreement shall not (i)&nbsp;conflict with, require a consent, waiver or approval
under, or result in a breach of or default under, any of the terms of any agreement to which Key Holder is a party or by which any of
Key Holder&rsquo;s assets are bound, or (ii)&nbsp;violate any order, writ, injunction, decree, judgment or any applicable law applicable
to Key Holder or any of Key Holder&rsquo;s assets, except for any such conflict, violation or any failure to obtain such consent, waiver
or approval that would not result in the Key Holder being able to perform its obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Key
Holder agrees that he, she, or it shall not, in his, her, or its capacity as a stockholder of the Company, bring, commence, institute,
maintain, prosecute or voluntarily aid any action, claim, suit or cause of action, in law or in equity, in any court or before any governmental
entity, which (i)&nbsp;challenges the validity of or seeks to enjoin the operation of any provision of this Agreement or (ii)&nbsp;alleges
that the execution and delivery of this Agreement by Key Holder, or the approval of the Purchase Agreement by the Company&rsquo;s Board
of Directors, breaches any fiduciary duty of the Board of Directors or any member thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Key
Holder shall not, directly or indirectly, take any action that would make any representation or warranty contained herein untrue or incorrect
in any material respects or in any way have the effect of restricting, limiting, interfering with, preventing or disabling Key Holder
from performing his, her or its obligations in any material respects under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD STYLE="text-align: justify"><B>CONFIDENTIALITY.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as required by applicable
law, Key Holder, until such time as the transactions contemplated by the Purchase Agreement are required to be publicly disclosed by the
Company as described in the Purchase Agreement, shall maintain the confidentiality of any information regarding this Agreement, the Purchase
Agreement, and the transactions contemplated hereby and thereby. Neither the Key Holder, nor any of its respective affiliates, shall issue
or cause the publication of any press release or other public announcement with respect to this Agreement, the Purchase Agreement or the
transactions contemplated hereby or thereby without the prior written consent of the Company, except as may be required by law or by any
listing agreement with, or the policies of, The Nasdaq Stock Market, in which circumstance such announcing party shall make all reasonable
efforts to consult with the Company in advance of such publication to the extent practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD STYLE="text-align: justify"><B>MISCELLANEOUS.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Ownership Interest</U>. Nothing contained in this Agreement shall be deemed to vest in the Company any direct or indirect ownership or
incidence of ownership of or with respect to any Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Third Party Beneficiaries</U>. Each Party acknowledges and agrees that the Parties are the only intended beneficiaries of this Agreement,
and that no third parties (including the Purchasers) may enforce the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
All notices, requests, and other communications hereunder shall be in writing and shall be deemed to have been duly given and received
(a)&nbsp;when personally delivered, (b)&nbsp;when sent by facsimile or email upon confirmation of receipt, (c)&nbsp;one business day after
the day on which the same has been delivered prepaid to a nationally recognized courier service, or (d)&nbsp;five business days after
the deposit in the United States mail, registered or certified, return receipt requested, postage prepaid, in each case addressed, as
to the Company, to the address or email address set forth below the Company&rsquo;s signature on the signature page&nbsp;of this Agreement,
and as to any Key Holder at the address, facsimile number or email address set forth with respect to Key Holder on <U>Schedule A</U> attached
to this Agreement. Any Party hereto from time to time may change its address, facsimile number, email address, or other information for
the purpose of notices to that Party by giving notice specifying such change to the other Parties hereto. Key Holder and the Company may
each agree in writing to accept notices and other communications to it hereunder by electronic communications pursuant to procedures reasonably
approved by it; provided that approval of such procedures may be limited to particular notices or communications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Interpretation.</U>
When a reference is made in this Agreement to sections, such reference shall be to a section of this Agreement unless otherwise indicated.
The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation
of this Agreement. The words &ldquo;include,&rdquo; &ldquo;includes&rdquo; and &ldquo;including&rdquo; when used herein shall be deemed
in each case to be followed by the words &ldquo;without limitation.&rdquo; The phrases &ldquo;the date of this Agreement,&rdquo; &ldquo;the
date hereof,&rdquo; and terms of similar import, unless the context otherwise requires, shall be deemed to refer to the date first above
written. Unless the context of this Agreement otherwise requires: (i)&nbsp;words of any gender include each other gender; (ii)&nbsp;words
using the singular or plural number also include the plural or singular number, respectively; and (iii)&nbsp;the terms &ldquo;hereof,&rdquo;
 &ldquo;herein,&rdquo; &ldquo;hereunder&rdquo; and derivative or similar words refer to this entire Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendments;
Waiver</U>. This Agreement may be amended by the Parties hereto, and the terms and conditions hereof may be waived, only by an instrument
in writing signed on behalf of each of the Parties hereto, or, in the case of a waiver, by an instrument signed on behalf of the Party
waiving compliance. The failure of either Party hereto to exercise any right, power or remedy provided under this Agreement or otherwise
available in respect of this Agreement at law or in equity, or to insist upon compliance by any other Party with its obligation under
this Agreement, and any custom or practice of the Parties at variance with the terms of this Agreement, shall not constitute a waiver
by such Party of such Party's right to exercise any such or other right, power or remedy or to demand such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Rules&nbsp;of
Construction</U>. The Parties hereto hereby waive the application of any law, regulation, holding or rule&nbsp;of construction providing
that ambiguities in an agreement or other document will be construed against the Party drafting such agreement or document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Specific
Performance; Injunctive Relief</U>. The Parties hereto agree that the Company will be irreparably harmed and that there will be no adequate
remedy at law for a violation of any of the covenants or agreements of Key Holder set forth herein. Therefore, it is agreed that, in addition
to any other remedies that may be available to the Company upon any such violation of this Agreement, the Company shall have the right
to enforce such covenants and agreements by specific performance, injunctive relief or by any other means available to the Company at
law or in equity and Key Holder hereby waives any and all defenses which could exist in its favor in connection with such enforcement
and waives any requirement for the security or posting of any bond in connection with such enforcement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Counterparts</U>.
This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same instrument and shall become
effective when one or more counterparts have been signed by each of the Parties and delivered to the other Parties hereto; it being understood
that all Parties need not sign the same counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Entire
Agreement; Non-Assignability; Parties in Interest; Death or Incapacity</U>. This Agreement and the documents and instruments and other
agreements specifically referred to herein or delivered pursuant hereto (i)&nbsp;constitute an inducement and condition to the Company
to enter into the Purchase Agreement, (ii)&nbsp;constitute the entire agreement among the Parties with respect to the subject matter hereof
and supersede all prior agreements and understandings, both written and oral, among the Parties with respect to the subject matter hereof
and (iii)&nbsp;are not intended to confer, and shall not be construed as conferring, upon any person other than the Parties hereto (including
the Purchasers) any rights or remedies hereunder. Neither this Agreement nor any of the rights, interests, or obligations under this Agreement
may be assigned or delegated, in whole or in part, by operation of law or otherwise, by Key Holder without the prior written consent of
the Company, and any such assignment or delegation that is not consented to shall be null and void. This Agreement, together with any
rights, interests or obligations of the Company hereunder, may be assigned or delegated in whole or in part by the Company to any affiliate
of the Company without the consent of or any action by Key Holder upon notice by the Company to the Key Holder as herein provided. Subject
to the preceding sentence, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by, the Parties hereto and
their respective permitted successors and assigns. All authority conferred herein shall survive the death or incapacity of a Key Holder
and in the event of Key Holder&rsquo;s death or incapacity, any obligation of Key Holder hereunder shall be binding upon the heirs, personal
representatives, successors and assigns of Key Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Additional
Documents</U>. Key Holder shall execute and deliver any additional documents necessary or desirable in the reasonable opinion of the Company
to carry out the purpose and intent of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction
to be illegal, void or unenforceable, the remainder of this Agreement shall continue in full force and effect and the application of such
provision to other persons or circumstances shall be interpreted so as reasonably to effect the intent of the Parties hereto. The Parties
hereto further agree to use their commercially reasonable efforts to replace such void or unenforceable provision of this Agreement with
a valid and enforceable provision that shall achieve, to the extent possible, the economic, business and other purposes of such void or
unenforceable provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies
Cumulative</U>. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a Party shall be deemed cumulative
with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and the exercise by a Party of any one
remedy shall not preclude the exercise of any other remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law; Consent to Jurisdiction</U>. This Agreement, and the provisions, rights, obligations, and conditions set forth herein, and the legal
relations between the Parties hereto, including all disputes and claims, whether arising in contract, tort, or under statute, shall be
governed by and construed in accordance with the laws of the State of Delaware without giving effect to its conflict of law provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Expenses</U>.
All costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the Party
incurring the expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement shall terminate and shall have no further force or effect from and after the earlier to occur of (i)&nbsp;date upon which
the stockholders of the Company, in any annual, special or adjourned meeting of the stockholders of the Company, or by written consent
in lieu of any such meeting, approve the matters contemplated by <U>Section&nbsp;2(a)</U>, and (ii)&nbsp;the termination of the Purchase
Agreement in accordance with its terms; provided, that no such termination shall relieve any Party from liability for any willful or intentional
breach of this Agreement prior to such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>WAIVER
OF JURY TRIAL</U>. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM
(WHETHER BASED ON CONTRACT, TORT, OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF ANY PARTY HERETO IN NEGOTIATION,
ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Parties have executed this Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MULTISENSOR AI HOLDINGS,&nbsp;INC.</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Robert Nadolny</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Chief Financial Officer</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for notices:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">2105 West Cardinal Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Beaumont, Texas 77705</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Attention: Robert Nadolny</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Email: robert.nadolny@multisensorai.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Signature
Page&nbsp;to Voting Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Parties have executed this Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KEY HOLDER:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[NAME] </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Signature
Page&nbsp;to Voting Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>KEY HOLDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 65%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name and Address</B></FONT></TD>
    <TD STYLE="width: 35%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Existing Shares</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 5.75pt"><P STYLE="margin-top: 0; margin-bottom: 0"><B><U>[NAME]&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></B> <U></U> </P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><U>[Address]&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&#8239;&nbsp;&nbsp;&nbsp;</U></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><U>[Address&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&#8239;&nbsp;&nbsp;&nbsp;</U></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Email:&#8239;<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</U></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 5.75pt; text-align: right">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Schedule A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>tm2529555d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase
Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of October&nbsp;24, 2025 (the &ldquo;<U>Subscription Date</U>&rdquo;), between
MultiSensor AI Holdings,&nbsp;Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature
pages&nbsp;hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section&nbsp;4(a)(2)&nbsp;of the Securities Act (as defined below), and Rule&nbsp;506
promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement for an aggregate amount of at least
$9,000,000 and up to $14,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE,&nbsp;IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;I.<FONT STYLE="font-size: 10pt"><BR>
DEFINITIONS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section&nbsp;1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>325 Capital</U>&rdquo;
means 325 Capital, LLC, or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Additional
Shares</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Additional
Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Beneficial
owner</U>,&rdquo; &ldquo;<U>beneficially own</U>&rdquo; and &ldquo;<U>beneficial ownership</U>&rdquo; shall have the meaning set forth
in Rule&nbsp;13d-3 promulgated by the SEC under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Certificate
of Designation</U>&rdquo; means the Certificate of Designation of the Preferred Stock, attached to this Agreement as <U>Exhibit&nbsp;D</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Haynes and Boone LLP, with offices located at 2801 N. Harwood St., Dallas, Texas 75201, Attention: Matthew L.
Fry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means any Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i)&nbsp;if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m.&nbsp;(New York City
time) and before midnight (New York City time) on any Trading Day, 9:01 a.m.&nbsp;(New York City time) on the Trading Day immediately
following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii)&nbsp;if this Agreement
is signed between midnight (New York City time) and 9:00 a.m.&nbsp;(New York City time) on any Trading Day, no later than 9:01 a.m.&nbsp;(New
York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of (a)&nbsp;the date that the initial Registration Statement has been declared effective by the Commission,
(b)&nbsp;the date that all of the Shares and Warrant Shares have been sold pursuant to Rule&nbsp;144 or may be sold pursuant to Rule&nbsp;144
without the requirement for the Company to be in compliance with the current public information required under Rule&nbsp;144 and without
volume or manner-of-sale restrictions, (c)&nbsp;the one (1)-year anniversary of the Final Closing Date, provided that a holder of Shares
or Warrant Shares is not an Affiliate of the Company, or (d)&nbsp;the date that all of the Shares and Warrant Shares may be sold pursuant
to an exemption from registration under Section&nbsp;4(a)(1)&nbsp;of the Securities Act without volume or manner-of-sale restrictions
and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders
of the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such
holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow
Agent</U>&rdquo; means, in such capacity, Continental Stock Transfer&nbsp;&amp; Trust Company..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow
Agreement</U>&rdquo; means the written agreement between the Company, the Placement Agent and the Escrow Agent on the date hereof for
the Escrow Agent to act as escrow agent in connection with the offering and sale by the Company of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Cap</U>&rdquo; means 6,970,899 shares of Common Stock (such number of shares equal to 19.99% of the number of shares of Common Stock
issued and outstanding immediately prior to the Subscription Date), which number of shares shall be reduced, on a share-for-share basis,
by the number of shares of Common Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated
with the transactions contemplated by this Agreement under applicable rules&nbsp;of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a)&nbsp;shares of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company,
(b)&nbsp;securities upon the exercise, exchange, or conversion of any Securities issued hereunder and/or other securities exercisable
or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such
securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise
price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend
the term of such securities, and (c)&nbsp;securities issued pursuant to asset acquisitions, business combinations, business acquisitions
or strategic transactions approved by a majority of the disinterested and independent directors of the Company, provided that such securities
are issued as &ldquo;restricted securities&rdquo; (as defined in Rule&nbsp;144) and carry no registration rights that require or permit
the filing of any registration statement in connection therewith during the prohibition period in Section&nbsp;4.11(a)&nbsp;herein, and
provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company
additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Final
Closing</U>&rdquo; means the closing of the purchase and sale of all of the Additional Shares and Additional Warrants pursuant to this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Final
Closing Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i)&nbsp;the Purchasers&rsquo; obligations to pay the full Subscription Amount and (ii)&nbsp;the
Company&rsquo;s obligations to deliver the Additional Shares and Additional Warrants, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Closing</U>&rdquo; means the closing of the purchase and issuance of the Initial Shares and Initial Warrants pursuant to Section&nbsp;2.1(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Closing Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i)&nbsp;the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii)&nbsp;the
Company&rsquo;s obligations to deliver the Initial Shares and the Initial Warrants, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Closing Statement</U>&rdquo; means the Initial Closing Statement in the form on <U>Annex A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Shares</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Warrants</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;2.1(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lien</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Nasdaq</U>&rdquo;
means The Nasdaq Stock Market LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $0.409, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the written agreement between the Company and the Placement Agent on the date hereof for the Placement
Agent to act as the exclusive placement agent in connection with the offering and sale by the Company of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Roth Capital Partners, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Preferred
Stock</U>&rdquo; means the non-voting Series&nbsp;A Preferred Stock of the Company, par value $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit&nbsp;A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Shares and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;144</U>&rdquo;
means Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;
means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants, and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule&nbsp;200 of Regulation SHO under the Exchange Act (but shall
not be deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules&nbsp;and regulations of the Nasdaq (or any successor
entity) from the stockholders of the Company with respect to the transactions contemplated by the Transaction Documents, including the
issuance of all of the Shares and Warrant Shares in excess of 19.99% of the issued and outstanding Common Stock on the Subscription Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page&nbsp;of this Agreement and next to the headings &ldquo;Initial Subscription Amount&rdquo;
and &ldquo;Additional Subscription Amount&rdquo; in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsequent
Financing</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.22.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company disclosed in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Registration Rights Agreement, the Voting Agreements, all exhibits and schedules
thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means, in such capacity, Continental Stock Transfer&nbsp;&amp; Trust Company, the current transfer agent of the Company,
with a mailing address of 1 State Street, 30th Floor, New York, NY 10004 and email addresses of vamodeo@continentalstock.com; and oplink@continentalstock.com,
and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.11(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Voting
Agreements</U>&rdquo; means the written agreements, in the form of <U>Exhibit&nbsp;C</U> attached hereto, of certain stockholders of
the Company on the date hereof to vote all Common Stock over which such Persons have voting control as of the record date for the meeting
of stockholders of the Company, amounting to, in the aggregate, at least 36.5% of the issued and outstanding Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if
the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the
Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants, in the form of <U>Exhibit&nbsp;B</U> attached hereto, delivered to the Purchasers
in accordance with Section&nbsp;2.2 hereof, with an exercise price of $0.409.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;II.<FONT STYLE="font-size: 10pt"><BR>
PURCHASE AND SALE</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Closings</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Initial
Closing</U>. On the Initial Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with
the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not
jointly, agree to purchase, (a)&nbsp;the number of Shares set forth under the heading &ldquo;Initial Subscription Amount&rdquo; on the
Purchaser&rsquo;s signature page&nbsp;hereto at the Per Share Purchase Price, provided, however, that the Shares issued shall not exceed
the Exchange Cap (the &ldquo;<U>Initial Shares</U>&rdquo;), and (b)&nbsp;Warrants to purchase up to a number of shares of Common Stock
equal to 200% of the Initial Shares set forth under the heading &ldquo;Initial Subscription Amount&rdquo; on the Purchaser&rsquo;s signature
page&nbsp;hereto, subject to adjustment therein (the &ldquo;<U>Initial Warrants</U>&rdquo;). Each Purchaser shall deliver to the Escrow
Agent (i)&nbsp;the aggregate Per Share Purchase Price for the Initial Shares and Initial Warrants and (ii)&nbsp;the aggregate Per Share
Purchase Price for the Additional Shares and Additional Warrants to the Escrow Agent (the &ldquo;<U>Additional Subscription Amounts</U>&rdquo;),
via wire transfer, immediately available funds, with the sum of such amounts to be delivered pursuant to clauses (i)&nbsp;and (ii)&nbsp;above
equal to such Purchaser&rsquo;s &ldquo;Total Subscription Amount&rdquo; as set forth on the signature page&nbsp;hereto executed by such
Purchaser, and the Company shall deliver to each Purchaser its respective Initial Shares and Initial Warrants, as determined pursuant
to Section&nbsp;2.2(a). On the Initial Closing Date, the Escrow Agent shall release to the Company the Initial Subscription Amount paid
by the Purchasers pursuant to the terms of the Escrow Agreement. The Company and each Purchaser shall deliver the other items set forth
in Section&nbsp;2.2 deliverable at the Initial Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and
2.3, the Initial Closing shall take place remotely by electronic transfer of the Initial Closing documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Subsequent
Closing</U>. On the Final Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and
the Purchasers, severally and not jointly, agree to purchase, (a)&nbsp;the number of Shares set forth under the heading &ldquo;Additional
Subscription Amount&rdquo; on the Purchaser&rsquo;s signature page&nbsp;hereto at the Per Share Purchase Price (the &ldquo;<U>Additional
Shares</U>&rdquo;), and (b)&nbsp;Warrants to purchase up to a number of shares of Common Stock equal to 200% of the Additional Shares
set forth under the heading &ldquo;Additional Subscription Amount&rdquo; on the Purchaser&rsquo;s signature page&nbsp;hereto, subject
to adjustment therein (the &ldquo;<U>Additional Warrants</U>&rdquo;). On the Final Closing Date, the Escrow Agent shall release to the
Company the Additional Subscription Amounts previously paid by the Purchasers pursuant to the terms of the Escrow Agreement. The Company
and each Purchaser shall deliver the other items set forth in Section&nbsp;2.2 deliverable at the Final Closing. Upon satisfaction of
the covenants and conditions set forth in Sections 2.2 and 2.3, the Final Closing shall take place remotely by electronic transfer of
the Final Closing documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to the Initial Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
legal opinion of Company Counsel, in form and substance satisfactory to the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
evidencing a number of the Initial Shares, registered in the name of such Purchaser, or, at the election of such Purchaser, evidence
of the issuance of such Purchaser&rsquo;s Initial Shares hereunder as held in DRS book-entry form by the Transfer Agent and registered
in the name of such Purchaser, which evidence shall be reasonably satisfactory to such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
Warrant in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 200% of the Initial Shares, subject
to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief
Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Voting Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Registration Rights Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to the Initial Closing Date, each Purchaser shall deliver or cause to be delivered to the Company or the Escrow Agent, as applicable,
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;this
Agreement duly executed by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
the Escrow Agent, such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in the Escrow Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Voting Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Registration Rights Agreement duly executed by such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to the Final Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
evidencing the Additional Shares, registered in the name of such Purchaser, or, at the election of such Purchaser, evidence of the issuance
of such Purchaser&rsquo;s Shares hereunder as held in DRS book-entry form by the Transfer Agent and registered in the name of such Purchaser,
which evidence shall be reasonably satisfactory to such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
Warrant in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 200% of the Additional Shares, subject
to adjustment therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
bringdown legal opinion of Company Counsel, in form and substance satisfactory to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
obligations of the Company hereunder in connection with each of the Initial Closing and the Final Closing are subject to the following
conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) on
the Initial Closing Date or the Final Closing Date, as applicable, of the representations and warranties of the Purchasers contained
herein (unless as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations
or warranties are qualified by materiality, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Initial Closing Date or the Final
Closing Date, as applicable, shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
delivery by each Purchaser of the items set forth in Section&nbsp;2.2(b)&nbsp;of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
respective obligations of the Purchasers hereunder in connection with each of the Initial Closing and the Final Closing are subject to
the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and as of the Initial Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date) and, as of the Final Closing Date, of the
representations and warranties of the Company in Section&nbsp;3.1(b), (d)&nbsp;and (f)&nbsp;(unless as of a specific date therein in
which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality
or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
obligations, covenants and agreements of the Company required to be performed at or prior to the Initial Closing Date or the Final Closing
Date, as applicable, shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
delivery by the Company of the items set forth in Section&nbsp;2.2(a)&nbsp;as of the Initial Closing Date and Section&nbsp;2.2(c)&nbsp;of
this Agreement as of the Final Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;there
shall have been no Material Adverse Effect with respect to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;as
of the Final Closing Date, the Company shall have obtained the Stockholder Approval;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Board of Directors shall have approved the Certificate of Designations; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;from
the date hereof to the Final Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Final Closing Date, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported
by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York
State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international
calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable
judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Initial Closing or the Final Closing,
as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;III.<FONT STYLE="font-size: 10pt"><BR>
REPRESENTATIONS AND WARRANTIES</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser as of the date hereof
and the Initial Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them
in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority
to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary
is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i)&nbsp;a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii)&nbsp;a
material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company
and the Subsidiaries, taken as a whole, or (iii)&nbsp;a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document (any of (i), (ii)&nbsp;or (iii), a &ldquo;<U>Material Adverse
Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i)&nbsp;as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which
it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i)&nbsp;conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)&nbsp;subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii)&nbsp;and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)&nbsp;the filings
required pursuant to Section&nbsp;4.4 of this Agreement, (ii)&nbsp;the filing with the Commission pursuant to the Registration Rights
Agreement, (iii)&nbsp;the notice and/or application(s)&nbsp;to each applicable Trading Market for the issuance and sale of the Securities
and the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, (iv)&nbsp;the filing of
Form&nbsp;D with the Commission and such filings as are required to be made under applicable state securities laws, (v)&nbsp;Stockholder
Approval and (vi)&nbsp;any corporate or stockholder approvals required in connection with the rights under Section&nbsp;4.23 of this
Agreement (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Issuance
of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than
restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the terms of the
Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other
than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock
the maximum number of Shares issuable pursuant to this Agreement and upon exercise in full of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U>&nbsp;shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof
and shall include the number of shares of Common Stock assuming issued and outstanding assuming the completion of the transactions contemplated
by this Agreement and the other Transaction Documents. As of the Subscription Date, except as set forth on <U>Schedule 3.1(g)</U>, the
Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to
the exercise of employee stock options under the Company&rsquo;s long-term incentive plans, the issuance of shares of Common Stock to
employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock
Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. Other than the Purchasers,
no Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except for the Securities or as provided herein or as set forth on <U>Schedule 3.1(g)</U>,
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents
or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue
shares of Common Stock or other securities to any Person (other than the Purchasers). Except for the Securities or as provided herein,
there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion,
exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. Except for the
Securities or as provided herein, there are no outstanding securities or instruments of the Company or any Subsidiary that contain any
redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital
stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal
and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to
subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required
for the issuance and sale of the Securities. Except as contemplated hereby, there are no stockholders agreements, voting agreements or
other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the
Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;thereof,
for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred
to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has
filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all
material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when
filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has
never been an issuer subject to Rule&nbsp;144(i)&nbsp;under the Securities Act. The financial statements of the Company included in the
SEC Reports comply in all material respects with applicable accounting requirements and the rules&nbsp;and regulations of the Commission
with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States
generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except
as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not
contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, (i)&nbsp;there has been no event, occurrence or development that has had or that could reasonably be expected to result
in a Material Adverse Effect, (ii)&nbsp;the Company has not incurred any liabilities (contingent or otherwise) other than (A)&nbsp;trade
payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B)&nbsp;liabilities not
required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii)&nbsp;the Company has not altered its method of accounting, (iv)&nbsp;the Company has not declared or made any dividend or distribution
of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v)&nbsp;the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing
Company long-term incentive plans. The Company does not have pending before the Commission any request for confidential treatment of
information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence
or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or
their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least one (1)&nbsp;Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Litigation</U>.
There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;).
Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim
of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to
the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any
current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their
relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is,
or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information
agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and
the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with
respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign
laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except
where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance</U>.
Neither the Company nor any Subsidiary: (i)&nbsp;is in default under or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company
or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit
agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not
such default or violation has been waived), (ii)&nbsp;is in violation of any judgment, decree, or order of any court, arbitrator or other
governmental authority or (iii)&nbsp;is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority,
including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health
and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Environmental
Laws</U>. The Company and its Subsidiaries (i)&nbsp;are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii)&nbsp;have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii)&nbsp;are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii)&nbsp;and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in
each case free and clear of all Liens, except for (i)&nbsp;Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii)&nbsp;Liens for the
payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment
of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2)&nbsp;years from the date of this
Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within
the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge
of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any
of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not
limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any
Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transactions
with Affiliates and Employees</U>. Other than as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to
any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i)&nbsp;payment
of salary or consulting fees for services rendered, (ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the
Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules&nbsp;and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Initial Closing Date. The Company and
the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i)&nbsp;transactions
are executed in accordance with management&rsquo;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii)&nbsp;access to assets
is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv)&nbsp;the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and
15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required
to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported,
within the time periods specified in the Commission&rsquo;s rules&nbsp;and forms. The Company&rsquo;s certifying officers have evaluated
the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by
the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented
in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness
of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have
been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its
Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting
of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this
Section&nbsp;that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section&nbsp;3.2, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby.
The issuance and sale of the Securities hereunder does not contravene the rules&nbsp;and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The
Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Rights</U>. Other than as disclosed in <U>Schedule 3.1(w)</U>&nbsp;and other than with respect to each of the Purchasers, no Person has
any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company
or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section&nbsp;12(b)&nbsp;or 12(g)&nbsp;of the Exchange Act,
and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as disclosed in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in
the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently
eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is
current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such
electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their
obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s
issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information (other than any information that may have been to provided
to a directors of the Company in such capacity). The Company understands and confirms that the Purchasers will rely on the foregoing
representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company
to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including
the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they
were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement
taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not
misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to
the transactions contemplated hereby other than those specifically set forth in Section&nbsp;3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section&nbsp;3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i)&nbsp;the Securities Act which would require the registration
of any such securities under the Securities Act, or (ii)&nbsp;any applicable stockholder approval provisions of any Trading Market on
which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Initial Closing Date, after giving effect to the receipt by the
Company of the proceeds from the sale of the Securities hereunder, (i)&nbsp;the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii)&nbsp;the Company&rsquo;s assets do not constitute unreasonably small capital to carry on
its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital
requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof,
and (iii)&nbsp;the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of
its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its
liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts
as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge
of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Final Closing Date. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo;
means (x)&nbsp;any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in
the ordinary course of business), (y)&nbsp;all guaranties, endorsements and other contingent obligations in respect of indebtedness of
others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of
business; and (z)&nbsp;the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Tax
Status</U>. Except as disclosed on <U>Schedule 3.1(cc)</U> and except for matters that would not, individually or in the aggregate, have
or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i)&nbsp;has made or filed all
United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by
any jurisdiction to which it is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material
in amount, shown or determined to be due on such returns, reports and declarations and (iii)&nbsp;has set aside on its books provision
reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations
apply. Except as disclosed on <U>Schedule 3.1(cc)</U>, there are no unpaid taxes in any material amount claimed to be due by the taxing
authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other &ldquo;accredited investors&rdquo; within the meaning of Rule&nbsp;501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Foreign
Corrupt Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i)&nbsp;directly or indirectly, used any funds for unlawful contributions,
gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii)&nbsp;made any unlawful payment
to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii)&nbsp;failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its
behalf of which the Company is aware) which is in violation of law or (iv)&nbsp;violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Accountants</U>.
The Company&rsquo;s independent registered public accounting firm is Weaver and Tidwell, L.L.P. To the knowledge and belief of the Company,
such accounting firm (i)&nbsp;is a registered public accounting firm as required by the Exchange Act and (ii)&nbsp;shall express its
opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report on Form&nbsp;10-K for the fiscal
year ending December&nbsp;31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Disagreements with Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(g)&nbsp;and 4.14 hereof), it is understood and acknowledged by the Company that: (i)&nbsp;none of the Purchasers has
been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities
of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term, (ii)&nbsp;past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short
Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities, (iii)&nbsp;any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock and (iv)&nbsp;each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y)&nbsp;one or more Purchasers may
engage in hedging activities at various times during the period that the Securities are outstanding, and (z)&nbsp;such hedging activities
(if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted.&nbsp;The Company acknowledges that such aforementioned hedging activities do not constitute a breach
of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Regulation
M Compliance.</U>&nbsp;The Company has not, and to its knowledge no one acting on its behalf has, (i)&nbsp;taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii)&nbsp;sold, bid for, purchased, or paid any compensation for soliciting purchases of,
any of the Securities, or (iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii)&nbsp;and (iii), compensation paid to the Placement Agent in connection
with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i)&nbsp;in accordance
with the terms of the Company&rsquo;s stock option plan and (ii)&nbsp;with an exercise price at least equal to the fair market value
of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted
under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no
Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with,
the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results
or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Cybersecurity</U>.&nbsp;(i)(x)&nbsp;There
has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology
and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors
and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;)
and (y)&nbsp;the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably
be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii)&nbsp;the Company and the Subsidiaries
are presently in compliance with all applicable laws or statutes and all judgments, orders, rules&nbsp;and regulations of any court or
arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security
of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification,
except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have
implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity,
continuous operation, redundancy and security of all IT Systems and Data; and (iv)&nbsp;the Company and the Subsidiaries have implemented
backup and disaster recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section&nbsp;897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(oo)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of
1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of
a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules&nbsp;and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(qq)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule&nbsp;506 under the Securities
Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company
participating in the offering hereunder, any beneficial owner of twenty percent (20%) or more of the Company&rsquo;s outstanding voting
equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule&nbsp;405 under the Securities
Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together,
 &ldquo;<U>Issuer Covered Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule&nbsp;506(d)(1)(i)&nbsp;to
(viii)&nbsp;under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by
Rule&nbsp;506(d)(2)&nbsp;or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject
to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule&nbsp;506(e),
and has furnished to the Purchasers a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(rr)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Other
Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that
has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ss)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Final Closing
Date of (i)&nbsp;any Disqualification Event relating to any Issuer Covered Person and (ii)&nbsp;any event that would, with the passage
of time, become a Disqualification Event relating to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Initial Closing Date and the Final Closing Date to the Company as follows (unless as of a specific date therein,
in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i)&nbsp;as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii)&nbsp;insofar as indemnification and contribution provisions may be limited by
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Own
Account</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered under
the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with
a view to or for distributing or reselling such Shares or any part thereof in violation of the Securities Act or any applicable state
securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Warrants, it will be, an &ldquo;accredited investor&rdquo; as defined in Rule&nbsp;501(a)(1), (a)(2), (a)(3), (a)(7),
(a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General
Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over
television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded (i)&nbsp;the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii)&nbsp;access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii)&nbsp;the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment.&nbsp;Such Purchaser acknowledges and agrees that
neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with
respect to the Securities nor is such information or advice necessary or desired.&nbsp;Neither the Placement Agent nor any Affiliate
has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may
have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it.&nbsp;In connection
with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial
advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other
portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets
managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to
other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors,
partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures
made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing,
for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the
representations contained in this Section&nbsp;3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s
representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document
or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions
contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation
or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV.<FONT STYLE="font-size: 10pt"><BR>
OTHER AGREEMENTS OF THE PARTIES</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule&nbsp;144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section&nbsp;4.1(b), the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and
the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration
Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchasers agree to the imprinting, so long as is required by this Section&nbsp;4.1, of a legend on any of the Securities in the following
form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">THIS SECURITY HAS NOT BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY&nbsp;NOT BE OFFERED OR SOLD EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY
MAY&nbsp;BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION
THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a)&nbsp;UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or
grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as
defined in Rule&nbsp;501(a)&nbsp;under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of
any required prospectus supplement under Rule&nbsp;424(b)(3)&nbsp;under the Securities Act or other applicable provision of the Securities
Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Certificates
evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section&nbsp;4.1(b)&nbsp;hereof),
(i)&nbsp;while a registration statement (including the Registration Statement) covering the resale of such security is effective under
the Securities Act, (ii)&nbsp;following any sale of such Shares or Warrant Shares pursuant to Rule&nbsp;144, (iii)&nbsp;if such Shares
are eligible for sale under Rule&nbsp;144, without the requirement for the Company to be in compliance with the current public information
required under Rule&nbsp;144 as to such Shares and without volume or manner-of-sale restrictions, or (iv)&nbsp;if such legend is not
required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff
of the Commission); provided that in the case of clauses (ii), (iii)&nbsp;and (iv), the Purchaser shall have first delivered a duly completed
customary representation letter as may be reasonably requested by counsel to the Company. The Company shall, at its expense, cause its
counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer
Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Warrant
is exercised at a time when there is an effective registration statement to cover the resale of the Warrant Shares, or if such Shares
or Warrant Shares may be sold under Rule&nbsp;144 and the Company is then in compliance with the current public information required
under Rule&nbsp;144, or if the Shares or Warrant Shares may be sold under Rule&nbsp;144 without the requirement for the Company to be
in compliance with the current public information required under Rule&nbsp;144 as to such Shares or Warrant Shares or if such legend
is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission) then such Shares or Warrant Shares shall be issued free of all legends. The Company agrees that
following the Effective Date or at such time as such legend is no longer required under this Section&nbsp;4.1(c), it will, no later than
the earlier of (i)&nbsp;two (2)&nbsp;Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period
(as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares, issued
with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser
a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation on
its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section&nbsp;4. Certificates
for Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of
the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Shares, issued with
a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i)&nbsp;as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Shares
or Warrant Shares are submitted to the Transfer Agent) delivered for removal of the restrictive legend together with a duly completed
customary representation letter as may be reasonably requested by counsel to the Company and subject to Section&nbsp;4.1(c), $10 per
Trading Day (increasing to $20 per Trading Day three (3)&nbsp;Trading Days after the Legend Removal Date) for each Trading Day after
the Legend Removal Date until such certificate is delivered without a legend and (ii)&nbsp;if the Company fails to (a)&nbsp;issue and
deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Shares or Warrant Shares
so delivered to the Company by such Purchaser that is free from all restrictive and other legends and (b)&nbsp;if after the Legend Removal
Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale
by such Purchaser of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal
to all or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any
restrictive legend, then, an amount equal to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions
and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket
expenses, if any) (the &ldquo;<U>Buy-In Price</U>&rdquo;) over the product of (A)&nbsp;such number of Shares or Warrant Shares that the
Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B)&nbsp;the lowest closing sale price of
the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the
applicable Shares or Warrant Shares and ending on the date of such delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section&nbsp;4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Furnishing
of Information; Public Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Until
the earlier of time that (i)&nbsp;no Purchaser owns Securities or (ii)&nbsp;the Warrants have expired, the Company covenants to maintain
the registration of the Common Stock under Section&nbsp;12(b)&nbsp;or 12(g)&nbsp;of the Exchange Act and to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;At
any time during the period commencing from the six (6)&nbsp;month anniversary of the date hereof and ending at such time that all of
the Securities may be sold without the requirement for the Company to be in compliance with Rule&nbsp;144(c)(1)&nbsp;and otherwise without
restriction or limitation pursuant to Rule&nbsp;144, if the Company (i)&nbsp;shall fail for any reason to satisfy the current public
information requirement under Rule&nbsp;144(c)&nbsp;or (ii)&nbsp;has ever been an issuer described in Rule&nbsp;144(i)(1)(i)&nbsp;or
becomes an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule&nbsp;144(i)(2)&nbsp;(a &ldquo;<U>Public
Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser,
in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities,
an amount in cash equal to two percent (2.0%) of the aggregate Subscription Amount of such Purchaser&rsquo;s Securities on the day of
a Public Information Failure and on every thirtieth (30<SUP>th</SUP>) day (pro rated for periods totaling less than thirty days) thereafter
until the earlier of (a)&nbsp;the date such Public Information Failure is cured and (b)&nbsp;such time that such public information is
no longer required&nbsp;for the Purchasers to transfer the Shares and Warrant Shares pursuant to Rule&nbsp;144.&nbsp;The payments to
which a Purchaser shall be entitled pursuant to this Section&nbsp;4.2(b)&nbsp;are referred to herein as &ldquo;<U>Public Information
Failure Payments</U>.&rdquo;&nbsp;Public Information Failure Payments shall be paid on the earlier of (i)&nbsp;the last day of the calendar
month during which such Public Information Failure Payments are incurred and (ii)&nbsp;the third (3<SUP>rd</SUP>) Business Day after
the event or failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information
Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated
for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public
Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section&nbsp;2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require
the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities
for purposes of the rules&nbsp;and regulations of any Trading Market such that it would require stockholder approval prior to the closing
of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a)&nbsp;by the Disclosure Time, issue a press release disclosing the material terms
of the transactions contemplated hereby, and (b)&nbsp;file a Current Report on Form&nbsp;8-K, including the Transaction Documents as
exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release,
the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any
of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or
agents, including, without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents
(with the exception of any information provided solely to a director of the Company in his or her capacity as a director of the Company).
In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality
or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective
officers, directors, agents, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and
any of the Purchasers or any of their Affiliates on the other hand, shall terminate and be of no further force or effect; provided that
this sentence shall not apply to fiduciary duties of directors of the Company or with respect to any confidentiality agreements with
325 Capital. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect
to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make
any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the
prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or
delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with
prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name
of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market,
without the prior written consent of such Purchaser, except (a)&nbsp;as required by federal securities law in connection with (i)&nbsp;any
registration statement contemplated by the Registration Rights Agreement and (ii)&nbsp;the filing of final Transaction Documents with
the Commission and (b)&nbsp;to the extent such disclosure is required by law or Trading Market regulations, in which case the Company
shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b)&nbsp;and reasonably cooperate with
such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Stockholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; (or similarly used term) under any control share acquisition, business combination, poison
pill (including any distribution under a rights agreement) or similar anti-takeover plan (a &ldquo;<U>Stockholder Rights Plan</U>&rdquo;)
or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any
such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the
Company and the Purchasers. The Company shall not adopt any Stockholder Rights Plan that would prevent any Purchaser and its Affiliates
from beneficially owning up to 49.5% of the issued and outstanding Common Stock, computed in accordance with Section&nbsp;13(d)&nbsp;of
the Exchange Act and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section&nbsp;4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees, counsel or Affiliates delivers any material,
non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser
shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of
their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade
on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant
to a Current Report on Form&nbsp;8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company. This Section&nbsp;4.6 shall not apply to 325 Capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes and other
general corporate purposes and shall not use such proceeds: (a)&nbsp;for the satisfaction of any portion of the Company&rsquo;s Indebtedness
(other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b)&nbsp;for the redemption
of any Common Stock or Common Stock Equivalents, (c)&nbsp;for the settlement of any outstanding litigation or (d)&nbsp;in violation of
FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section&nbsp;4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, stockholder, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers, stockholders, agents,
members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by the
Company in this Agreement or in the other Transaction Documents or (b)&nbsp;any action instituted against the Purchaser Parties in any
capacity (including a Purchaser Party&rsquo;s status as an investor), or any of them or their respective Affiliates, by the Company or
any stockholder of the Company who is not an Affiliate of such Purchaser Party, arising out of or relating to any of the transactions
contemplated by the Transaction Documents. For the avoidance of doubt, the indemnification provided herein is intended to, and shall
also cover, direct claims brought by the Company against the Purchaser Parties; provided, however, that such indemnification shall not
cover any loss, claim, damage or liability to the extent it is finally judicially determined to be attributable to any Purchaser Party&rsquo;s
breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in any Transaction Document or
any conduct by a Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct.
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such
Purchaser Party shall promptly notify the Company in writing, and, except with respect to direct claims brought by the Company, the Company
shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i)&nbsp;the employment thereof
has been specifically authorized by the Company in writing, (ii)&nbsp;the Company has failed after a reasonable period of time to assume
such defense and to employ counsel or (iii)&nbsp;in such action there is, in the reasonable opinion of counsel to the applicable Purchaser
Party (which may be internal counsel), a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement for any settlement by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed. In addition, if any
Purchaser Party takes actions to collect amounts due under any Transaction Documents or to enforce the provisions of any Transaction
Documents, then the Company shall pay the costs incurred by such Purchaser Party for such collection, enforcement or action, including,
but not limited to, attorneys' fees and disbursements. The indemnification and other payment obligations required by this Section&nbsp;4.8
shall be made by periodic payments of the amount thereof during the course of the investigation, defense, collection, enforcement or
action, as and when bills are received or are incurred; provided, that if any Purchaser Party is finally judicially determined not to
be entitled to indemnification or payment under this Section&nbsp;4.8, such Purchaser Party shall promptly reimburse the Company for
any payments that are advanced under this sentence. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at
all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue
Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Listing
of Common Stock; Stockholder Approval; Reimbursement of Warrant Purchase Price</U>. The Company hereby agrees to use best efforts to
maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the
Initial Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure
the listing of all of the Shares and Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have
the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and
will take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading
Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its
Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under
the bylaws or rules&nbsp;of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer
through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of
fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer. In addition,
the Company shall file a proxy statement on Schedule 14A within fifteen (15) days of the Initial Closing and hold a special meeting of
stockholders (which may also be at the annual meeting of stockholders) at the earliest practical date after the date following the filing
thereof for the purpose of obtaining Stockholder Approval, with the recommendation of the Company&rsquo;s Board of Directors that such
proposal be approved, and the Company shall solicit proxies from its stockholders in connection therewith in the same manner as all other
management proposals in such proxy statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal.
The Company shall use its reasonable best efforts to obtain such Stockholder Approval. In the event the Company fails to obtain Stockholder
Approval as contemplated by the terms hereof by February&nbsp;28, 2026, each Purchaser shall be refunded all pre-paid aggregate amounts
for the Additional Shares and Additional Warrants paid by such Purchaser as promptly as practicable following the Company&rsquo;s failure
to obtain such Stockholder Approval in accordance with the terms of the Escrow Agreement, but in any event no later than three (3)&nbsp;Trading
Days thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Subsequent
Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;From
the date hereof until 90 days after the later of the receipt of Stockholder Approval or the Effective Date, neither the Company nor any
Subsidiary shall (i)&nbsp;issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common
Stock or Common Stock Equivalents or (ii)&nbsp;file any registration statement or any amendment or supplement thereto, in each case other
than as contemplated pursuant to the Registration Rights Agreement; provided that nothing herein shall prohibit the Company from supplementing
or amending any existing registration statement in order to keep such registration statement current.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;From
the date hereof until 24 months after the date of the Final Closing, the Company shall be prohibited from effecting or entering into
an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction absent the prior approval of the Company&rsquo;s Finance Committee. &ldquo;<U>Variable
Rate Transaction</U>&rdquo; means a transaction in which the Company (i)&nbsp;issues or sells any debt or equity securities that are
convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either (A)&nbsp;at
a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations
for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B)&nbsp;with a conversion,
exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security
or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market
for the Common Stock or (ii)&nbsp;enters into, or effects a transaction under, any agreement, including, but not limited to, an equity
line of credit or an &ldquo;at-the-market offering&rdquo; whereby the Company may issue securities at a future determined price, regardless
of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled.
Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be
in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[Reserved].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
the foregoing, this Section&nbsp;4.11 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall
be an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it,
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short
Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such
time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described
in Section&nbsp;4.4.&nbsp;Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section&nbsp;4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information
included in the Disclosure Schedules (other than as disclosed to its legal and other representatives).&nbsp;Notwithstanding the foregoing
and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i)&nbsp;no
Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of
the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section&nbsp;4.4, (ii)&nbsp;no Purchaser shall be restricted or prohibited from effecting any transactions
in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section&nbsp;4.4 and (iii)&nbsp;no
Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries,
or any of their respective officers, directors, employees, Affiliates or agent, including, without limitation, the Placement Agent after
the issuance of the initial press release as described in Section&nbsp;4.4. Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the
portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Form&nbsp;D;
Blue Sky Filings</U>. The Company agrees to timely file a Form&nbsp;D with respect to the Securities as required under Regulation D and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Final Closing
under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions
promptly upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Capital
Changes</U>. Until the one (1)-year anniversary of the date of this Agreement, the Company shall not undertake a reverse or forward stock
split or reclassification of the Common Stock without the prior approval of the Company&rsquo;s Finance Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>[Reserved]</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acknowledgment
of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common
Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under
the Transaction Documents, including, without limitation, its obligation to issue the Shares pursuant to the Transaction Documents, are
unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any
such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have
on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.18&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers
to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise
the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions
and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.19&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance
with Rules&nbsp;of Trading Market</U>. Until the Stockholder Approval is obtained, the Company shall not issue or sell any shares of
Common Stock to the Purchasers hereunder to the extent that, after giving effect thereto, the aggregate number of shares of Common Stock
that would be issued pursuant to this Agreement and the transactions contemplated hereby would exceed 6,970,899 (such number of shares
equal to 19.99% of the number of shares of Common Stock issued and outstanding immediately prior to the Subscription Date), which number
of shares shall be reduced, on a share-for-share basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction
or series of transactions that may be aggregated with the transactions contemplated by this Agreement under applicable rules&nbsp;of
the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.20&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Board
Size. </U> Until the two (2)-year anniversary of the Final Closing, the Company shall not increase the size of the Board of Directors
to more than seven (7)&nbsp;directors without the prior written consent of 325 Capital</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.21&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Future
Purchases of Company Equity Securities</U>. From and after the date of this Agreement and except as contemplated by this Agreement, each
Purchaser represents, warrants and agrees that it will not purchase equity or equity-linked securities of the Company if such purchase
would cause the Purchaser and its Affiliates to beneficially own more that 49.5% of the issued and outstanding Common Stock, computed
in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and regulations promulgated thereunder, absent the
prior approval of the Company&rsquo;s Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.22&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Participation
in Future Financings</U></FONT>. <FONT STYLE="font-size: 10pt">The Company agrees to afford each Purchaser the opportunity to participate
in any financing involving the issuance by the Company of Common Stock or Common Stock Equivalents (the &ldquo;<U>Subsequent Financing</U>&rdquo;)
on the same terms, conditions and price provided for in the Subsequent Financing, and in an amount not to exceed their pro rata interest
in the Company, computed on a fully diluted basis; provided however that this right to participate in future financing shall be null
and void to the extent that any such participation would cause the Purchaser and its Affiliates to beneficially own more that 49.5% of
the issued and outstanding Common Stock, computed in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and
regulations promulgated thereunder, absent the prior approval of the Company&rsquo;s Board of Directors, and the Company shall make provision
to issue non-voting equity or equity-linked securities to a purchaser upon exercise of such right in lieu of voting equity to the extent
such limit would otherwise be exceeded; provided further however that neither this Section&nbsp;4.22 nor the participation rights of
325 Capital under the Securities Purchase Agreement dated June&nbsp;27, 2024, by and between the Company and 325 Capital shall apply
to any sale under any equity line of credit or &ldquo;at the market offering&rdquo; approved by the Company&rsquo;s Finance Committee.
Such participation right shall not be in duplication of any other participation rights of the Purchasers, and the Purchasers agree that
the execution of this Subscription Agreement shall be deemed to satisfy all preemptive rights of the Purchasers with respect to sales
of securities of the Company through the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.23&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Most
Favored Nation Status</U>. Subject to the listing rules&nbsp;of Nasdaq and any required approvals of the Company&rsquo;s stockholders,
from the date hereof through the date that no Warrants are outstanding, the Company shall not enter into any public or private offering
of its equity or equity-linked securities (including securities convertible into shares of Common Stock) with any individual or entity
(an &ldquo;<U>Other Investor</U>&rdquo;) that has the effect of establishing rights or otherwise benefiting such Other Investor in a
manner more favorable to such Other Investor than the rights and benefits established in favor of the Purchasers by the Warrants and
the Transaction Documents, unless, in any such case, the (i)&nbsp;the Company shall notify the Purchasers of such additional or more
favorable term within five (5)&nbsp;Business Days of the issuance of the respective security, and (ii)&nbsp;such term, at the Purchaser&rsquo;s
option, shall become a part of the Transaction Documents with the Company (regardless of whether the Company complied with the notification
provision of this Section&nbsp;4.23). The types of terms contained in another security that may be more favorable to the holder of such
security include, but are not limited to, terms addressing redemption features, rights of first refusal, dividends and conversion lookback
periods. To the extent any such adjustment shall require stockholder approval under the listing rules&nbsp;of Nasdaq, the Company shall
use commercially reasonable efforts to obtain such stockholder approval, and such adjustment shall not become effective until such stockholder
approval has been obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.24&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Preferred
Stock</U>. The Company shall take such steps as are necessary to adopt the Certificate of Designations prior to the Initial Closing Date
and issue the Preferred Stock upon the occurrence of the events specified in Section&nbsp;3 of the Warrant. To the extent that the Preferred
Stock is to be issued to the Purchaser upon exercise of the Warrant, such Purchaser shall have the right to exercise the Warrant on a
cashless basis based on the market price of the Common Stock at the time of exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;V.<FONT STYLE="font-size: 10pt"><BR>
MISCELLANEOUS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.&nbsp;This
Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Final Closing has not
been consummated on or before February&nbsp;28, 2026; <U>provided</U>, <U>however</U>, that no such termination will affect the right
of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fees
and Expenses</U>. At the Initial Closing, the Company has agreed to reimburse 325 Capital the non-accountable sum of $100,000 for its
legal fees and expenses, and has agreed to reimburse the Placement Agent for its legal fees and expenses as set forth in the Placement
Agency Agreement. The Company shall deliver to each Purchaser, prior to the Initial Closing, a completed and executed copy of the Initial
Closing Statement, attached hereto as <U>Annex A</U>. Except as expressly set forth in the Transaction Documents to the contrary, each
party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred
by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay
all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered
by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the
delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered via
facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages&nbsp;attached hereto at
or prior to 5:30 p.m.&nbsp;(New York City time) on a Trading Day, (b)&nbsp;the next Trading Day after the time of transmission, if such
notice or communication is delivered via email attachment at the email address as set forth on the signature pages&nbsp;attached hereto
on a day that is not a Trading Day or later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (c)&nbsp;the second (2<SUP>nd</SUP>)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d)&nbsp;upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages&nbsp;attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial
Subscription Amounts hereunder or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought,
provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers),
the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with
respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver
of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any
party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately,
materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the
other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with
this Section&nbsp;5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,
by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third-party beneficiary of the representations and warranties of the
Company in Section&nbsp;3.1 and the representations and warranties of the Purchasers in Section&nbsp;3.2. This Agreement is intended
for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any
provision hereof be enforced by, any other Person, except as otherwise set forth in Section&nbsp;4.8 and this Section&nbsp;5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the
obligations of the Company under Section&nbsp;4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing
party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Survival</U>.
The (a)&nbsp;representations and warranties contained herein and (b)&nbsp;the agreements between the parties set forth in Article&nbsp;IV
shall survive the Final Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page&nbsp;were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any
of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind
or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in
whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and
hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law
would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a
Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or
any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The
Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained
in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company
and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Liquidated
Damages</U>.&nbsp;The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Saturdays,
Sundays, Holidays,&nbsp;etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule&nbsp;of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference
to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,&nbsp;IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Pages&nbsp;Follow]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"><B>MULTISENSOR AI HOLDINGS, INC.</B></TD><TD STYLE="width: 50%; text-align: left"><U>Address for Notice:</U></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">MultiSensor AI Holdings, Inc.</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">2105 West Cardinal Drive</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Beaumont, Texas 77705</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Attention: Chief Financial Officer</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Email:robert.nadolny@multisensorai.com</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD>By:</TD><TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 3%">&nbsp;</TD><TD STYLE="text-align: left; width: 5%">Name:</TD><TD STYLE="text-align: justify; width: 42%">Robert Nadolny</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify">Chief Financial Officer</TD>
    <TD>&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Haynes and Boone LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2801 N. Harwood St., Ste. 2300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dallas, Texas 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Matthew L. Fry</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE
AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
has caused this Securities Purchase Agreement to be duly executed by its respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory: _____________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Shares to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Initial Subscription Amount</U></B>: $[__________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Initial Shares of Common Stock: _________________<SUP></SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Initial Warrant Shares: _________________<SUP></SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Additional Subscription Amount</U></B>: $[________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additional Shares of Common Stock: _______________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additional Warrant Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Total Subscription Amount</U></B>: $[________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Warrants Beneficial Ownership Blocker</U></B>: <FONT STYLE="font-family: Wingdings">&#168;</FONT>
4.99% or <FONT STYLE="font-family: Wingdings">&#168;</FONT> 9.99% or <FONT STYLE="font-family: Wingdings">&#168;</FONT> 19.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>ANNEX A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INITIAL CLOSING STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the attached
Securities Purchase Agreement, dated as of the date hereto, the Purchasers shall purchase an aggregate of $[______] of Common Stock and
Warrants from MultiSensor AI Holdings,&nbsp;Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;). A portion of the funds will
be wired to the Company and the balance of the funds will be wired into an account maintained by the Escrow Agent and disbursed to the
Company in accordance with the terms of the Escrow Agreement, in each case as indicated below. All funds will be disbursed in accordance
with this Initial Closing Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -1.25in"><B>Disbursement
Date:</B>&#9;October&nbsp;[__], 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; width: 85%"></TD><TD STYLE="width: 15%; text-align: left">&nbsp;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>I.
                                            &nbsp;<U>PURCHASE PRICE</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P></TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 27%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 51%; padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gross
    Proceeds to be Received </B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 22%; padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>II.&nbsp;<U>DISBURSEMENTS</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Amount Disbursed:</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>WIRE
                                            INSTRUCTIONS</U>:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Please see attached.</B></P></TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acknowledged and agreed to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">this [___] day of October, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[____________________________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 45%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>Name:</TD><TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>Title:</TD><TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>7
<FILENAME>tm2529555d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of October&nbsp;30, 2025, between MultiSensor AI Holdings,&nbsp;Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages&nbsp;hereto (each, including its successors and
assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;). This Agreement is made pursuant to the
Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the mutual
covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged,
the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Capitalized terms used
and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.</B>
As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section&nbsp;6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the thirtieth (30<SUP>th</SUP>)
calendar day following the Filing Date and with respect to any additional Registration Statements which may be required pursuant to Section&nbsp;2(c)&nbsp;or
Section&nbsp;3(c), the thirtieth (30<SUP>th</SUP>) calendar day following the date on which an additional Registration Statement is required
to be filed hereunder; <U>provided</U>, <U>however</U>, that in the event the Company is notified by the Commission that one or more of
the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date
as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such date precedes
the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness
Date shall be the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section&nbsp;2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section&nbsp;2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section&nbsp;2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the forty-fifth (45<SUP>th</SUP>) calendar
day following the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section&nbsp;2(c)&nbsp;or
Section&nbsp;3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration
Statement related to the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section&nbsp;5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section&nbsp;5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section&nbsp;5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Plan of
Distribution</U>&rdquo; shall have the meaning set forth in Section&nbsp;2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule&nbsp;430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a)&nbsp;all Shares, (b)&nbsp;all Warrant Shares (or Preferred Stock, if
applicable) then issued and issuable upon exercise of the Warrants (assuming on such date the Warrants are exercised in full without regard
to any exercise limitations therein), (c)&nbsp;any additional shares of Common Stock issued and issuable in connection with any anti-dilution
provisions in the Warrants (without giving effect to any limitations on exercise set forth in the Warrants), (d)&nbsp;any Common Stock
issuable upon conversion of the Preferred Stock, and (e)&nbsp;any securities issued or then issuable upon any stock split, dividend or
other distribution, recapitalization or similar event with respect to the foregoing; <U>provided, however</U>, that any such Registrable
Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file
another, Registration Statement hereunder with respect thereto) for so long as (i)&nbsp;a Registration Statement with respect to the sale
of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been
disposed of by the Holder in accordance with such effective Registration Statement, (ii)&nbsp;such Registrable Securities have been previously
sold in accordance with Rule&nbsp;144, or (iii)&nbsp;such securities become eligible for resale without volume or manner-of-sale restrictions
and without current public information pursuant to Rule&nbsp;144 as set forth in a written opinion letter to such effect, addressed, delivered
and acceptable to the Transfer Agent and the affected Holders (assuming that such securities and any securities issuable upon exercise,
conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any
Affiliate of the Company, as reasonably determined by the Company, upon the advice of counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section&nbsp;2(a)&nbsp;and any additional
registration statements contemplated by Section&nbsp;2(c)&nbsp;or Section&nbsp;3(c), including (in each case) the Prospectus, amendments
and supplements to any such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto,
and all material incorporated by reference or deemed to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;415</U>&rdquo;
means Rule&nbsp;415 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;
means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted from
time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section&nbsp;3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i)&nbsp;any publicly available written or oral guidance of the Commission staff, or any comments, requirements or requests of the
Commission staff and (ii)&nbsp;the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">2.&#8239;&#8239;&#8239;&#8239;&#8239;<U>Shelf
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all
of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous
basis pursuant to Rule&nbsp;415. Each Registration Statement filed hereunder shall be on Form&nbsp;S-3 (except if the Company is not then
eligible to register for resale the Registrable Securities on Form&nbsp;S-3, in which case such registration shall be on another appropriate
form in accordance herewith, subject to the provisions of Section&nbsp;2(e)). Subject to the terms of this Agreement, the Company shall
use its best efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under Section&nbsp;3(c))
to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the
applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement continuously effective under the Securities
Act until the date that all Registrable Securities covered by such Registration Statement (i)&nbsp;have been sold, thereunder or pursuant
to Rule&nbsp;144, or (ii)&nbsp;may be sold without volume or manner-of-sale restrictions pursuant to Rule&nbsp;144 and without the requirement
for the Company to be in compliance with the current public information requirement under Rule&nbsp;144, as determined by the counsel
to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders
(the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness of a Registration Statement as
of 5:00 p.m.&nbsp;(New York City time) on a Trading Day. The Company shall immediately notify the Holders via e-mail of the effectiveness
of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which
shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m.&nbsp;(New York City time)
on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by
Rule&nbsp;424. Failure to so notify the Holder within one (1)&nbsp;Trading Day of such notification of effectiveness or failure to file
a final Prospectus as foresaid shall be deemed an Event under Section&nbsp;2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
the registration obligations set forth in Section&nbsp;2(a), if the Commission informs the Company that all of the Registrable Securities
cannot, as a result of the application of Rule&nbsp;415, be registered for resale as a secondary offering on a single registration statement,
the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the
Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered
by the Commission, on Form&nbsp;S-3 or such other form available to register for resale the Registrable Securities as a secondary offering,
subject to the provisions of Section&nbsp;2(e); with respect to filing on Form&nbsp;S-3 or other appropriate form, and subject to the
provisions of Section&nbsp;2(d)&nbsp;with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to
filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of
all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation
612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT>Notwithstanding
any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section&nbsp;2(d), if the Commission
or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration
Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the
registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable
Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced or eliminated to exclude
any securities other than Registrable Securities. In the event of a cutback hereunder, the Company shall give the Holder at least three
(3)&nbsp;Trading Days prior written notice along with the calculations as to such Holder&rsquo;s allotment. In the event the Company amends
the Initial Registration Statement in accordance with the foregoing, the Company will use its best efforts to file with the Commission,
as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration
statements on Form&nbsp;S-3 or such other form available to register for resale those Registrable Securities that were not registered
for resale on the Initial Registration Statement, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If:
(i)&nbsp;the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section&nbsp;3(a)&nbsp;herein
or the Company subsequent withdraws the filing of the Registration Statement, the Company shall be deemed to have not satisfied this clause
as of the Filing Date (i)), or (ii)&nbsp;the Company fails to file with the Commission a request for acceleration of a Registration Statement
in accordance with Rule&nbsp;461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the date that
the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo;
or will not be subject to further review, or (iii)&nbsp;prior to the effective date of a Registration Statement, the Company fails to
file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement
within ten (10)&nbsp;calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order
for such Registration Statement to be declared effective, or (iv)&nbsp;after the effective date of a Registration Statement, such Registration
Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such Registration Statement,
or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten
(10)&nbsp;consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days)
during any twelve (12)-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>,&rdquo; and for purposes of
clause (i), the date on which such Event occurs, and for purpose of clause (ii)&nbsp;the date on which such five (5)&nbsp;Trading Day
period is exceeded, and for purpose of clause (iii)&nbsp;the date which such ten (10)&nbsp;calendar day period is exceeded, and for purpose
of clause (iv)&nbsp;the date on which such ten (10)&nbsp;or fifteen (15) calendar day period, as applicable, is exceeded being referred
to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Holders may have hereunder or under applicable law,
on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by
such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages
and not as a penalty, equal to (1)&nbsp;the product of (A)&nbsp;2.0% multiplied by (B)&nbsp;the quotient of (I)&nbsp;the number of such
Holder&rsquo;s Registrable Securities that are not then covered by a Registration Statement that is then effective and available for use
by such Holder divided by (II)&nbsp;the total number of such Holder&rsquo;s Registrable Securities multiplied by (2)&nbsp;the aggregate
purchase price paid by such Holder pursuant to the Purchase Agreement; <U>provided</U>, <U>however</U>, that, in the event that none of
such Holder&rsquo;s Registrable Securities are then covered by a Registration Statement that is effective and available for use by such
Holder, the quotient of (I)&nbsp;divided by (II)&nbsp;in clause (1)(B)&nbsp;herein shall be deemed to equal 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
Form&nbsp;S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i)&nbsp;register
the resale of the Registrable Securities on another appropriate form and (ii)&nbsp;undertake to register the Registrable Securities on
Form&nbsp;S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement
then in effect until such time as a Registration Statement on Form&nbsp;S-3 covering the Registrable Securities has been declared effective
by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any
Underwriter without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Procedures</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Company&rsquo;s
registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Not
less than five (5)&nbsp;Trading Days prior to the filing of each Registration Statement and not less than one (1)&nbsp;Trading Day prior
to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i)&nbsp;furnish to each Holder copies of all such documents proposed to be
filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such
Holders, and (ii)&nbsp;cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries
as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the
meaning of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements
thereto to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company
is notified of such objection in writing no later than five (5)&nbsp;Trading Days after the Holders have been so furnished copies of a
Registration Statement or one (1)&nbsp;Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments
or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement
as <U>Annex A</U> (a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2)&nbsp;Trading Days
prior to the Filing Date or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft
materials in accordance with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(i)&nbsp;Prepare
and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used
in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities
for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for
resale under the Securities Act all of the Registrable Securities, (ii)&nbsp;cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule&nbsp;424, (iii)&nbsp;respond as promptly as reasonably possible to any comments received from the Commission with respect to a
Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies
of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information
contained therein which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv)&nbsp;comply
in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of
all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this
Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in
such Prospectus as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the
applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii)&nbsp;through (vi)&nbsp;hereof, be accompanied
by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible
(and, in the case of (i)(A)&nbsp;below, not less than one (1)&nbsp;Trading Day prior to such filing) and (if requested by any such Person)
confirm such notice in writing no later than one (1)&nbsp;Trading Day following the day (i)(A)&nbsp;when a Prospectus or any Prospectus
supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B)&nbsp;when the Commission notifies the
Company whether there will be a &ldquo;review&rdquo; of such Registration Statement and whenever the Commission comments in writing on
such Registration Statement, and (C)&nbsp;with respect to a Registration Statement or any post-effective amendment, when the same has
become effective, (ii)&nbsp;of any request by the Commission or any other federal or state governmental authority for amendments or supplements
to a Registration Statement or Prospectus or for additional information, (iii)&nbsp;of the issuance by the Commission or any other federal
or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the
Registrable Securities or the initiation of any Proceedings for that purpose, (iv)&nbsp;of the receipt by the Company of any notification
with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any
jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v)&nbsp;of the occurrence of any event or passage
of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made
in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any
material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration
Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading, and (vi)&nbsp;of the occurrence or existence of any pending corporate development with respect to the Company that the
Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow
continued availability of a Registration Statement or Prospectus; <U>provided</U>, <U>however</U>, that in no event shall any such notice
contain any information which would constitute material, non-public information regarding the Company or any of its Subsidiaries, and
the Company agrees that the Holders shall not have any duty of confidentiality to the Company or any of its Subsidiaries and shall not
have any duty to the Company or any of its Subsidiaries not to trade on the basis of such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Use
its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i)&nbsp;any order stopping or suspending the effectiveness
of a Registration Statement, or (ii)&nbsp;any suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject
to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by
each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any
amendment or supplement thereto, except after the giving of any notice pursuant to Section&nbsp;3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Prior
to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with
the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of such
Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States
as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the
Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of
the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
the occurrence of any event contemplated by Section&nbsp;3(d), as promptly as reasonably possible under the circumstances taking into
account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii)&nbsp;through (vi)&nbsp;of
Section&nbsp;3(d)&nbsp;above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then
the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be
resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section&nbsp;3(j)&nbsp;to suspend
the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant
to Section&nbsp;2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Otherwise
use commercially reasonable efforts to comply with all applicable rules&nbsp;and regulations of the Commission under the Securities Act
and the Exchange Act, including, without limitation, Rule&nbsp;172 under the Securities Act, file any final Prospectus, including any
supplement or amendment thereof, with the Commission pursuant to Rule&nbsp;424 under the Securities Act, promptly inform the Holders in
writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule&nbsp;172 and, as
a result thereof, the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take
such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall use its best efforts to maintain eligibility for use of Form&nbsp;S-3 (or any successor form thereto) for the registration
of the resale of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall (i)&nbsp;cause all the Registrable Securities to be listed on each securities exchange on which securities of the same class
or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules&nbsp;of
such exchange, or (ii)&nbsp;secure designation and quotation of all the Registrable Securities on the Trading Market (as defined in the
Purchase Agreement). The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall cooperate with the Holders to facilitate the timely preparation and delivery of the Registrable Securities (not bearing
any restrictive legend) either by DWAC, DRS, or in certificated form if DWAC or DRS is unavailable, to be offered pursuant to any registration
statement and enable such Registrable Securities to be in such denominations or amounts as the Investor may reasonably request and registered
in such names as such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially
owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the
shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable
Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s request, any liquidated
damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of
such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall take all other reasonable actions necessary to expedite and facilitate disposition by the Holders of Registrable Securities
pursuant to any registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">4.&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
Expenses</U>. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by
the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to
in the foregoing sentence shall include, without limitation, (i)&nbsp;all registration and filing fees (including, without limitation,
fees and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A)&nbsp;with respect to filings made
with the Commission, (B)&nbsp;with respect to filings required to be made with any Trading Market on which the Common Stock is then listed
for trading, and (C)&nbsp;in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing
(including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions
of the Registrable Securities), (ii)&nbsp;printing expenses (including, without limitation, expenses of printing certificates for Registrable
Securities), (iii)&nbsp;messenger, telephone and delivery expenses, (iv)&nbsp;fees and disbursements of counsel for the Company, (v)&nbsp;Securities
Act liability insurance, if the Company so desires such insurance, and (vi)&nbsp;fees and expenses of all other Persons retained by the
Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible
for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including,
without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any
annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange
as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to
the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">5.&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification
by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the
officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a
result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons
with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each
of them, each Person who controls any such Holder (within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the
Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally
equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person,
to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,
without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred, arising out
of or relating to (1)&nbsp;any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus
or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to
any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the
case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2)&nbsp;any
violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule&nbsp;or
regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the
extent, that (i)&nbsp;such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing
to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder&rsquo;s
proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly
for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto, or (ii)&nbsp;in the case of an occurrence
of an event of the type specified in Section&nbsp;3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable
Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for
use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section&nbsp;6(c). The Company shall notify the
Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated
by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in
accordance with Section&nbsp;6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification
by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents
and employees, each Person who controls the Company (within the meaning of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of
the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable
law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement
of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading (i)&nbsp;to the extent, but only to the extent, that such untrue statement or omission is contained in any information
so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii)&nbsp;to
the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in the Selling Stockholder
Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such
Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto. In no event shall the
liability of a selling Holder be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in
connection with any claim relating to this Section&nbsp;5 and the amount of any damages such Holder has otherwise been required to pay
by reason of such untrue statement or omission) received by such Holder upon the sale of the Registrable Securities included in the Registration
Statement giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Conduct
of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the
 &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including
the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection
with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party
of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a
court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially
and adversely prejudiced the Indemnifying Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">An Indemnified Party
shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1)&nbsp;the Indemnifying Party has agreed in writing
to pay such fees and expenses, (2)&nbsp;the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and
to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3)&nbsp;the named parties to any such
Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified
Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified
Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to
employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense
thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party).
The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent
shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Subject to the terms
of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred
in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid
to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that the
Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions
for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal
or further review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Contribution</U>.
If the indemnification under Section&nbsp;5(a)&nbsp;or 5(b)&nbsp;is unavailable to an Indemnified Party or insufficient to hold an Indemnified
Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party,
in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with
the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative
fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in
question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has
been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative
intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or
payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable
attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have
been indemnified for such fees or expenses if the indemnification provided for in this Section&nbsp;was available to such party in accordance
with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The parties hereto
agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;5(d)&nbsp;were determined by pro rata allocation
or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section&nbsp;5 and the amount of
any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The indemnity and
contribution agreements contained in this Section&nbsp;are in addition to any liability that the Indemnifying Parties may have to the
Indemnified Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">6.&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies</U>.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the
Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery
of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder agrees that
monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions
of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall
not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Except as set forth on <U>Schedule 6(b)</U>&nbsp;attached
hereto, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities
of the Company in any Registration Statements other than the Registrable Securities. The Company shall not file any other registration
statements until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission,
provided that this Section&nbsp;6(b)&nbsp;shall not prohibit the Company from filing amendments to registration statements filed prior
to the date of this Agreement so long as no new securities are registered on any such existing registration statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Discontinued
Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the
occurrence of any event of the kind described in Section&nbsp;3(d)(iii)&nbsp;through (vi), such Holder will forthwith discontinue disposition
of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;) by the
Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its
best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject
to the provisions of Section&nbsp;2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendments
and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the
Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes
any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or waiver
disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group
of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or
amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall
be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted
from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect
to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights
of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates;
<U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance
with the provisions of the first sentence of this Section&nbsp;6(d). No consideration shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the
parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth
in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the
parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder
without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective
rights hereunder in the manner and to the Persons as permitted under Section&nbsp;5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company
or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would
have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except
as set forth on <U>Schedule 6(i)</U>, neither the Company nor any of its Subsidiaries has previously entered into any agreement granting
any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Execution
and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file or any electronic signature complying with the U.S. federal ESIGN Act of 2000 (e.g., www.docusign.com),
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such &ldquo;.pdf&rdquo; signature page&nbsp;were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in
accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Cumulative
Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or
affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Independent
Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations
of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder
hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder
pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind
of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to
such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders
are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.
Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement,
and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of
a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or
decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by
any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder,
solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Pages&nbsp;Follow]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase"><FONT STYLE="font-size: 10pt">MULTISENSOR
    AI HOLDINGS,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: &nbsp;</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE OF HOLDER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[SIGNATURE
PAGE OF HOLDER TO REGISTRATION RIGHTS AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Holder: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Signature of Authorized Signatory of Holder</I>: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory: _________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title of Authorized Signatory: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>tm2529555d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MultiSensor AI Holdings,&nbsp;Inc. Announces
Pricing of $14 Million Private Placement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: #FEFEFE"><B>Houston, TX</B>,
October&nbsp;24, 2025 &ndash; MultiSensor AI Holdings,&nbsp;Inc. (NASDAQ: MSAI) (&ldquo;MSAI,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo;
or the &ldquo;Company&rdquo;), a pioneer in AI-powered industrial condition-based maintenance and process control solutions, today announced
that it has executed a securities purchase agreement to raise gross proceeds of approximately $14.0 million, before deducting placement
agent fees and offering expenses, in a private placement of common stock and warrants anchored by 325 Capital, LLC and including other
existing and new investors. The initial closing of the offering, representing gross proceeds of approximately $2.8 million, is expected
to close on October&nbsp;27, 2025, subject to satisfaction of customary closing conditions. The balance of the offering is expected to
close in December&nbsp;2025, subject to receipt of requisite stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">The Company intends to
use the net proceeds from the offering for working capital and other general corporate purposes, including driving strategic growth initiatives
and continuing to advance the development of the MSAI Connect platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&ldquo;The reaffirmed
commitment from our investors reinforces our strategic vision and validates the progress we continue to make,&rdquo; said Asim Akram,
Chief Executive Officer and President. &ldquo;We remain focused on disciplined execution, operational excellence, and delivering sustainable
long-term value for our shareholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Roth Capital Partners,
LLC is acting as the sole placement agent in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">The securities purchase
agreement provides for the private offer and sale of an aggregate of 34,229,826, shares of the Company&rsquo;s common stock and warrants
to purchase an aggregate of 68,459,652 shares of common stock or common stock equivalents at an offering price of $0.409 per share and
accompanying warrants. The warrants are not exercisable unless and until approved by the Company&rsquo;s stockholders and have a seven-year
term and an exercise price of $0.409 per share of common stock or common stock equivalent, subject to adjustment following a reverse stock
split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The common stock, along with the accompanying warrants, are being offered
and sold in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;),
pursuant to the exemption for transactions by an issuer not involving any public offering under Section&nbsp;4(a)(2)&nbsp;of the Securities
Act and Rule&nbsp;506 of Regulation D promulgated thereunder. Accordingly, the common stock, warrants and underlying shares of common
stock and common stock equivalents may not be offered or sold in the United States except pursuant to an effective registration statement
or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. The Company
has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the shares of common
stock issuable in the private placement as well as the shares of common stock and common stock equivalents issuable upon exercise of the
warrants issued in connection with the private placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release is not an offer to sell, or a solicitation of an
offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale
would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About MultiSensor AI Holdings,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">MultiSensor AI builds and deploys intelligent multi-sensing platforms
incorporating edge and cloud software solutions that leverage artificial intelligence. MSAI's integrated solutions utilize data generated
from an array of sensors and sensor modalities including high-resolution thermal imagers, visible and acoustic imagers, as well as vibration
and laser spectroscopy sensors, to protect customers' most critical assets. MSAI's platform combines condition-based monitoring data with
proprietary edge and cloud software to generate actionable insights that, we believe, minimize unplanned downtime, reduce maintenance
costs, prevent hazards, and extend asset life.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>About&nbsp;325 Capital,&nbsp;LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">325 Capital is a long-term, significant, minority owner of high-quality,
small, public companies. 325 Capital strives to constructively partner with management teams and boards that are committed to driving
long-term, fundamental value. As lead shareholders, 325 Capital supports its portfolio by working from deeply researched facts, acting
as discrete advisors or constructive board members, providing access to a network of relationships, and providing direct growth capital.
The team at 325 Capital has worked together for more than 20 years developing this approach, strategy, and process and values facts, transparency,
alignment, and partnership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MSAI Contact:<BR>
E-mail:&nbsp;<U>ir@multisensorai.com</U><BR>
Website:&nbsp;<U>www.multisensorai.com</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release contains &quot;forward-looking statements&quot;
within the meaning of Section&nbsp;27A of the Securities Act of 1933, Section&nbsp;21E of the Securities Exchange Act of 1934, and the
safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be
identified by words such as &quot;anticipate,&quot; &quot;believe,&quot; &quot;could,&quot; &quot;estimate,&quot; &quot;expect,&quot;
 &quot;intend,&quot; &quot;plan,&quot; &quot;will,&quot; &quot;would&quot; or their negatives or variations of these words, or similar
expressions. All statements contained in this press release that do not strictly relate to matters of historical fact should be considered
forward-looking statements, including, without limitation, statements regarding our ability to close the offering, the intended use of
proceeds of the offering, our planned expansion across the United States, management's expectations regarding its strategic priorities
and objectives, product development, future plans and business prospects. These forward-looking statements are subject to risks, uncertainties
and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect
to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in
the forward-looking statements as a result of a number of factors, including those identified in the &quot;Risk Factors&quot; section
of the Company's Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024, as such factors may be updated from time to
time in the Company's other filings with the SEC. Because forward-looking statements are inherently subject to risks and uncertainties,
you should not rely on these forward-looking statements as predictions of future events. Any forward-looking statement made in this press
release is based only on information currently available and speaks only as of the date on which it is made. Except as required by applicable
law, the Company expressly disclaims any obligation to publicly update any forward-looking statements, whether written or oral, that may
be made from time to time, whether as a result of new information, future developments or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>msai-20251024.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaiFubOdzZR+WYkxtmB+bQlaHy0uY0cfSyWWYeKG4UID -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:MSAI="http://infraredcameras.com/20251024" elementFormDefault="qualified" targetNamespace="http://infraredcameras.com/20251024">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://infraredcameras.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="msai-20251024_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="msai-20251024_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="msai-20251024_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="MSAI_CommonStock0.0001ParValuePerShareMember" name="CommonStock0.0001ParValuePerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MSAI_WarrantsToPurchaseCommonStockMember" name="WarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>msai-20251024_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="msai-20251024.xsd#Cover" roleURI="http://infraredcameras.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://infraredcameras.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="msai-20251024.xsd#MSAI_CommonStock0.0001ParValuePerShareMember" xlink:label="loc_MSAICommonStock0.0001ParValuePerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_MSAICommonStock0.0001ParValuePerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="msai-20251024.xsd#MSAI_WarrantsToPurchaseCommonStockMember" xlink:label="loc_MSAIWarrantsToPurchaseCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_MSAIWarrantsToPurchaseCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>msai-20251024_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="msai-20251024.xsd#MSAI_CommonStock0.0001ParValuePerShareMember" xlink:label="MSAI_CommonStock0.0001ParValuePerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MSAI_CommonStock0.0001ParValuePerShareMember" xlink:to="MSAI_CommonStock0.0001ParValuePerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MSAI_CommonStock0.0001ParValuePerShareMember_lbl" xml:lang="en-US">Common Stock 0. 0001 Par Value Per Share [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="msai-20251024.xsd#MSAI_WarrantsToPurchaseCommonStockMember" xlink:label="MSAI_WarrantsToPurchaseCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MSAI_WarrantsToPurchaseCommonStockMember" xlink:to="MSAI_WarrantsToPurchaseCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MSAI_WarrantsToPurchaseCommonStockMember_lbl" xml:lang="en-US">Warrants To Purchase Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US">Document Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>msai-20251024_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="msai-20251024.xsd#Cover" roleURI="http://infraredcameras.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://infraredcameras.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiDocumentInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="msai-20251024.xsd#MSAI_CommonStock0.0001ParValuePerShareMember" xlink:label="loc_MSAICommonStock0.0001ParValuePerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_MSAICommonStock0.0001ParValuePerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="msai-20251024.xsd#MSAI_WarrantsToPurchaseCommonStockMember" xlink:label="loc_MSAIWarrantsToPurchaseCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_MSAIWarrantsToPurchaseCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 24, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 24,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MultiSensor AI Holdings, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001863990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-3938682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2105 West Cardinal Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Beaumont<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">861-0788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=MSAI_CommonStock0.0001ParValuePerShareMember', window );">Common Stock 0. 0001 Par Value Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MSAI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=MSAI_WarrantsToPurchaseCommonStockMember', window );">Warrants To Purchase Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase common stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MSAIW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=MSAI_CommonStock0.0001ParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=MSAI_CommonStock0.0001ParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=MSAI_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=MSAI_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2529555d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infraredcameras.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>msai-20251024.xsd</File>
    <File>msai-20251024_def.xml</File>
    <File>msai-20251024_lab.xml</File>
    <File>msai-20251024_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2529555d1_8k.htm">tm2529555d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="49">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2529555d1_8k.htm": {
   "nsprefix": "MSAI",
   "nsuri": "http://infraredcameras.com/20251024",
   "dts": {
    "schema": {
     "local": [
      "msai-20251024.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "msai-20251024_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "msai-20251024_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "msai-20251024_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2529555d1_8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 49
   },
   "report": {
    "R1": {
     "role": "http://infraredcameras.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-10-24",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2529555d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-10-24",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2529555d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "auth_ref": []
    },
    "MSAI_CommonStock0.0001ParValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://infraredcameras.com/20251024",
     "localname": "CommonStock0.0001ParValuePerShareMember",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock 0. 0001 Par Value Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "MSAI_WarrantsToPurchaseCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://infraredcameras.com/20251024",
     "localname": "WarrantsToPurchaseCommonStockMember",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants To Purchase Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://infraredcameras.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001104659-25-104389-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-104389-xbrl.zip
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M'W5%#_43L$9W#Q0[+190N$+:_J%7"E-7_Z"_RZZ;'^8/[.@K_P-02P,$%
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M'&PN'L7LG$^3>E:VHO<)3\-V&S^E.%B$3(<]*9)A2,1Y(JGR4$@'0PVE:WH
MJR8WABPH8NS>0%:4'$F]?T@NTF4O1$J='T ,FW8\"E& <-2==:'!U3[!N(RS
M""?*RR7?UO8+C$7K&A#0K@E)0Q@4*) [$!85H)F1(5Z!^0_!K!\N%:4?6!I6
M[:B4L@!!,;UU82+T7B YWS)6<PV/.+#4%29=9C4GD"X(4#K,-9Y$4O(:*)Y&
MH(LTC_-GL;CA>FMY\L@N<<4&9$XS8>X/@@7 E,F DB&A0TKHI>7UKP1I+I:4
M@-4Q96X)L)NL4U#7!$2"U1A PUXK5_AX(>*<]TP,)]-T27:_DV>P7@V=6R8
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MTG!-42%%2NLC.U7-K*4ZQGY7 %AMZ::O[0RBT6V.&E_^6EM[ZO(O=M$=-T6
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MNM3+4+4 M!#/B!5%H*^B$"1+L;V_O+KIBG_BF_4F_M<"9X1O^0-02P,$%
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M.E]L7E]T_BHV#FNU<_@'$2/9[)*=2XUKG.IURA2OO2DN#ZU<]#L]HG>E>LV
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MV'OH/]8U?-'7F4TXXBS5%JBWCJ*TB7?V!]M(&TV.-09"6EH"!;#&;!<7?2_
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MHK)8"^4<E<@E3>O4SSF&DZZYQTEH3)9F77].XJJ==$$ZS=>/?WXK]?,_4M(
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M?-3?\N+]:Z:)5V.T&3KO"N!U !AZI539(S]2V1<18'X$1%S$UV JSV=+E[K
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MUG!0*)@Z+A[(0)@1K,$?\AS>4$:\YD.]B3CJIJ8"W%XS=;CI8Z79GK-Y,*4
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M 07-?DDIRRW;M@S:_ HLQ)J\[_BL?I!^K#DUG97O*S36$IG990T&QA7;LC!
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M>+,2QSNC\:RKRWV_C);N)V$(=1Z#5M)%5AH^R78F-GT:8[YG,$U H/9![AK
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M.>$D ]$CVB?B3V"7P"WOG!'3O.1.EM$,_95KUQ>*5,V\H(N;9%AN*E[7Y(I
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M0NN,L#*BV!F <V&D?2+L[$A%14ED:UK3&N^ 7F+7(?U_X:*_GY(]YVX!=B\
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MXA.2ZN<X'\? 'H&C%HMVB14GK#*KQ=],DY"*XAWHY:Y@ CN:L? =L8+D2_>
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M..\2N,3=)9 ^H6/JCBT^"AO:+K**1CE#<M85+^W)5K:]M;_-?\!QQ5>H:W
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MZ=2H+$ U(N\XFV=CD%9H@X"&7,'3<.'8*CRG?%^3D/J/;#8'X[Z!]UO'^I=
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M/#D82%)[!>H?# 5T;)H%O.2D02J/Q=-+MO-WWVG;^0%3J:#"!7'X#Z2I231
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ME])E[P5C! @_J^DV 1')W&[JRK2%F3)#CXUCXF79/4=;6R]@_NV7%3#_]FO
M_$\V T9W90;H=,*8)1#K-/Z9=L -2CHKG"NU].1.E72G8VQN?):2^-%Z^K"V
M$W&.W:IVG425ZY[JAFW9/H)^GZ=C]\AG56SN'W^CCAW1,7TU>\497TO-L'#U
M/6I%=%,,/UP5]:+%[K#*OWLK6@>G!7R:VA'!T8YJ'1Z9XCH'W]U/4SH2JW/X
M^_$)&@=/PQ_F/T7A^"@WVOX=2867O/M2U7B/J?5)[O,[<JJ]K2B.['5^'K9A
MX@87 D2B*=FS-ON6F!<#_^&>;]'>QVU0<2<;%#0OXP:SVCI6^W*;%L1](.@M
M4S3;W"CS"T0TG1>5V)OF1!^"N -MCL))%$H2!1&=O]A\THB,NEGV(T8/CNZW
M1?@,L5SG-MN\:$";J+E0L:C:KEF8!NVUR1]A:7@@^)_RB. A!5^[SCK<;[ZB
MX/2$:J^XU3QV0L8&P--B3+G\.<$(CRG^K;3+ODLQ%7@FXF(28.3ZLVG@!\-<
M@=0H&R38Y6"%C\F[<ULKHZL<!WQK@:/**YN[!%L1I_;R] Q,\/K](R!)PY4W
M7K6EHY?4@\JR+'37T+HXNF^F[<+\*FD@O!7^$ _M5EQ][J7(;/N8U6?J%HVA
M\%BOMD7N\8ZMY]+Z[LMR:7WWU:7UE[&#S^8&H9JG#'.5_FV[8@>*M(WZA+WG
M*'2DA2L)1S-RF7=P)-'W(=E<@1YY6>13K#2CB#:\_NT49">K^/1=(M6[P%+D
MJWO,,SYI6V]+]:$-#0MVJ%3BH1'LLRE&I%H-9[G*ZGEPEO[=^,W7M_17>N16
M&?O:12"!=.V.3(-49?9X?74'W*H[X&'KX+=,U*Z63"'OE Y88[%0_&CIYVJ8
M6X#IH_B]!3<Q&G_H$']P&_15?O[99N6GB$__B#\X"3K^TR3H4!CNJZ?\3Q>-
M]][G&(U.WZ&K,0D\C5P@.B#<[L#%>,-R-C>^NACO/.#Q9SL<(^?[!I_C Q3I
MMQD_&6$'ATE]725W$[NZQ[+_H[(*'M^%+''%.>B<,RDA7],+UO[/.>JF]:B4
MUET]%%$G;R)0,Z01#:3BFA1P7__"[+0@J\_J4*@6V*2>44ZX87GW5;-:U\+(
ML%MJ-J9*8Y33,VDI;#+K6RSI3@W987+(Y)M\#E^;#";"&9+*3:R PNU"(<(6
M,J@49DP"S9'WF.&Q])VM]9C7ROB;8OIX4"!OD33\J>&)4G.3IU2B&X)Q9%R_
M;5+W%E6),#N9%&.+M3_F2GZ3X%<8&(0Q)>%=YDNGZ3!1N_QSB$I&R:=3E2=O
M 0BV[[%.M5X0\/LO*PCX_=<@X,-1V!% 78G+-$A+51AM<&<#CX%%!1<LYKP1
M&-:L2]9Q_'LLU";6QWFHBE".L$6P?=E7=?XF.6H+A#$3V-]!8Z_?G.IL$^@?
M?+OR.XJ&D6*J:@(C.JH2_7>JI@9AL.2KFOH?I*;BH[^:5QQ,X&*#CG=$+9BX
M.Z:O;%TC#L\LFW"K)@?K%N?''Z.H&HO*:JF)KZ120ZB_4$OU:0JS^42BWJS
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MQ['U0MZM9TVR,5 ]P0PIF69%O)H^NM_:!$112CMF#QRFHTC6'^7W1?(#4TF
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M^R[G%/:CF"]*K=$Z$>!7U4Q#14):$5,XI;,)_52W*:G]T<BMEL$8WP495Q
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MH$%ZK+4Z&#+I7OJ,RJ10$"SY^+*JR_IBR25[^+8%6F7<5@OKS?/NNJ:.\9?
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M9!"N"<\YJ-(,P4@1-0Y;3IEV$Y680KG% %0M>7-LF5QS/K.TV9!4#.3Y-GI
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ME(Q ?H;L$54&$IQ(L]AH_S;]3F!_P4L?'/N[FVQ=8G^Z&)1.@PD>S3"_E2M
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M_I/][MW#U976"& X6\=@.1V?+=#O4)&R6,?K-[B_,2,YYI:MP:  V-H6-\A
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M>:3UE0]=V[P#!:^W]90PO%41L 3K)^!&#"IL'[\4JIL6I""*7\5O(K+(LSQ
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M; X96 6BV/*^JZ)9YW&>2[M-94^M0OC1#<7W/<"[77TKFCI0BIW78749U+#
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M*7Y>7A]431VX M:>KC^Y*5!S881,SWFM[JL'\H1$)>U)3+)4?0@W0;U&!GH
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MJ$@^^QC,ZAK$),6 F4RIHYJ?GIT>,720U.-XFHD'SFY&]/2R-L__Q2Y\S9T
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M%*F[,W ;,WM,=,LP(/:%)L(" W6J.?%:%PUIY@7X'UG Y'4,ID@U"S%$V/K
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M,"],D7JCQV)H/ET>:=C)U*VZ*R#6TEB8PBAN\7]:"Q#K!2W(P""$+/I9W)O
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M<6.NL,2- 0U08L7<J!HE,]D -S@^'2"S[B+O,]P=:O7=KI.):Q'--3<)JL%
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MEN/;G:.]7W'YO3O]^>#-_P=02P,$%     @  H)>6U@FC,M'0   35P! !8
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MGMK0"_NVLTIP*L6JLU-Z_8BW,@LX%UBDY_#=N!7/MBL:19(,#T"*V=P8N#E
M(R!)D,Q6=@1V_)#^L0!IP,XU6@R]T\]H2,+MI'9OMII$H()4,'C?T%YU>/#H
M$9TJC!(,HV[.W"R*-1 $,/T41\6C@X. O7>,[+S(FC5'_!)@+^7]8G6?'H#G
MX-(0NZD8-F%_ J\O\5PWS1P8<:A$*54EF"E22L!+DNBB1"4+KM\&+##X;6;@
MGZ6+\O'VQL@N82H5WK4E+(04"YX/;(W9U+2=0E4GP)HJ8"Q@G>$$[?5)Z%5P
MMN+*4_R?;FQ[V^CE71[4%2PQXJ,\;P/^\7%QEN2GQN&8Z(10/_-\B=X@7[9'
MOH#5*7Z7R+]PY)B_A.GFXD(\,YE5\*:3@Q7<[E1DK^(9))I+X#4@<.;9I1/+
M@:K)#]+$:+\(9($O6A1-7IG,[J\\>O<5GI:+O.LX0/(8T/;'<1)C40*G(@G]
M>4UA.ND?C%%Y9KW)K*(Z&'B(>N(.7HL&0XJ!=.BVGK7U;:55\]5KJ>=.Y UL
M":ER_FU*>2_-?;IN8UH\B#S#^.O*2J%8., -*/=7K.46T_YV[OG]9]';#7'U
MI_A>H8IGT7\G68-?_^6\]VJM=I7/HI/+#;SZ (1MNG@6O0%ZXIUX4^#Z]@-_
MN_T5?G.;8P&WC^(^E]MZ-\B#QST>H>#[<2])&R[>T@1)"K(2YMXIX5OE.4F1
M[( E6=</F'<J9,>B'+F#& NE>Q6I5:=-QKP"652R0ETF61:;_NF"TD>.P&8.
MG"5'_W-V*8KQFK#OJ(PRO)F8(@&@W )N,1/ZXTAB_]$X2>P_^D827P-)')N,
MD27D*I" ^_]IP#R!7<L34+4^R^/^\$Y[W#4PI.<Z>>,=?;MDSP'1)><)4#-:
M.\Y&0X@#Z%BG%F/BC0Q+OD"TJY6[$![0*>HPZXIT*W['L[,NYNFD_0[V!3F;
MMGMS;_%I;7=&^W1(^]ND=. 1@IVW"D.:MSQ3XY-H%JV?&TAQ>9L3G&=3I@7Y
M%LC(47#SN,?!!OQ^@Z8W)36EXBQIT_N@NXN"'Q9Q)MX6=,)E&3F\1L(F+O4$
M/7SDZV0;A&(IY.N\TNE$+AX*2DK@ABT>RJBC2:.]F.9-T8 E-T\J!)+U^FQ
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MA0L)PM&#F?D5ZU)=Z[,G^GR+F?BGW;/5ET%^ &6@-^+4*A9H5I>H!ON&(RQ
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M="(\?)] >%/ "$1V8O$HXCY&-\4C"A+D^5@'P0/ W<#R=OO !GIF [QZAC;
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M2VU.7OS=RFQ,67&=)",E(E]3!U(IO*U^+U0FC24<::X%7HZ"V_7R'3-&ESA
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M,N7@(7:FJEQ-,T!>8B83:P!6$99: 8P"?HFS$?T9$E],"CSZ=YB>4I6&Q!2
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M=GNT5D2'O@FKIC^T=EOGA,.O1=<V%)+'5YL:/) E04ZN0BNTC5EZ]6U(2<?
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M,M+T,SD7W2%.-_C;BV,S-H4)@-MJ?L$4"MAZ-QQ,[ 7LSYR%'ZS?;%H"/9L
MU'G%A/>/GRXF_7%O,!Z.>#&=OO@PO,!]CML,F?Z@J]J"XL3P9W)N+;QFL7"^
M,LC""_!_([WM6]\IC:P ]^HON?'J'OO^Q^V>>WWXEU^YOGO$P]FZT*+V5E!O
M9)?WMBZ&S\OD):]AA.<P%0/'BX)P7;G&.I#>G6 VOG#_QV$ NLF;PBYY&7I=
M#WH *J%QC]N=8+'%FTJ=MGOERQF(M!"L,_(Z,)/F5: F-L8N=JD3WX4*7A)G
M/=V5VO] VIJZ=>@6J3>F?ZYB25J2=L@_=0WOAS\TO*>DX550[:?3WO]\Z)_U
M)\JJ1%/U<5-F]5Y:$U(K>Y9::2[%$T1H@AH]D0MX4QAT[ZGM'C#9'0X^]T;C
M_G @!L-)O]N[5RS63OMN.'J8B3#XUAOU>V/1$;S721]U\LM1[UUO-.JAS!UV
M__[4Z-?(*0QT4@H*7?O"#5L=W4.EE8OV,F$7DTKM&\1+P9E;[C(O#'[[R2C=
MHP<S?<0FL6,9)A@)[_-%F7XX3[2E$+H'E9= &INN?.F?NAW>AYFO(VP(MZZX
M7.Y?]G\;<ZVI,LA Q^6X2J(B.4ZLRD3_?'AP>'AXA.DNN@ZVP@9M%79B1:Q+
M .(\)CM'E(/*U$)%EX1EZ0JWJ! ;JOFMIF=J,$H\T.DIE!M<51!E$9V&NTIA
M2=3&ZRZQJ[B]HNJ**,HMH!OZ9FW[AAI.!$SS=$\^=_O^(^I[!F"B:_4J=X&E
M]C*[>!'[TLRSL;=.KM(9KYF/O3!/ERM'N9,#(Y$\'M9%5^A[S9R5.BV[X)S'
M.\#P?,#.J+61RC^C7A*;B. 1^S%?V+=N8BUUP8KX5^U_3V1/?<H/(3Q4&TA;
M_&DV!IV//3%\1_Z4WFB'C;$?T&7U3;X;<K;<J[OD5E/\,;IX+F,_1*?"0E:O
M_9$ME'T#NUAII5/C<6V^XWDQU^4HD;(+0&SKS;M_>-W_S,:S\T1].V864/'Z
MI>O28YE7A3#?716$J:HZCI+JO*="G4-BW$$+F(;NBUXY,:A24BLYJ$@^XFL3
M:F U[K\?=":?1CWQ_E-GU!E,>F"8G?W\]#8R^0"R<_CQ\M.D,T&;&B3VX-/'
ML]X(_P4_?(3OQA\Z([!')\-FXZPG1KUNK_\9MML?BW%O(L RGGP0\-AEYWU/
M'.-[/&C!3G_4*MTV3L ?WXHAY0TD;W!<E2+[,)[!LK.@Q,#SOK_#BCEUV L.
M.NZ-@9AS[^G-OA63]1+&[<3.U'??LN@F@( 1 AL^ROD$]5OX2^9]JKB5_O?E
MS'QTBNG]!D\S$CJN1#J9Y=[&V&FE&^R>@WBBTABKTFKN%4(JZ39"%>HWA4*]
M25H"Q3TIM0^S+X!QJV",[]6"^C=>YX ]0TI!*BUS%Y'"AW+*?SK=6H,09[UF
M0VL0[,-^!GZ!,CTML6@TG+/H>F7)>OIBFA?T)45 _7[PNO1$(&=IQ?M5ZH%>
M@A&63(KWES! 952\\\U>1W,3R>W>BV^#&R5M/A.P;LF;[P"Z)[7];Z0J?8.?
MSR'1H_;AX>$W4MJNB*D&<KOAR96>9X+ CL+2@YK[DVSGP1XKXT\Z+^;%Z65
M;;#Y>C KS,-*IMT-K97L&14P#Q8JI\<0R"S"OM=4ZD:MK.&51^Q#V,Y._JME
M)U]@/\$G:R%_DVU\?$^V\<,9JB_/AN<_XQ%\^6'R\>+T_P%02P,$%     @
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MYV6,O X LF0)8RO5S\'[^6(VXM>=!\< IC*M4J$'9S6\&9<3P+P:1!=B6B>
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M=52RR?GQDWG=L#K_@)^-@,HGI?YL-P,$BA[#BJHB2R>PJG6.SY>/8,[ ]"-
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M&IS$2&+_\KB_L[,3H,)^LH*FL<:84^MPD?8 HHU#2'I]7,P.J?NVC0@C9_
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M;#1[C<KB@R<7;%%I A"LT*LJ?D@Z";U$0XY[*I7-L\7RL'B_IFDYLPQ\NFY
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MW3<TG!$:ODDH0L26K2[E(]U'KT&'%>&E>K!YJI0WW0^36]<:\@I20U^+*Y(
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MZ=>-;OCJD-\2X^!)F>9U[RMLS/[PYD/^66 9<"?YU3CY'X2'_T$HIW[[2G+
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M^DQ\BKX\CW%(K!^0-(-&2"FHR:(<5!(X*$EB)^^DM-DX_CTN"F 6^%NADR3
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M)$0_L+HSG9\A_N>P!?B2^LGQQ+)AX<$F5I[7A#?8M? :*:'$2N@MLGGH*]!
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MDX*!E!Z$1@91&+$.TX2F5N!*Z*,09PJSV[9XJ=KH2<P2%H:3]CV]OB(9&PV
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MY$^;MY@XRM*TM[=B0T=H0A+;, D4U(__QI4\477Z>+)[7\MHA&'9U/C?&<D
MDO!2Y$_"R]O'>[X6\WD[SPRNL29V06!&=QQ6'0^FV4*9K"IR;E/0@Z%+$XQ7
MU*+Q*..>U(U&NTTQY>#W'36J/UICDLU(TC0C38+LCM(.IMDZ$;2)M[:.4QJ<
M","I^>1R>Q"3YUB#"\TAJ>[C?N\@',,WB.?NJ/U'O8,.6L6LI944*#C5>2ZG
M%+VAIM-Q+.  <6K24#ACB(Z-19/9OV(R55$1XD15(\O]]1&MCU%P\B#8<#3[
MO%G;)8S"X9[KXLV#%9R05-<:+Q)\H )K+23W(N($$A&CZUF7+D@&*;5&F"WL
M8SDD,-NT_G'KO;9/K^6U'73?#+K#;G_4H;230+WO# :=_JC7A7]W^L?J%-.I
MU-'INVX?OAZJTY?JG]T/ZM7IR7%W<%M]NVW,4L!53"N_M#G2+-Q-2'P=P/\V
MZ58_OL>[EKO#UJD-Z6\&S7 ,']K08L>R[6G# =EW62MEX9?/:"LPP.O)0>4[
MVUNCM2VDL"QUB'2I_L:Z'E",PI<X%5!@,;187'P<VI\39V3]D-W)&*=,42Y-
MU%A,8!PD<-E 23@/6JEB$//*D%= -.8X75;@J4!(W>L U)LL3(P[ZQM2?(=F
M<(/UL^_O>*JA0B'K^SDH,C%5;:$M"82Z'::.LMYJ&>ORV%&-JHE4[&*L=:HF
M%8CDFAXOUJ!>RDVG<BZ@>50SX^R?5,X[;Z,ZC8*YWK(TVJ:%JSP;$'-$8"MX
M.%9%RL:P.S:0UM=2VW2FNBMB38J2MJ8B>5S8J6V#/KPHMG&8?LRK>1DM LRM
M*++D M-JER-A9VB4P))4,^8XXD@.+TF5$C^L<;?P4MDH5IG*3,)Q(]B&&-HJ
M_MM 4]:-&W!TL(L]H X(R)(L XZM"^,D'&/\"&V"H#T1ZH=8+P.7!-/8_JA2
MD\*<Q'KJ4I20!$N:?XZ!KIL-C/LVGIJG?RVGS-,[I\RM<BR/$)BV;#9P/)9R
M#]RQ;F0PK8J$1^/6LCNT5!/T-3/*2P((HU,,TAQ0K!=K#";&"8S7E-@P^ZJK
MA TVA;3#S@3X8:*G(?XBCWHXM(W3)\77+[S" 81UO#U47)A#\F2YG $UYD<&
M6=4*I)4NN<8')5R9C#Z9+N>S<<T..LT!0>N.(?+Z A<&)OE'-3FSZ8JU( WD
M[;68C;HK7)ZO":W&"*T8FLK#'"\MNQ'XB7?\^Q38.FJ)+H#/O.%O$T76V5@T
M+]@0-]WM50-"8,\_38S#Z:BP$HI,)X(+&^%^E\?P&1J>#UJ=:\29.",I]DXE
M99<;%3TP.OK*@(JEZ-UQ3BX@K"FH1<J+@H59/$ R2#8!*OD%%U2"'BZRI(+O
M\Q@#^&-&DD(Y!U$2QJ#1%!6'I3"FC.=6?D<G%)P#PL98;7 )\E%6Y26;92A*
MZ+LSL'[S%,D&>0@YTA:F=IAC2+@:.CV3F#Y2"T65D:!1*>#T1R:$7,N'EB!(
M"25<9H$U;H ]G6D?[+^.,NLKI":QP8L"7>&MJ6O!EBL<9F$^H1"98PGD*0)A
MJ(*[3N-)A76)%J"$EY:9TGO*?\TPC)FFR-GR5IEB>N,'U3N-JPH2E.%'[1T4
MG\W.S$_UPD#8@B!!G$4>4H2T@,-P /-*,&:P6K ;+@O"8>.P9&%BX.Q"CAO^
M=ADN7,82@],<6<CA8\0,R,2A?Y&+:LKN1!;V,$(,>I1@P@D5[,,/?B0](0@B
M$=H0!%] K!SR-Y8<MQZW_?E:N.W1:?]E[[C;'_4Z)[W1A]L*Q#H/L"BQ9-?[
M2AK5RO"Y=H658B3% D.N!2C\W.P5VR_[0^<5G(T(7;)Q$24@<\W[+AN#LB6*
M*(_'Z_(EC%?*B'#.DD4_,15$#8VIS[$_9 T0T\$2H+E46UCVYK248'551E<O
M@8D)2%WM0=C+6.+BZ\[$U"G"R"N\S$+T-R<Q-%B8R5&Z!JFO+EJ:5[ AVW5!
MH ?EBUC0@I_$3"A0^J/VJB+K%J&N(= >_>D29+E9 9M%P#YN](LV W::NIH#
MH=![/]8UHA6MBI89)%,B$+.SE9A_B](QSQ(L^%80X(V8=#\L)N&_)-/E=9A_
MU*Q:LJ;E!R0P[<NJ$1),MI8AMX]:4$E)5$(S=(KH-JE@.#6T)YI%W4D.3"Y,
M?B=UX>]D/0AYC@55^(3>B83/%PG/KB427O>&./=.OWOZ]B[K\MHALOW,KQ71
MD]@?\D:CAYVB_)V6MRK>W]82()\4!@\):W?U:Q>B@_H:J)^^G*.>&*$8X+-6
MRVS.EL,L7-&?6V(/;,8U(UL\PKJP5!YSX<J$Y'(_Q8[J(MC%OZZ-42F]&INH
M)I#-FB8+%S_U)T5G)1C4!+Q0N5KBU+'VTT$;>7L/2++<IGJTWP-[)5(H\1H6
MVG10EM@ZQ&\8+H6#6_AN'X1?JE2$7;$4&C/67B2V5\VEQ@W(JG/>.KZXA,.6
M(PT?T UD(A8OS^$W+B!!T3;6F^=%&-(SA< /TS JP"I,2'W2H%0F')<CD8=6
MW9*JLH&+$J1 PJH K@8ZV"1<<(D<]OOBQWH9171R.Z^C&15J<'-$FJ@R'(<
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M4[ >:6%P /0PTFDC9<OPEN:I-8XLVEX3O])TN)'3--<HBSCJYYSO,:;=LW5
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MK^6/?7;GC_U.:NT?&U9K.Q-S%_'VUK'1.UD[72J*+Q:6;Z2P!+!M>*HK&+W
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M!-M,H3[H4"$4(VQ#.0/HJ"5W:;$SDFL_&TD:@T'ZL?Y7"1V*F5LJ TK>;6E
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M0Q:%3D'F,J1<.K "PI@'C0^_C1QI04/$Z'/J,G)Z^O*A@T5/:.9S5$=S(:E
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M#2V?1]-7U/\%4$L! A0#%     @  H)>6\E"&JW+ P  V0X  !$
M     ( !     &US86DM,C R-3$P,C0N>'-D4$L! A0#%     @  H)>6QU/
M4('["   W&D  !4              ( !^@,  &US86DM,C R-3$P,C1?9&5F
M+GAM;%!+ 0(4 Q0    (  *"7EO!M,CC[@L   V0   5              "
M 2@-  !M<V%I+3(P,C4Q,#(T7VQA8BYX;6Q02P$"% ,4    "  "@EY;L\GP
MPE8(  !V9   %0              @ %)&0  ;7-A:2TR,#(U,3 R-%]P<F4N
M>&UL4$L! A0#%     @  H)>6U\EG"Z2*   <_   !(              ( !
MTB$  '1M,C4R.34U-60Q7SAK+FAT;5!+ 0(4 Q0    (  *"7EN&[WP%#S8
M +L7 0 5              "  91*  !T;3(U,CDU-35D,5]E>#$M,2YH=&U0
M2P$"% ,4    "  "@EY;X9)0=J6R  "JS0, %@              @ '6@
M=&TR-3(Y-34U9#%?97@Q,"TQ+FAT;5!+ 0(4 Q0    (  *"7EM8)HS+1T
M $U< 0 6              "  :\S 0!T;3(U,CDU-35D,5]E>#$P+3(N:'1M
M4$L! A0#%     @  H)>6XCX :MW)   /<L  !4              ( !*G0!
M '1M,C4R.34U-60Q7V5X,RTQ+FAT;5!+ 0(4 Q0    (  *"7EL]GF1I54<
M ,=E 0 5              "  =28 0!T;3(U,CDU-35D,5]E>#0M,2YH=&U0
M2P$"% ,4    "  "@EY;\3]7 /HF  "_U@  %0              @ %<X $
M=&TR-3(Y-34U9#%?97@Y+3$N:'1M4$L! A0#%     @  H)>6U?,?\@E#@
M3"T  !8              ( !B0<" '1M,C4R.34U-60Q7V5X.3DM,2YH=&U0
52P4&      P #  @ P  XA4"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>tm2529555d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:MSAI="http://infraredcameras.com/20251024"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="msai-20251024.xsd" xlink:type="simple"/>
    <context id="AsOf2025-10-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001863990</identifier>
        </entity>
        <period>
            <startDate>2025-10-24</startDate>
            <endDate>2025-10-24</endDate>
        </period>
    </context>
    <context id="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001863990</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">MSAI:CommonStock0.0001ParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-24</startDate>
            <endDate>2025-10-24</endDate>
        </period>
    </context>
    <context id="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001863990</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">MSAI:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-24</startDate>
            <endDate>2025-10-24</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-10-24" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2025-10-24" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-10-24" id="Fact000005">0001863990</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-10-24" id="Fact000011">8-K</dei:DocumentType>
    <dei:DocumentType contextRef="AsOf2025-10-24" id="Fact000012">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-10-24" id="Fact000013">2025-10-24</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-10-24" id="Fact000014">2025-10-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-10-24" id="Fact000015">MultiSensor AI Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityRegistrantName contextRef="AsOf2025-10-24" id="Fact000016">MultiSensor AI Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-10-24" id="Fact000017">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-10-24" id="Fact000018">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-10-24" id="Fact000019">001-40916</dei:EntityFileNumber>
    <dei:EntityFileNumber contextRef="AsOf2025-10-24" id="Fact000020">001-40916</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-10-24" id="Fact000021">86-3938682</dei:EntityTaxIdentificationNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-10-24" id="Fact000022">86-3938682</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-10-24" id="Fact000023">2105 West Cardinal Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-10-24" id="Fact000024">2105 West Cardinal Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-10-24" id="Fact000025">Beaumont</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-10-24" id="Fact000026">Beaumont</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-10-24" id="Fact000027">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-10-24" id="Fact000028">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-10-24" id="Fact000029">77705</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-10-24" id="Fact000030">77705</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-10-24" id="Fact000031">866</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-10-24" id="Fact000032">861-0788</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-10-24" id="Fact000033">false</dei:WrittenCommunications>
    <dei:WrittenCommunications contextRef="AsOf2025-10-24" id="Fact000034">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-10-24" id="Fact000035">true</dei:SolicitingMaterial>
    <dei:SolicitingMaterial contextRef="AsOf2025-10-24" id="Fact000036">true</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-10-24" id="Fact000037">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-10-24" id="Fact000038">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-10-24" id="Fact000039">false</dei:PreCommencementIssuerTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-10-24" id="Fact000040">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember"
      id="Fact000041">Common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember"
      id="Fact000042">Common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember"
      id="Fact000043">MSAI</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember"
      id="Fact000044">MSAI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember"
      id="Fact000045">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="From2025-10-242025-10-24_custom_CommonStock0.0001ParValuePerShareMember"
      id="Fact000046">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember"
      id="Fact000047">Warrants to purchase common stock</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember"
      id="Fact000048">Warrants to purchase common stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember"
      id="Fact000049">MSAIW</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember"
      id="Fact000050">MSAIW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember"
      id="Fact000051">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="From2025-10-242025-10-24_custom_WarrantsToPurchaseCommonStockMember"
      id="Fact000052">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-10-24" id="Fact000053">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-10-24" id="Fact000054">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-10-24" id="Fact000055">false</dei:EntityExTransitionPeriod>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-10-24" id="Fact000056">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
